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Abstract
Hypoxic-ischaemic (HI) encephalopathy is a common cause of brain injury in
neonates. The physiological processes occurring in the brain during asphyxia and
in recovery are complex, and many aspects are not well understood. Piglets are
often used as experimental models when investigating HI and testing new treat-
ments.
This thesis focuses on the development and application of a mathematical
model of blood flow and energy metabolism in the piglet brain during oxygen de-
privation. The model consists of differential and algebraic equations which aim to
describe the relevant cerebral physiology. The multiscale nature of the model, and
its level of simplification, arise from its aim of helping to interpret experimental
non-invasive measurements from near-infrared spectroscopy (NIRS) and magnetic
resonance spectroscopy (MRS).
NIRS uses light to determine concentration changes of oxy and deoxyhaemo-
globin in tissue. It can also detect changes in the oxidation of cytochrome-c-
oxidase (CCO), an important marker of aerobic metabolism. This complements
the information gained from MRS, which can measure the concentrations of key
metabolites in tissue such as ATP, phosphocreatine and lactate. Multimodal mon-
itoring with NIRS and MRS simultaneously gives a more complete picture of the
metabolic state of the brain.
The model has been compared with extensive multimodal data from piglets:
both averaged, from brief anoxia studies, and individual datasets, from HI studies.
Morris sensitivity analysis was implemented in order to systematically investigate
the effects of altering all parameters. Optimisation of important parameters was
also implemented. Simulations of anoxia lead to the suggestion that autoregulation
in the newborn piglets was impaired. The consequences of cell death in the brain
caused by HI were also investigated with simulations. The model is a novel tool
which can be used to help test physiological hypotheses of clinical importance and
increase understanding of the mechanisms of HI.
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Chapter 1
Introduction
1.1 Motivation
Most of the work described in this thesis is concerned with hypoxia ischaemia (HI)
in neonates. HI caused by birth asphyxia is a major cause of perinatal brain injury.
In developed countries, its incidence is 1 to 2 per 1000 live births, and asphyxia is
estimated to account for 23 % of worldwide neonatal deaths [1]. HI leads to long term
problems in up to 25 % of survivors [2]. These include conditions such as cerebral
palsy, epilepsy and mental retardation [3].
It is believed that much of the damage to the brain caused by HI occurs as a result
of metabolic disruptions during the recovery period. This is known as secondary, or
delayed energy failure. Measurements of brain function often return to normal after a
hypoxic-ischaemic episode but show an impairment again after several hours [4]. The
severity of secondary energy failure has been shown to be correlated with outcome [5].
Treatment given during the crucial hours before this has the potential to reduce the
severity of damage and improve outcome.
A number of therapies have been investigated, one of the most promising and widely
used being hypothermia. Hypothermia has been shown to be beneficial [6, 7]; and its
benefit may be increased if it is used together with neuroprotective drugs. It is thought
hypothermia may increase the window during which such drugs can have an effect.
Drugs used include erythropoietin, melatonin, magnesium sulphate and xenon [8].
Some of the difficulties in the treatment of HI include identifying which individuals are
at risk of long-term damage and could therefore benefit from treatment, and monitoring
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progress during treatment. Magnetic resonance spectroscopy (MRS) has been used to
predict outcome in infants [9, 10] but cannot be used for continuous monitoring for
practical reasons. Both near-infrared spectroscopy (NIRS) and electroencephalography
(EEG) have also been used to follow the progress of asphyxiated infants [11]. NIRS can
measure brain oxygenation and metabolism (see Section 1.3.1) and can be used safely
for extended periods.
Mathematical modelling could help to bring together measurements from these differ-
ent modalities, giving a fuller picture of the state of the brain. It could also be used to
predict quantities that cannot be measured. Ultimately, the aim is to develop a model of
the human neonatal brain which can be used clinically. The process of developing the
model and its predictions may also help increase understanding the physiological pro-
cesses involved in birth asphyxia and subsequent cellular damage. A successful model
could also be used to suggest new treatments or predict their effects by simulation.
As a first step towards this goal, a mathematical model of the neonatal piglet brain,
which is often used as a model of the neonatal human brain, has been developed. This
model, which will be referred to as BrainPiglet, is the first of this kind which has been
used to investigate HI in piglets. The model has been used to simulate oxygen chal-
lenges in the piglet brain and has been compared with both individual and averaged
measured data. The experimental data with which the model is compared is drawn
from NIRS and MRS. The BrainPiglet model is the first physiological model to com-
bine measurements from these two modalities. It has been used to help investigate
associations between their measurements, and has also been used to help generate hy-
potheses concerning the vascular and chemical process occurring in HI.
The BrainPiglet model was created by adapting and extending a model of the adult
brain (BrainSignals [12]). Before beginning the development of BrainPiglet, this model
was used to investigate a hypercapnia challenge in healthy adult brain. This work is of
interest in its own right (see Section 4.1) but also serves as an introduction to the NIRS
measurements and the use of the model to interpret them.
1.1.1 Aims
The aims of this thesis are:
• To use the BrainSignals model to simulate NIRS signals during hypercapnia.
• To extend and adapt the BrainSignals model to simulate circulation and
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metabolism in the brain of a neonatal piglet.
• To use this model to simulate NIRS and MRS signals during anoxia and HI in
piglets.
• To use the simulations to help generate and evaluate physiological hypotheses,
and to understand NIRS and MRS measurements.
1.2 Physiology
The brain makes up only about 2 % of human body weight, but is responsible for about
20 % of the body’s oxygen consumption and 25 % of glucose consumption. It also
receives about 15 % of resting cardiac output [13]. This results in a cerebral blood flow
(CBF) of around 50 ml min−1 100 gbrain−1.
Brain tissue is made up of neurons, blood vessels and glial cells. Neurons are the cells
that carry the nerve impulses. An average human brain contains an estimated 100 billion
of them, each with approximately 10 000 connections to other neurons [14]. A neuron
is made up of a cell body and an axon. The brain is separated into grey matter, which
contains mostly cell bodies, and white matter, which contains mostly axons. There are
at least as many glial cells in the brain as neurons. They support the neurons structurally,
supply nutrients and oxygen, help to insulate neurons and to destroy dead neurons.
The brain is surrounded by three membranes, or meninges, which protect the brain,
called the pia mater, arachnoid mater and dura mater. Between the arachnoid mater and
the pia mater is the subarachnoid space. This is filled with cerebrospinal fluid (CSF),
a fluid similar in composition to blood plasma. It is also found in the ventricles of the
brain. Its functions are to protect the brain mechanically, to clear metabolic waste and
provide nutrients, and to help regulate intracranial pressure.
The basic structure of the brain is shown in Figure 1.1. It is divided into three main
parts, the cerebrum, the cerebellum and the brain stem. The brain stem controls basic
functions such as breathing and blood pressure. The cerebellum controls balance and
coordination. The cerebrum controls higher level thinking. It is the largest part of the
brain and is divided into four lobes.
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Figure 1.1: Structure of the brain [14]
1.2.1 Circulation
The brain is supplied by the internal carotid and the vertebral arteries. These join at
the base of the brain to form the circle of Willis which allows blood flow to the brain
to continue if the supply from one of the arteries is interrupted. Blood travels to the
brain tissue through the cerebral arteries. This is illustrated in Figure 1.2. The middle
cerebral artery is important for blood flow measurements, since it passes under a thin
part of the skull. Doppler ultrasound can be used to measure the speed of blood in this
artery.
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Figure 1.2: Diagram showing the blood supply to the brain [15]
Blood vessels are classified as arteries, arterioles, capillaries, venules and veins. Arter-
ies are vessels that carry blood away from the heart. In the brain, this means they carry
oxygenated blood. Haemoglobin in the arteries is usually about 96–100 % saturated
with oxygen. Arteries have a layer of smooth muscle and elastic tissue. The elastic
tissue allows the vessels to respond passively to changes in pressure. The smooth mus-
cle can contract or relax in response to certain stimuli to change the rate of blood flow.
Vasodilation and constriction can be caused by many different chemicals, for example
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nitric oxide. Physiological conditions which lead to vasodilation include hypoxia and
hypercapnia. Conversely, hyperoxia and hypocapnia lead to vasoconstriction. This is
discussed further below.
Capillaries are vessels connecting arterioles and venules the diameters of which are
comparable to the diameter of a red blood cell. Their wall is a single layer, which
allows substances to pass between the blood and the surrounding tissue. In the brain,
the endothelial cells lining the capillaries are packed more tightly than in other tissues.
This forms what is called the blood brain barrier, because it separates the circulating
blood from the brain tissue and CSF. Substances such as bacteria and large hydrophilic
molecules, which are normally able to pass though capillary walls, are unable to do so
in the brain. Glucose is actively transported across the barrier, as are other important
substrates. Small molecules including oxygen and carbon dioxide are able to diffuse
across the barrier. Cerebral capillaries are surrounded by astrocytes, a type of glial cell
whose functions include helping to maintain the blood brain barrier.
Blood from the capillaries flows into the veins. Veins contain blood which is usually
about 60 % saturated with oxygen. Veins in the brain have no muscular tissue and have
no valves. Most veins drain into the venous sinuses. These drain into the jugular vein.
Roughly three quarters of the brain blood volume is venous blood.
1.2.2 Blood flow regulation
It is crucial that the brain has a constant supply of metabolites, in particular oxygen.
If the flow of blood to the brain is stopped, neuronal electrical activity stops within
seconds, and irreversible cell damage occurs after a few minutes [16]. It is therefore
important that blood flow to the brain is matched to demand.
Mechanisms
The mechanisms by which cerebral blood flow regulation occurs are complex, but are
generally divided into three classes: myogenic, metabolic and neurogenic [13].
Myogenic refers to the direct response of the vessel wall to changes in the transmural
pressure gradient. The vascular smooth muscle cells contain stretch-activated ion
channels. When activated, these allow the influx of cations, which causes mem-
brane depolarisation. This leads to an influx of calcium ions, causing muscle
constriction. The endothelium is also thought to have mechanoreceptor proper-
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ties, and respond to changes in transmural pressure and flow velocity [17].
Metabolic describes the process by which the vessels respond to changes in concen-
trations of certain metabolites. For example, an increase in carbon dioxide (CO2)
causes an increase in hydrogen ions, which stimulates vasodilation. The mecha-
nism by which changes in oxygen concentration are coupled to flow are not fully
understood, but adenosine is known to play a role [17].
Neurogenic mechanisms can also cause changes in vascular tone. This is thought to be
more important for larger arterioles, since they are more densely innervated [18].
Autoregulation
Cerebral autoregulation is the ability of the brain to maintain a constant blood flow,
despite changes in perfusion pressure [19]. Cerebral perfusion pressure is defined as
the pressure difference that drives blood flow through the brain. It is a function of the
arterial and venous pressures, as well as the intracranial pressure, and is between 70
and 90 mmHg under normal conditions in a healthy adult human. The CBF is deter-
mined by the perfusion pressure and the cerebrovascular resistance, which varies with
the radius of the blood vessels. The process of autoregulation involves changes in ves-
sel radius, mainly of the small arteries, to counteract the effect of perfusion pressure
changes on CBF. Usually, normal CBF can be maintained for blood pressures in the
range of about 60–140 mmHg as illustrated in Figure 1.3. This range is shifted in pa-
tients with chronic hyper- or hypotension [20]. The blood pressure CBF curve is less
well defined in newborns [21], but the lower threshold appears to be below 30 mmHg
[22] and absent autoregulation has been observed following severe birth asphyxia [23].
O2
The normal partial pressure of oxygen in the arterial blood (PaO2) is around 100 mmHg.
A reduced concentration of oxygen in the blood is known as hypoxia. When this oc-
curs, the cerebral blood vessels dilate, thus increasing CBF, and the amount of oxygen
available. An increased concentration is called hyperoxia, and leads to a constriction of
the cerebral arteries, and therefore to a reduced CBF. The relationship between PaO2
and CBF in adult rats is shown in Figure 1.4.
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Figure 1.3: Diagram illustrating autoregulation in adult humans adapted from Folino
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Figure 1.4: Effect of PaO2 on CBF in rats [24]
CO2
Increased levels of CO2 in the blood lead to brain blood vessel dilation, and decreased
levels lead to constriction. Figure 1.5 shows the results of an experiment carried out
on eight rhesus monkeys, to investigate the relationship between blood CO2 levels and
CBF [25]. Also shown is the line of fit proposed by the authors.
1.2.3 Metabolism
One of the most important metabolic process that takes place in the brain is respira-
tion. Respiration involves the conversion of glucose and oxygen to CO2 and water, and
produces energy in the form of adenosine triphosphate (ATP) which can be used in the
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Figure 1.5: CBF vs PaCO2 in rhesus monkeys. The dotted line shows the best fit
proposed by the author [25].
cell. In other tissues, substrates other than glucose are sometimes used. However, the
brain uses almost exclusively glucose, because fatty acids cannot cross the blood brain
barrier. Respiration is divided into three stages. The first is glycolysis, which takes
place in the cell cytoplasm. This is followed by the Krebs cycle and then oxidative
phosphorylation, both of which are carried out in the mitochondria. These processes
are explained below. More detail can be found in Siesjö [26].
Glycolysis
Glycolysis is the name given to the set of reactions that result in the break down of
glucose to pyruvate. Two molecules of three carbon pyruvate are formed for each six
carbon glucose molecule. In the process, two adenosine diphosphate (ADP) molecules
are phosphorylated and two nicotinamide adenine dinucleotide (NAD) molecules are
reduced. The overall reaction is
Glucose + 2 Pi + 2 ADP + 2 NAD+ −−→ 2 Pyruvate + 2 ATP + 2 NADH (1.1)
Glycolysis takes place in ten steps as shown in Figure 1.6. These can be considered in
two stages, each consisting of five steps. During the first stage, known as the investment
stage, energy from two ATP molecules is used. The first ATP is used in an irreversible
phosphorylation of glucose, which is the first step of glycolysis. The second is used
in a step important to the control of glycolysis, a phosphorylation catalysed by phos-
phofructokinase. At the end of the first stage, two three carbon molecules have been
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formed. In the second stage, or generation stage, these molecules are rearranged to
form pyruvate, and energy is regained by the phosphorylation of four ADP molecules.
The reduction of NAD+ also occurs in the second stage. The NADH produced cannot
cross the mitochondrial inner membrane. However, it is effectively transported into the
mitohchondrial matrix by the malate-aspartate shuttle.
In the brain, the main function of glycolysis is to produce pyruvate. Under normal
conditions, glycolysis produces only a small fraction of the ATP used by the cell. In
anaerobic conditions however, it becomes more important. The pyruvate produced by
glycolysis can be converted into lactate. This regenerates the NAD+ necessary for gly-
colysis to continue, and keep producing ATP. The conversion of pyruvate to lactate
also produces a proton. This is a major cause of the acidosis that occurs in hypoxia or
ischaemia. Lactate can be converted back to pyruvate, or transported to the liver.
Krebs cycle
In aerobic respiration, the pyruvate produced by glycolysis is transported into the mito-
chondria and further metabolised. The set of reactions know as the Krebs, tricarboxylic
acid (TCA) or citric acid cycle involves the oxidation of pyruvate to CO2. It takes place
in the mitochondrial matrix. For each molecule of pyruvate oxidised, one molecule
of guanosine diphosphate (GDP) is phosphorylated, and four molecules of NAD and
one molecule of flavin adenine dinucleotide (FAD) are reduced to NADH and FADH2
respectively. The overall reaction is shown below; a more detailed reaction scheme is
illustrated in Figure 1.7
Pyruvate + 4 NAD+ + FAD + GDP + Pi −−→ 3 CO2 + 4 NADH + FADH2 + GTP
(1.2)
The NADH produced function as electron donors in the electron transport chain. The
step of the cycle involving the oxidation of succinate to fumerate is coupled to the
reduction of ubiquinone to ubiquinol, which also takes part in the electron transport
chain. Whilst aerobic respiration is the main function of the cycle, its intermediates
also have a number of other functions in the cell.
Oxidative phosphorylation
The chemiosmotic theory of oxidative phosphorylation was proposed by Mitchell in
1961 [27]. It states that ATP synthesis is coupled to electron transfer by a proton elec-
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Figure 1.6: Intermediates of glycolysis
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trochemical gradient. The electron transport chain involves the passage of electrons
between donors and acceptors down an energy gradient. The initial electron donor is
the NADH produced by the TCA cycle. The electrons pass through Complex I which
oxidises the NADH and reduces ubiquinone to ubiquinol, and also pumps protons across
the inner mitochondrial membrane. Ubiquinone is also reduced by succinate dehydro-
genase (Complex II) coupled to a step in the TCA cycle. Electrons pass from ubiquinol
to cytochrome c via Complex III which is also coupled with a net transport of protons
out of the mitochondrial matrix. The final donor is the cytochrome-c-oxidase (CCO)
complex (Complex IV), which passes electrons to oxygen to form water. Four electrons
and four protons are needed to reduce oxygen to water. CCO has three redox centres.
Electrons are first transferred from cytochrome c to the CuA and haem a centres. They
are then transferred to the haem a3-CuB centre and from there to oxygen [28]. The
oxidation state of the CuA centre can be measured by near-infrared spectroscopy (see
Section 1.3.1).
As electrons pass from NADH to oxygen, their energy decreases. This energy is used to
pump protons from the mitochondrial matrix into the intermembrane space. This cre-
ates an electrochemical gradient, combining a concentration gradient and an electrical
potential. The molecular motor ATP synthase is found in the inner mitochondrial mem-
brane. It couples the movement of protons into the mitochondrial matrix, down their
energy gradient, to the phosphorylation of ATP. Under certain conditions, it also oper-
ates in reverse, using energy from ATP hydrolysis to pump protons. It is thought that
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the translocation of between three and four protons is coupled to the phosphorylation of
one ATP molecule [29]. The newly synthesised ATP must also be transported out of the
mitochondrial matrix, and the ADP must be transported in. This is done by an enzyme
called ADP/ATP translocase. Since in the cell ATP exists as ATP4− and ADP as ADP3−,
this is equivalent to the transport of a proton across the membrane. Phosphate is also
transported across the membrane by a specialized transporter; this is a neutral process.
Not all the protons pumped by the electron transport chain return to the matrix via
ATP synthase. The electrochemical gradient is also used to drive other processes, such
as transport processes. Protons also travel through leak channels. The proportion of
protons travelling through these channels varies with the tissue. In the brain it is thought
to be between 10 and 40 % [30]. This decreases when the rate of energy generation
increases. The overall efficiency of oxidative phosphorylation is often quantified by the
P:O ratio. This is the number of moles of ATP phosphorylated per mole of oxygen
consumed. The maximum for this ratio (if all protons are used for ATP synthesis) is
around 2.5 [31].
Energy and metabolic regulation
The energy required to phosphorylate ATP depends on the standard Gibbs free energy
of the reaction, and also the relative concentrations of metabolites in the cell.
∆G = ∆G0 + RT ln
(
[ATP]
[ADP][Pi]
)
(1.3)
This ∆G is known as the phosphorylation potential, although this term is sometimes
used to describe the ratio [ATP]/([ADP][inorganic phosphate (Pi)]). The standard Gibbs
energy for the reaction (∆G0) is 30.5 kJ mol−1. Typical concentrations in the cytoplasm
for ATP and ADP are 3 mM and 0.3 mM. Inorganic phosphate is present at concen-
trations of around 1.5 mM [26]. This gives a ∆G of about 52 kJ mol−1. However, the
situation is complicated by the fact that the concentrations of metabolites are different
inside and outside the mitochondria. Also, ATP, ADP and Pi can all exist bound to
metal ions, most importantly magnesium. Most of the ATP in the cell is bound to Mg2+
ions, whereas most of the ADP is not [26]. In the mitochondria, bound forms participate
in the ATP synthesis reaction, and unbound forms are transported across the membrane
[32]. Another variable that has been suggested as a useful measure of the energy state
of the cell is the ‘energy charge’ [33].
Energy charge =
[ATP] + 0.5[ADP]
[ATP] + [ADP] + [AMP]
(1.4)
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These measures are useful because it is important that ATP concentration is kept high,
so that the many cellular reactions relying on ATP can continue. In order to keep ATP
concentration constant there are many methods of regulation, although the full details
of regulation are not known.
An important step in the control of glycolysis is the reaction catalysed by phospho-
fruktokinase. The activity of this enzyme is reduced by allosteric ATP binding, but
increased by adenosine monophosphate (AMP) binding.
Two reactions are important for buffering ATP levels in the cytoplasm. The first is the
phosphocreatine system. Phosphocreatine exists mainly in the cytoplasm of the cell.
Its concentration can be measured with magnetic resonance spectroscopy (see Section
1.3.2). In conditions where ATP synthesis cannot meet demand, a phosphate can be
transferred from phosphocreatine (PCr) to ATP, catalysed by creatine kinase.
PCr2− + ADP3− + H+
Creatine Kinase−−−−−−−−−−−−−−⇀↽ − Cr + ATP4− (1.5)
This reversible reaction is fast, so it is usually considered to always be in equilibrium.
The reaction also involves a proton, which means that it is pH sensitive. The second
reaction is the conversion of two molecules of ADP to one each of ATP and AMP. This
is catalysed by the enzyme adenylate kinase.
AMP2− + ATP4−
Adenylate Kinase−−−−−−−−−−−−−−−−⇀↽ −− 2 ADP3− (1.6)
Again, it is a fast reaction and is usually considered to always be at equilibrium.
Oxidative phosphorylation is regulated by ADP concentration. It has also been sug-
gested that CCO is regulated allosterically at ADP/ATP binding sites [34]. ATP synthe-
sis rate could also be increased by a greater substrate (NADH) supply. Several enzymes
involved in the TCA cycle have been suggested as regulatory sites. The oxygen concen-
tration is another important factor. If there is not enough oxygen to receive electrons,
the components of the electron transport chain will become more reduced, and the rate
of proton pumping across the membrane will decrease. It has been shown in mitochon-
drial suspensions that cerebral metabolic rate of oxygen consumption (CMRO2) begins
to decrease when the oxygen concentration falls below 20 µM [35]. The concentration
at which metabolism is impaired is often called the critical oxygen concentration.
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Metabolite transport
In order for respiration to occur, metabolites need to be transported from the blood into
the cell. Glucose and lactate are transported by facilitated diffusion. The family of trans-
porters responsible for glucose transport are the GLUT transporters. There are twelve
of these proteins, but GLUT1 and GLUT3 are responsible for the majority of glucose
transport in the brain. GLUT1 is found at the blood-brain barrier, and (in the brain)
GLUT3 is found almost exclusively in neurons [36]. The kinetics of these transporters
have been studied in red blood cells [37].
The proteins responsible for transporting lactate are the monocarboxylate transporter
(MCT) proteins. They also transport other monocarboxylates such as pyruvate. There
are four types of MCTs that are known to transport metabolites and all of these have
been found in the brain, although MCT3 has a limited distribution. MCT2 is found only
in neurons in the brain; it is widely expressed in rats, but not in humans. The kinetics
and rate constants of the different MCTs for lactate varies, for example, the kinetics of
MCT1 are sensitive to pH, whereas those of MCT2 are not. Because the different MCTs
are expressed differently in astrocytes and neurons, the lactate transport properties of
the two cell types differ, with the transporters of astrocytes having on average a greater
affinity for lactate [36].
These different lactate and glucose transport behaviours are important when consider-
ing the astrocyte-neuron lactate shuttle (ANLS). This is a hypothesis concerning the
coupling of neuronal activity and glucose use [38]. It states that the increase in gluta-
mate (a neurotransmitter) caused by neuronal activity leads to an increase in glucose
uptake and glycolysis in astrocytes. This means that lactate production is increased,
and lactate is released from the astrocytes and taken up by neurons where it is used
to fuel the TCA cycle to produce ATP. Since it was first suggested, there has been a
considerable amount of experimental evidence collected which is consistent with the
theory [39]. There has also been a lot of mathematical modelling investigating ANLS.
The concept of ANLS is not universally accepted, and some mathematical models have
been used to argue that neurons meet their energy needs in rested and activated states
almost exclusively by the uptake and metabolism of glucose (see Jolivet et al. [40] and
Mangia et al. [41] for an overview of the disagreement).
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1.2.4 Hypoxia-Ischaemia
Hypoxia at birth is usually caused by insufficient placental or pulmonary gas exchange.
Ischaemia follows from cardiac depression. The lack of oxygen reaching the cells leads
to energy failure, which in time, leads to cell death. A large part of what is known about
the biochemistry of HI has been discovered from experiments on rats.
In general, cell death can be divided into three types: necrosis, apoptosis and phago-
cytosis. Necrosis is death caused by external factors. The cell membrane is damaged,
and the cellular contents are released into the extracellular space causing inflammation.
Apoptosis is a type of programmed cell death. It is important for development, and is a
highly regulated process. It occurs in response to a variety of signals and results in cell
fragments which are engulfed by other cells. Phagocytosis occurs when a signal from
the cell causes the cell to be phagocytosed (engulfed and destroyed by another cell) and
it has not undergone cell death by another method [42]. All three forms contribute to
the cell death caused by HI. The relative importance of the three is not precisely known,
but it varies based on the severity of the insult, the time after the insult, and the area of
the brain. It has also been observed that the apoptosis caused by HI is different from
apoptosis that occurs as a normal part of development, and hybrid necrotic-apoptotic
cell deaths are seen. In fact, when considering HI it may be more accurate to consider
necrosis and apoptosis as two ends of a continuum [43].
During the insult itself, necrosis is the leading cause of cell death. The lack of oxygen
causes a reduction in pH, an increase in lactate, and a decrease in ATP concentration.
The cell may no longer be able to pump sufficient Na+ out of the cell causing water to
enter, and the cell membrane to depolarise [44].
There are several ways in which cell damage and death following HI during secondary
energy failure is thought to occur. Glutamate is an excitatory neurotransmitter which re-
quires energy for its reuptake. The reduction in available energy caused by HI therefore
leads to a build up of glutamate in the extracellular space. This build up, known as ex-
citotoxicity, causes over-activation of N-methyl-D-aspartate (NMDA) receptors which
leads to a high level of calcium ions entering the cell. This can affect biochemical
pathways in the brain leading to apoptosis, and can also cause depolarisation leading to
necrosis [45]. It is possible that the immature brain is more sensitive to glutamate ex-
citotoxicity, since NMDA receptors are present in greater numbers, as glutamate plays
an important role in growth and development [2]. It has been observed in rats that those
areas of the brain most sensitive to HI are also more sensitive to glutamate toxicity [46].
Another factor contributing to cell damage in HI is oxidative stress [47]. The term re-
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active oxygen species (ROS) describes molecules containing oxygen with an unpaired
electron, which are therefore highly reactive. Examples include superoxides and perox-
ides. Under normal conditions, cells are protected against ROS by antioxidants. How-
ever, if there is increased production, they can cause damage, particularly to mitochon-
dria, and this can trigger apoptosis. This is known as oxidative stress. The immature
brain is more vulnerable to oxidative stress because it has a lower antioxidant capac-
ity. In addition, there is a high concentration of iron present which is involved in the
formation of free radicals and damage to membrane proteins.
One contributor to oxidative stress is nitric oxide (NO). NO has many different functions
in the brain. These include acting as a potent vasodilator, and as a neurotransmitter. It is
synthesised by nitric oxide synthase (NOS) which exists in different forms. In neurons,
NO is mainly produced by neuronal NOS (nNOS). The process is Ca2+ dependent, and
so the Ca2+ influx caused by HI leads to increased NO production [48]. Excess NO can
lead to cell damage in a number of ways, including reacting with the superoxide ion to
form peroxynitrite, an inhibitor of mitochondrial function. It has been found in mice,
that disruption of the nNOS gene reduces neuron damage from HI [49]. However, some
studies have found inhibition of NOS is not beneficial for HI. This may be because an
increase in epithelial NOS activity causes dilation of the blood vessels and increased
blood flow which decreases the damage caused by HI. In fact, this vasodilation effect
makes NO a potential treatment for ischaemia, and NO inhalation has recently been
shown to reduce damage from ischaemia following traumatic brain injury in adult mice
[50].
A number of therapies have been investigated for HI. Many of these are intended to
disrupt the pathways of the biochemical processes discussed above. One of the most
promising therapies is hypothermia. Rather than acting on a particular target, hypother-
mia is thought to decrease damage from all of the above causes via a reduction in the
metabolic rate [7]: it decreases the rate of glutamate release, decreases the activity of
NMDA receptors and decreases the rate of production of free radicals. Studies in hu-
man neonates show an overall positive effect of hypothermia [6]. Many studies have
also been carried out in animal models, including in piglets (see Section 1.3.5).
1.3 Measurements
There are many different ways of making measurements of the brain. The technique
used depends on what is being measured. One measurement that is often of interest is
the CBF. The first quantitative measurements of this were made by Kety and Schmidt in
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1948 using a technique involving nitrous oxide and measurements of blood gases [51].
Other ways of monitoring cerebral blood flow or its changes include MRI arterial spin
labelling, NIRS techniques and Doppler ultrasound. The latter measures the speed of
blood flow through major arteries supplying the brain.
Information about the activity of the brain can also be obtained using a variety of meth-
ods. NIRS uses the difference in the absorption properties between oxygenated and
deoxygenated haemoglobin to measure changes in brain oxygenation, which may be
related to changes in brain activity. Functional MRI (fMRI) uses the different magnetic
properties to detect the decrease in deoxygenated haemoglobin that accompanies an in-
crease in electrical activity. Direct measurements of the electrical activity of the brain
can be made by electroencephalography (EEG), however this does not offer the spatial
resolution of MRI.
NIRS can also be used for monitoring oxygen metabolism, by measuring the oxidation
state of CCO. MRS is another way to measure metabolic changes. It uses similar prin-
ciples to MRI, but measures the concentration of a greater range of compounds, with
a much lower spatial resolution [52]. Nuclei used for MRS include 1H, 31P, 19F, 13C
and 23Na. This allows measurement of concentrations of metabolites including ATP,
PCr and lactate. Positron emission tomography (PET) is another technique which can
give useful metabolic information [53]. It involves the use of radioactive tracers which
can be used to label almost any biological compound. This makes PET a very flexible
technique, however it involves exposure to ionising radiation. If invasive measurements
are possible, microdialysis can be used to measure metabolite concentrations in extra-
cellular fluid [54].
This work involves comparing the outputs of a mathematical model with physiological
data, particularly data from NIRS and MRS. These techniques and their measurements
are explained in more detail below.
1.3.1 NIRS
When light travels through a solution it is absorbed by coloured compounds called chro-
mophores. Tissue can be thought of a solution of these chromophores. Visible light can-
not travel far through tissue, since it is strongly absorbed and scattered. Near-infrared
describes light of wavelength 650–1000 nm. In this range of wavelengths, absorption
by water is lower, as shown in Figure 1.9, which allows light to travel further through
tissue. Near-infrared spectroscopy can be used to make quantitative measurements of
the chromophore concentrations in tissue [56]. The three main absorbing chromophores
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Figure 1.9: Absorption spectrum of water in the wavelength range 200–10 000 nm [55]
in the near infrared wavelength range are oxyhaemoglobin, deoxyhaemoglobin and ox-
idised cytochrome c oxidase (see 1.2.3). The absorption spectra for haemoglobin and
oxyhaemoglobin are shown in Figure 1.10.
The Beer-Lambert law can be used to calculate the concentrations of absorbers in a
solution, by measuring the absorption of light at known wavelengths. However, the
effects of scattering in tissue mean that total concentrations of the chromophores cannot
be measured, and a modified Beer-Lambert must be used which can only determine
their concentration changes [56].
NIRS is most often used to measure blood flow and metabolism in the brain and in
muscles [57]. It is especially useful for situations where other types of monitoring are
not practical. It is often used on infants because their thinner skulls allow for greater
penetration of the light. This means that NIRS measurement will cover a larger area of
the brain. In some cases, the light is detected having passed through the head, whereas
in adults, reflected light must always be used. Its uses include identifying cerebral
hypoxia and monitoring during procedures [58]. One of its main advantages over other
measurement techniques is that it can detect changes in the oxidation state of CCO.
NIRS is also used for animal studies [59].
36
00.001
0.002
0.003
0.004
0.005
0.006
0.007
0.008
0.009
650 700 750 800 850 900 950 1000 1050
Sp
ec
ifi
c
ab
so
rp
tio
n
co
effi
ci
en
t(
µM
−1
cm
−1
)
λ (nm)
Hb
HbO2
Figure 1.10: Absorption spectra for Hb and HbO2 in the near-infrared region
Haemoglobin
Haemoglobin and oxyhaemoglobin changes can be measured by NIRS. It is possible
to measure the change in brain tissue concentration of oxyhaemoglobin (∆HbO2) and
the change in brain tissue concentration of deoxyhaemoglobin (∆HHb). These mea-
surements are affected by volume changes and by oxygen saturation changes. The two
signals can be added to give the change in total brain tissue haemoglobin concentration
(∆HbT), and subtracted to give the change in difference in brain tissue concentration
between oxy and deoxyhaemoglobin (∆Hbdiff). ∆Hbdiff is considered a more reliable
signal since some sources of noise will be removed by the subtraction. Changes in
∆HbT can be used to estimate changes in cerebral blood volume (CBV). Techniques
exist by which these haemoglobin signals can be used to make absolute CBF [60] and
CBV [61] measurements.
Cytochrome c oxidase
CCO plays an important role in mitochondrial respiration (see Section 1.2.3). Monitor-
ing of oxidation changes at its CuA centre with NIRS was first proposed by Jöbsis [62].
The CuA centre is strongly absorbing in the near infrared region. Whilst the overall con-
centration of CCO does not change over short periods of time, the fraction of CuA that
is oxidised does. The difference extinction spectrum of the oxidised and reduced forms
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Figure 1.11: Difference extinction spectrum of cytochrome oxidase
of cytochrome oxidase (Figure 1.11) can be used to measure these changes. The spec-
trum shown includes a small contribution from other forms of cytochrome oxidase, but
is mainly due to cytochrome c oxidase. Because the concentration of CCO in tissue is
only about 10 % that of haemoglobin, it is more difficult to measure. Consequently, one
of the main difficulties in measuring CCO is ensuring that the changes seen are actually
CCO changes, and not artefacts from haemoglobin. Multiple methods have been used to
calculate CuA oxidation changes from optical measurements. Gagnon et al. compared
13 algorithms and found a general agreement in their calculated CuA oxidation changes
[63]. Matcher et al. [64] compared algorithms used by four different groups. They
found that some of the algorithms showed more interference from the haemoglobin
measurements than others. The main determinant of the oxidation state of CuA is the
concentration of oxygen in the mitochondria. It is also affected by changes in substrate
concentration and protonmotive force. NIRS measurement of CCO has advantages over
direct methods of oxygen concentration measurement such as microelectrodes, because
it is non-invasive and sensitive to the concentration at the mitochondria, which is where
oxygen is used [65]. When oxygen concentration is low, electrons cannot be transferred
to oxygen, and so CuA becomes more reduced.
CCO measurements in vivo The first measurements of CCO redox changes in vivo
were reported by Jöbsis in 1977 [62]. CCO was seen to become more reduced dur-
ing episodes of anoxia and ischaemia in anaesthetised cats. It became more oxidized
during stimulated activity in the cortex, and also when CO2 or PaO2 were increased.
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A later study also using cats [66] found that CCO became more reduced when oxygen
delivery was decreased, but that no changes were seen if the changes in oxygen (O2) de-
livery were only small. This experiment used blood-fluorocarbon exchanged cats thus
removing the possibility of haemoglobin contamination in the signal.
The same pattern has been observed in other animals. For example, Hoshi et al. [67]
lowered fractional inspired oxygen (FiO2) in adult rats from 100 % to 10 % and, al-
though changes in ∆HbO2 and ∆HHb were seen, there was no change in change in con-
centration of oxidised CCO (∆oxCCO). When FiO2 was lowered further, CCO became
reduced. The point at which no further reduction of CCO was seen coincided with
the flattening of the EEG measurement. Experiments involving blood-fluorocarbon
exchanged rats have also confirmed that NIRS is sensitive to CuA oxidation changes
[68, 69] and again shown that a lowered FiO2 leads to a reduction of CCO [70] . Sim-
ilarly, Cooper et al. [71] found a linear relationship between the cerebral O2 delivery
rate and the decrease in ∆HbO2 in adult rats. CCO redox state did not change until
the O2 delivery rate had reached half its normal value. They estimated that CCO was
82 % oxidised under baseline conditions. In another study, Cooper et al. used cyanide
to completely reduce the CCO in piglets [72]. When afterwards, the piglets were sub-
jected to anoxia, no further changes were seen in the ∆oxCCO confirming that NIRS
can be used to measure changes in CCO redox state in piglets.
In experiments with foetal lambs, an oxidation of CCO has been observed in the brain
during decreased oxygen delivery [73, 74]. In one of these studies, a reduction was
measured simultaneously in the leg, suggesting there may be mechanisms in the brain
which help to protect it against hypoxia.
In summary, the majority of studies of CCO during hypoxia have shown that, unlike
∆HbO2 and ∆HHb, CCO redox state is not sensitive to small changes in oxygen deliv-
ery, and CuA becomes reduced during hypoxia only after a delay. This may be because
CCO has a high affinity for oxygen [75]. Edwards et al. found similar results in human
infants, with no changes in CCO observed in arterial oxygen saturation (SaO2) range
85–99 % [76], but an increase in ∆oxCCO was seen when PaCO2 was increased. An
earlier study in human infants [61] also found an oxidation of CCO in response to an
increase in PaCO2. However, an oxidation was also observed when SaO2 was increased.
The situation in adult humans is different: changes in CCO oxidation are seen with
small changes in SaO2. Tisdall et al. found a linear correlation between ∆oxCCO and
cerebral oxygen delivery [77]. ∆oxCCO changes were also found to correlate with SaO2
changes during sleep apnea [78]. CCO redox changes have also been observed during
functional activation, for example during visual stimulation [79, 80]. Some functional
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activation studies have used Monte Carlo simulations to show that changes measured in
CuA oxidation could not be attributed to cross talk from haemoglobin alone [81]. A re-
cent study involving an anagram task in healthy adults found that whilst the majority of
subjects showed a significant oxidation of CCO during the task, some subjects showed a
reduction [82]. Finally, ∆oxCCO changes have also been observed during hypercapnia
in healthy adults [83].
Aside from differences in experimental methods and algorithms, the differences in CCO
redox state changes during hypoxia between animals, infant humans and adult humans
may be caused by the differing resting metabolic rates of these groups. In the majority
of animal studies, anaesthesia is used, which may affect the metabolic rate and the
baseline redox state of CCO.
TOS
In this thesis, the term tissue oxygen saturation (tissue oxygen saturation (TOS)) will
be used to describe the percentage of haemoglobin that is oxygenated in a volume of
tissue.
TOS =
[HbO2]
[HbO2] + [HHb]
× 100% (1.7)
TOS can be measured by spatially resolved spectroscopy.
There is a variety of approaches to measuring TOS. Different instruments have dif-
ferent measurement techniques and different algorithms for calculating the estimate of
TOS. There are several commercially available spectrometers which measure TOS [84].
Some are listed below, along with the specific name given to the measurement of TOS
from that particular instrument, where this exists.
• NIRO by Hamamatsu, Japan measures tissue oxygenation index (TOI)
• INVOS by Somanetics, USA measures regional oxygen saturation (rSO2)
• TRS-20 by Hamamatsu, Japan
• FORE-SIGHT by Casmed, USA measures cerebral tissue oxygen saturation
(SctO2)
• NIMO by NIROX, Italy measures tissue oxygen saturation (StO2)
• O2C by LEA, Germany measures the oxygen saturation of haemoglobin (SO2)
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• OxiplexTS by ISS, USA
• T.Ox by ViOptix, USA
• EQUANOX, Nonin, USA measures rSO2
• InSpectra by Hutchinson, USA measures tissue oxygen saturation (StO2)
TOI [85] (a measurement of TOS from the NIRO spectromenters) is used in this work
for comparison with TOS from the model. There have been several comparisons be-
tween the experimental methods, for example TOI and rSO2 (INVOS) have been com-
pared many times [86, 87, 88, 89]. In general the comparisons have shown that whilst
the two measurements do not always agree numerically, they show similar changes in
response to certain stimuli.
In principle, TOS is a simple measurement: the percentage of haemoglobin in tissue
which is saturated with oxygen. However, in practice it can be difficult to interpret,
because there are several physiological variables involved. It is most sensitive to venous
oxygenation, because venous blood makes up approximately 75 % of the blood in the
brain. One way of expressing TOS during steady state conditions is
TOS = SaO2 −
(
Vven
Vart + Vven
)
CMRO2
k CBF [Hbtot]
(1.8)
where k is the oxygen carried per haemoglobin (about 1.3 ml g−1) [90]. From this ex-
pression, it can be seen that TOS can be affected by a number of variables. An increase
in arterial saturation (with all other variables constant) would increase TOS, as would
an increase in arterial volume. A decrease in CMRO2 or an increase in CBF would lead
to a lower oxygen extraction fraction and therefore a higher venous oxygenation, which
again would increase TOS.
TOS measurements vary between individuals, and between different sites of measure-
ment [91]. It is not fully known which factors contribute most to these differences. In
general, the algorithms for calculating TOS attempt to give a measurement originating
mainly from the deeper tissue, so that when used on the brain the signal comes mainly
from the cerebral tissue, rather than from the overlying layers. However, there is con-
cern that the measurements may be subject to extracerebral contamination. There is
some evidence from theory and experiment to suggest that TOI is sensitive to changes
in brain tissue, as opposed to extracranial tissue [92, 93].
The measurement of TOS has been used to study the injured brain [94]. For example,
to monitor patients after traumatic brain injury [95] or during coronary bypass [96].
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Figure 1.12: Example of TOI and CCO measurements by near-infrared spectroscopy
during a hypocapnia challenge in a healthy adult. The hypocapnia period is indicated
by the shaded area.
Despite results showing its monitoring can improve treatment, the clinical usage of
TOS has been impeded by the lack of a well defined range of normal values, and the
difficulty in validating the NIRS measurements. TOS has also been used to investigate
responses in healthy subjects. TOI decreases have been observed during hypoxia and
hypocapnia and increases during hyperoxia and hypocapnia [97, 88]. The TOI signal
for a healthy adult during hypocapnia is shown in Figure 1.12.
1.3.2 MRS
Magnetic resonance spectroscopy uses the principle of nuclear magnetic resonance
(NMR). This depends on the magnetic properties of the nucleus. A nucleus with a
magnetic moment placed in a strong magnetic field, has a resonant frequency. This
frequency depends on the properties of the nucleus and on the strength of the magnetic
field. By applying a pulse of RF magnetic field matched to the resonant frequency, nu-
clei can be made to transition into an excited state for a short time. Whilst in this state,
they give rise to a measurable, oscillating magnetic field. In a biological sample, this
field will be made up of several components with slightly different frequencies. These
correspond to the different molecules in the sample, since the resonant frequency of a
nucleus is altered slightly by its chemical environment. By taking a Fourier transform
of the measured field, the different molecules can be identified. The strength of the
signal depends on the number of nuclei present, and therefore on the concentration of
the substance.
The area of a peak in a spectrum is proportional to the concentration of that metabolite in
the sampled region. Concentrations are often expressed as ratios. This allows cancelling
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of unknowns relating to the measurement, however it can be more difficult to interpret.
An alternative is to use a phantom with known concentrations as a reference. The main
nucleus used in biological applications is 1H. 31P is also used and is discussed here.
Only metabolites with concentrations greater than about 1 mM are detectable, although
this depends on the system being used.
Figure 1.13 shows an example of an 1H spectrum from a normal human frontal lobe.
The position of the peaks is expressed in parts per million (ppm). This is the shift in
frequency from a given reference compound. The main peaks that can be distinguished
in the 1H spectrum are described below.
NAA N-acetyl aspartate (NAA) is a molecule which is found in neurons, but not in
glial cells. It is synthesised in mitochondria, and is thought to play a role in myelinogen-
esis and in fluid balance [98]. NAA is used as marker for neuron number and function.
A decreased concentration is seen in diseases which cause neuron loss or damage, such
as Alzheimer’s disease and multiple sclerosis, and also in tumours.
Lactate In a healthy human brain, lactate is present at concentrations of around 0.5
mM, and so is not normally detectable. However, increases in lactate commonly oc-
cur when aerobic metabolism is compromised. Under these conditions, a lactate peak
becomes detectable. Lactate peaks are visible in hypoxia, ischaemia, mitochondrial dis-
orders, and some tumours. It is difficult to quantify the change in lactate concentration
relative to baseline during an experiment, since this can depend strongly on the estimate
of baseline concentration [99].
Choline Choline is generally found in compounds involved in membrane synthesis.
Once it is incorporated into the membrane, choline cannot be seen by MRS. Therefore,
an increased choline signal indicates increased membrane turnover or cell breakdown.
This occurs in conditions such as tumours and multiple sclerosis.
Creatine Creatine is involved in cellular energy generation as discussed in Section
1.2.3. Here, it is the total creatine concentration ([Cr] + [PCr]) that is measured. This is
not likely to change significantly over the course of an experiment. However, regional
variations in creatine concentration can sometimes be seen in the brain, and the signal
may change with age or disease [100].
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Myo-inositol mIns is a sugar synthesised in glial cells. It can be used as a glial marker
and increased mIns is seen in inflammation, and disorders such as Alzheimer’s disease
[101].
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Figure 1.13: An example 1H MRS spectrum from a normal human frontal lobe taken
from [52]
Figure 1.14 shows an example 31P spectrum from a healthy brain taken from [102]. The
main peaks that can be distinguished are PCr, Pi and α, β and γ nucleotide triphos-
phate (NTP), which mostly originate from ATP. Also visible are peaks from phospho-
monoesters (PME) and phosphodiesters (PDE). These are groups of compounds the
concentrations of which are reduced in neurodegenerative diseases. Individual metabo-
lites from these groups can be identified with more advanced MRS techniques [103].
ADP concentration is often inferred from the creatine kinase equilibrium. 31P MRS can
also be used to determine pH, from the shift in one or more of the peaks relative to the
PCr peak as indicated by δ in Figure 1.14. It is considered to be a reliable estimate of
intracellular pH [104].
1.3.3 TCD
Transcranial doppler (TCD) is a technique which uses ultrasound to measure the ve-
locity of blood through cerebral blood vessels. It uses the Doppler effect: an effect by
which the frequency of a wave is altered by motion between the source and detector.
The observed frequency shift can be used to calculate the relative velocity between the
source and the detector in the direction of wave travel. In the case of TCD, the source is
the reflection of ultrasound waves from the moving blood cells, and the detector is the
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Figure 1.14: An example of a typical 31P MRS spectrum taken from [102].
stationary ultrasound probe. The use of Doppler ultrasound for cerebral measurements
was first proposed in 1982 by Aaslid et al. [105]. Its main use is for monitoring CBF.
Blood flow cannot be measured directly, since it depends on the radius of a vessel as
well as the speed of flow through it. However, TCD can be used to monitor changes in
CBF, since it can often be assumed that the radius of the insonated vessel is constant.
Low frequencies must be used to allow enough ultrasound to pass through the skull
This means the technique has a poor spatial resolution, so is not suitable for imaging.
However, the temporal resolution is good [106]. TCD relies on acoustic windows: ar-
eas of the skull where the bone is thinner than elsewhere. The blood vessels shown in
Figure 1.15 can be investigated through the several available windows. These are the
transtemporal, transorbital, transformial and submandibular windows [107]. However,
approximately 10 % of people lack an acoustic window altogether, meaning TCD is not
possible. The most commonly used window is the transtemporal window. One impor-
tant vessel that can be insonated through this window is the middle cerebral artery. This
measurement is known as the velocity of blood in the middle cerebral artery (Vmca).
Clinically, the uses of TCD include monitoring CBF after traumatic brain injury, and
intra-operative monitoring [108]. It is also used to monitor autoregulation, including
the cerebrovascular response to CO2.
1.3.4 Systemic measurements
There are several systemic measurements that can be made simply and non-invasively
which are relevant to the circulation and metabolism of the brain. These include heart
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Figure 1.15: A diagram illustrating the use of TCD through the temporal window
[108]. The vessels marked are the anterior cerebral artery (ACA), middle cerebral artery
(MCA), posterior cerebral artery (PCA), basilar artery (BA) and both vertebral arteries
(VA).
rate, blood pressure, CO2 levels and arterial oxygen saturation.
Pulse oximetry
Pulse oximetry was first developed in 1974 [109]. It was based on oximeters used
to detect hypoxia in pilots in the 1940s [110]. Like NIRS, it measures the absorp-
tion of known wavelengths of light to determine blood oxygenation. However, unlike
NIRS and the early oximeters, pulse oximetry measures the variation in light attenu-
ation across the cardiac cycle. If two wavelengths are used, the oxygen saturation of
haemoglobin in the pulsatile component of the blood (SpO2) can be calculated [111].
If it is assumed that pulsatile volume changes are entirely caused by arterial volume
changes, SpO2 will be equivalent to SaO2. Pulse oximetry measurements are usually
made on the ear or the finger because of the ease of measurement.
Pulse oximetry is now very common in clinical use. It has been shown to produce
accurate results for saturations above 80 % [112]. Below this, measurements are less
accurate, in part because there is less data from other methods available to compare
with. However, clinically, it is not usually necessary to have an accurate saturation
measurement below 80 %. Other limitations of pulse oximetry include being unable to
distinguish HbCO from HbO2.
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CO2 measurements
Carbon dioxide produced during respiration is removed from the body by transport in
the blood, followed by diffusion into the lungs. The partial pressure of carbon diox-
ide (PCO2) in the airways at the end of expiration is known as end tidal CO2 (EtCO2).
Under normal conditions, an equilibrium is quickly reached between the blood in the
pulmonary capillaries and the gas in the alveoli. Therefore, EtCO2 is equal to the partial
pressure of carbon dioxide in the arterial blood (PaCO2) [113]. The measurement of
PCO2 in the airways is known as capnometry, and its visualisation over time as capnog-
raphy.
A typical capnograph is shown in Figure 1.16. During inhalation, and at the beginning
of exhalation PCO2 is effectively zero. There is a rapid increase when exhalation of
alveolar air begins, followed by a more gradual increase, at the end of which EtCO2 is
measured. A normal EtCO2 measurement is around 35–40 mmHg. Finally, there is a
rapid decrease back to zero at the start of inhalation.
EtCO2 can be measured in a number of ways, the most common being with an infrared
capnometer [114]. It is often used clinically during anaesthesia to monitor ventilation.
CO2 levels in the blood can also be measured transcutaneously [115]. This involves
warming the skin under the sensor, to dilate the capillaries, making their blood compo-
sition more similar to arterial blood. CO2 concentration is determined by measuring pH
in an electrode separated from the skin by a CO2 permeable membrane. Alternatively,
PCO2 can be measured optically in a small sample of gas adjacent to the skin.
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Figure 1.16: A typical capnograph [113]
Blood pressure
The most common method of measuring blood pressure is to use a sphygmomanometer
[116]. The measurement involves using an inflatable cuff to determine the pressure
necessary to occlude the arteries. The site of measurement is usually the upper arm,
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since it is at the same height as the heart, but measurements are also frequently made at
the wrist or the finger. Blood pressure is typically quoted as two values: the maximum
(systolic) and minimum (diastolic) arterial pressures in the cardiac cycle. Their normal
values are around 120 and 80 mmHg respectively, although there is a wide variation
between people, with age, and in response to situations such as stress or exercise [14].
Sometimes, it is the mean arterial blood pressure (MABP), the time average of arterial
pressure, that is of interest. The shape of the blood pressure curve means that MABP is
closer to diastolic pressure. It can be estimated as the diastolic pressure plus one third
of the systolic to diastolic pressure difference, although more accurate estimates exist
[117].
1.3.5 Piglet experiments
Several animal models have been used to investigate perinatal hypoxia-ischaemia, in-
cluding rats, mice, rabbits, sheep, non-human primates and piglets [118]. Piglets have
commonly been used for investigating HI. Animal models are useful, because it is dif-
ficult to make measurements on humans during hypoxia-ischaemia, and animal models
allow for controlled conditions. However, animal models have the disadvantage that
the findings in the animal may not be applicable to humans, and that long term mea-
surements are more difficult [119]. A 1997 review by Roohey et al. [120] found that
of 292 animal studies related to perinatal hypoxic ischaemic encephalopathy, 23% used
piglets. A newborn piglet is similar in size to a newborn human, however its brain
matures faster. Another difference is that piglets are usually anaesthetised during the
experiments.
31P-MRS has often been used to study both birth-asphyxiated human infants [121, 9]
and piglet models. Lorek et al. [122] developed a piglet model of secondary energy fail-
ure which they monitored with MRS. The piglets were subjected to temporary bilateral
carotid artery occlusion and hypoxia, and then studied for 48 h during recovery. During
the insult phase the concentration ratios PCr/Pi and NTP/EPP fell to almost zero but
returned to their baseline values soon after the insult. Both ratios then began to decline
again around 24 h later despite no changes in PaO2 or blood pressure. The magnitude
of the changes seen during secondary energy failure was related to the severity of the
initial energy depletion. The same model was also used by Mehmet et al. [123] to show
that the time integral of the fall in NTP/exchangeable phosphate pool (EPP) was di-
rectly related to the fraction of cells undergoing apoptosis 48 h following the insult, as
identified by light and electron microscopy and DNA fragmentation. In another study
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31P-MRS and 1H-MRS spectra were acquired alternately [124]. The 1H-MRS lactate
peak was observed to rise during the insult, then return to baseline, and then rise again
over the following 48 h. The NAA peak was reduced in height, but appeared broader
after 48 h. The maximum in the Lac/NAA ratio during delayed energy failure was pos-
itively related to the severity of the insult as measured by the integral of the NTP/EPP
fall.
One of the first investigations into the relationship between NIRS measurements and
MRS measurements in hypoxic piglets was done by Tsuji et al. [125]. They used four
week old anaesthetised piglets, which were subjected to four increasingly severe hy-
poxic episodes with recovery in between. The FiO2 was reduced from 25 % to 12 %,
8 %, 6 %, or 4 % for 10 min and then returned to 25 % for a recovery period of approxi-
mately 30 min before the next hypoxia. The ∆HbO2 decreased and the ∆HHb increased
at all levels of hypoxia, however there was no significant decrease of ∆oxCCO until
FiO2 reached 6 %. No significant decrease in NTP and PCr concentrations were seen
at FiO2 levels of 12 % and 8 % but a decrease was seen at FiO2 of 6 %. A correlation
was seen between the values of ∆oxCCO and both NTP and PCr at the end of hypoxia.
However, no correlation was seen between NTP or PCr with either ∆HbO2 or ∆HHb.
The authors attributed this to the changes in systemic blood pressure which were ob-
served and would have affected the CBF. The findings were in agreement with an earlier
study which found a correlation between ∆oxCCO and the PCr/Pi ratio in hypoxic dogs
and cats [126].
Cooper and Springett [75] used NIRS and MRS to investigate HI in piglets caused by
occlusion of the carotid arteries and a reduction in FiO2. They found an excellent corre-
lation between the fall in ∆oxCCO and the fall in NTP concentration during the period
of delayed energy failure. A correlation was not seen between the ∆oxCCO signal and
the PCr/Pi ratio. However, the authors point out that some of this correlation may be
explained by changes in the optical properties of the brain (for example increased water
content of the cells) giving misleading values for ∆oxCCO.
Tichauer et al. [127] used NIRS to measure CBF and CMRO2 in newborn piglets fol-
lowing HI. The measurement of CBF was made using a intravascular tracer (indo-
cyanine green). CMRO2 was calculated from the CBF measurement combined with
a measurement of absolute haemoglobin concentration (also measured by NIRS). They
found that immediately following HI, CBF was around 70 % greater than at baseline and
CMRO2 was 30 % lower than baseline. CMRO2 remained decreased for several hours
following the insult, whilst the other measurements returned to their baseline values.
The method of estimating CMRO2 assumes a constant arterial to venous volume ratio,
which means that the estimates may be inaccurate during the insult itself. Other studies
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in neonatal animals have also found a CMRO2 reduction following HI [128, 129], but
some studies found no changes [130, 131]. An increased CMRO2 has been observed in
human infants with brain injuries, including those caused by HI, compared with healthy
infants in the first few days of life [132].
NIRS has also been used together with EEG to monitor piglets subjected to HI This was
first done by Ioroi et al. [133] using the previously described piglet model of secondary
energy failure [122]. They recorded a decrease in the amplitude integrated EEG (aEEG)
signal during HI and during the reperfusion period. Similar to previous studies, a drop
in ∆HbO2 and a rise in ∆HHb were seen during HI which quickly returned to baseline in
the first minutes of reperfusion. The aEEG signal, although it showed recovery during
the reperfusion phase, recovered more slowly, and did not reach baseline levels after
2 h. This appears to be consistent with the reduced CMRO2 suggested by the work of
Tichauer et al.. Studies of human asphyxiated infants have found that aEEG in the first
3 h of life could be used to predict the severity of outcome [134].
1.3.6 Current research at UCL
NIRS and MRS are two non-invasive methods for monitoring the brain which are cur-
rently being used at UCL. NIRS is used for adults, babies and animals. In adults, it
is being used for patients with brain injuries, to add to current monitoring methods.
NIRS studies are also being carried out on healthy volunteers to validate the measure-
ments and help to understand how to interpret them. These studies include hypercap-
nia experiments, which are the subject of Chapter 4. Whilst there has been extensive
work carried out on modelling light transport in tissue to understand the measurements,
there has been less work on physiological modelling to help to interpret the measure-
ments and investigate their compatibility with current knowledge of brain circulation
and metabolism.
NIRS is used for animal models simultaneously with MRS at UCL to monitor piglets
subjected to HI. One of the aims of these experiments is to establish if the NIRS mea-
surement of ∆oxCCO can be used to predict outcome and to monitor treatment. Com-
bining NIRS with the more widely used MRS helps to validate the measurements and
can also be used to gain an insight into metabolism and pathology following HI.
50
1.4 Summary
The brain requires a constant supply of oxygen and glucose from its circulation. This
is metabolised to generate the ATP necessary to carry out the brain’s vital functions.
Cerebral autoregulation ensures that the supply is maintained despite systemic changes.
However, if the changes are too large, the autoregulation mechanisms can no longer
compensate and damage can occur. HI in neonates is one example of this, and is a sig-
nificant cause of brain injury. Although several mechanisms responsible for the damage
caused by HI are known, there are many questions remaining. Detecting these mecha-
nisms at an early stage to help inform treatment is a particular challenge.
Two tools which can help with this are NIRS and MRS, both non-invasive modalities
that can safely be used to monitor the brains of newborns. The two are complemen-
tary, with NIRS using light to monitor changes in tissue oxygenation and mitochondrial
metabolism, and MRS using magnetic fields to monitor pH and the concentration of cer-
tain metabolites, the most relevant being ATP, PCr, Pi and lactate. The two modalities
can be used simultaneously.
Piglets are often used as models of human neonates to investigate HI. There have been
many previous studies where the brains of piglets subjected to HI have been monitored
using either MRS or NIRS, and several where both have been used. Many of these have
focused on one or two specific measurements as markers of outcome. Whilst this is
valuable from a clinical perspective, it is important to try to understand the measure-
ments together, at the level of the individual. This is where computational modelling
could help. A model could help with the understanding of complex, non-linear relation-
ships between the measurements, and help to link them to the biochemical mechanisms
occurring at the cellular level. The form and content of the model will be strongly
influenced by the experimental measurements available. However, it is important to al-
low for measurements which are not performed in the particular experiments used, but
may be used by others or become available in future. A physiological approach will
help to give the model the flexibility necessary for this. Chapter 2 discusses the use of
mathematical modelling to investigate biological systems, and reviews some common
approaches and some of the existing models relevant to the applications in this thesis.
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Chapter 2
Modelling biological systems
Mathematical modelling is a powerful tool for investigating biological systems. Physio-
logical modelling in particular, is a useful way to collate knowledge about a system and
make explicit the assumptions that are being made. There is a long history of applying
mathematics to biological problems. However, computational advances have led to an
ability to solve complex sets of equations in short spaces of time. Also, developments in
experimental biology have made available large amounts of data with which to develop
and validate models. This creates the opportunity to use sophisticated mathematical
models in medicine. The development of such models relies upon, and also informs,
a biological understanding of the systems involved. The ultimate aim of this type of
modelling is to have a set of integrated models coving all aspects and scales of human
physiology, which can be tailored to individuals. Projects with the objective of achiev-
ing these aims already exist [135, 136]. These projects will only be possible with the
development of mathematical models of many different systems. Therefore biological
modelling and systems biology are growing fields [137].
A model has been defined as an abstract representation of a complex system in math-
ematical form [138]. The formulation of a model usually requires some simplifying
assumptions, and the accuracy of the model relies on the validity of these assumptions.
A mathematical model representing an entire human is a huge challenge. Hunter and
Borg [139] pointed out that the range of scales required in such a model would stretch
from 1 nm to 1 m on the spatial scale and from 1 µs to 109 s on the temporal scale.
Southern et al. [138] classify biological models in terms of ‘levels of biological organ-
isation’. These range from environmental to quantum, and also include (among others)
organ, cellular and molecular. Multiscale models include a mixture of these levels and
must include interactions between them.
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The nature of the model will depend on the scale (or scales) that it represents. Models
on the cellular scale deal with chemical reactions, whereas models on the organ or tissue
scale tend to involve physical properties of the system. The models used in this thesis
are concentrated on these scales, and involve both physical modelling of the blood flow
in the brain, and modelling of chemical reactions taking place at the cellular level.
This chapter contains background information relating to biological modelling. The
first section introduces some of the standard methods used to model biological processes
which are relevant to this work. The following section concerns existing models in the
areas of cerebral blood flow and metabolism.
2.1 Methods used in biological modelling
2.1.1 Chemical reactions
Mass action
The rate of a reaction obeying the law of mass action depends only on the concentration
of the reactants and products. For example, in the reaction.
nwW + nxX
k1−−⇀↽−−
k−1
nyY + nzZ (2.1)
the rate of formation of the product is given by
˙[Y] = k1[W]nw[X]nx − k−1[Y]ny[Z]nz . (2.2)
At equilibrium the forwards and backwards rates are equal, therefore the ratio of the
rate constants is given by
k1
k−1
=
[Y]nyeq[Z]
nz
eq
[W]nweq [X]
nx
eq
= Keq (2.3)
where Keq is the equilibrium constant for the reaction. At equilibrium the Gibbs free
energy change for the reaction is zero. Away from equilibrium it can be calculated as
∆G = RT
− ln Keq + ln ( [Y]ny[Z]nz[W]nw[X]nx
) . (2.4)
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Michaelis Menten
The Michaelis Menten equation describes a simple enzyme mediated reaction. For the
conversion of a substrate S to a product P catalysed by an enzyme E, the reaction scheme
is
S + E
k1−−⇀↽−−
k−1
ES
k2−→ E + P (2.5)
where ES is the enzyme substrate complex. The formation of the complex is reversible,
but dissociation of the product from the enzyme is assumed to be fast and irreversible.
Total enzyme concentration is constant.
[ET] = [ES] + [E]. (2.6)
In steady state, the fraction of enzyme bound to the substrate is also constant
˙[ES] = k1[S]([ET] − [ES]) − (k−1 + k2)[ES] = 0. (2.7)
The rate of formation of product can then be calculated.
˙[P] = k2[ES] =
vmax[S]
kM + [S]
, kM =
k−1 + k2
k1
, vmax = k2[ET] (2.8)
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Figure 2.1: Reaction rate vs substrate concentration for a reaction obeying Michaelis
Menten kinetics
The relationship has two parameters: vmax the maximum reaction rate, which is limited
by the enzyme concentration, and kM, the substrate concentration at which the reac-
tion rate is half maximal. The relationship between rate and substrate concentration is
illustrated in Figure 2.1. This equation is very commonly used in the description of
biological reactions which show saturation kinetics.
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2.1.2 Transport
Passive diffusion of a substance across a barrier, between two compartments with con-
centrations c1 and c2 can be modelled as a mass action process.
∂c1
∂t
= −k(c1 − c2) (2.9)
where k is a constant relating to the properties of the barrier. Transport of substances
across a biological membrane is often controlled by membrane proteins. In these cases
the movement of the substances can be described as a more complex chemical reaction,
for example, a Michaelis-Menten reaction catalysed by the membrane protein.
2.2 Overview of circulation and metabolism models
The rest of this chapter is devoted to discussing existing models of circulation and
metabolism. In the case of models of blood flow, only models of the brain will be
discussed, since these are the most relevant. On the other hand, energy metabolism is
very similar across cell types, so some of the models discussed are general models, or
models of different cell types. Some of the more recent models of brain circulation and
energy metabolism are summarised in Table 2.1 and are discussed below. In this section,
models which describe only cerebral circulation, oxygen delivery, or specific aspects of
metabolism are described. These models are focused relative to the scope required to
simulate brain circulation and metabolism as a whole, and to simulate measurements
from a variety of modalities. Many of them have been included in, or used to help
construct more general models, which are the subject of the Section 2.3.
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Paper and year Main Aspect Summary Situation modelled
Korzeniewski and
Froncisz [32] 1991
Oxidative
phosphoryla-
tion
Dynamic model of respiration in
isolated cells including substrate
dehydrogenation, respiratory chain,
CCO, ATP synthesis and use.
Oxygen concentration, CCO
oxidation and ATP concentrations in
cellular suspensions.
Czosnyka et al.
[140] 1993
Circulation Cerebrovascular resistance and
compliance as a function of cerebral
perfusion pressure and arterial CO2
pressure
Interhemispheric asymmetry of CBF
reactivity to arterial CO2 in patients
with carotid artery stenosis.
Hyder et al. [141]
1998
Oxygen
delivery
Oxygen concentration and transport,
CBF, oxygen extraction and CMRO2
Relationship between CBF and
CMRO2 for graded anaesthesia in rats
and humans and functional activation
in humans.
Ursino and Lodi
[142] 1998
Circulation Interaction between CBF, CBV, ICP
and autoregulation.
ICP dynamics and cerebral dynamics
in response to CO2 changes.
Table 2.1: A summary of some of the models of brain circulation and metabolism
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Paper and year Main Aspect Summary Situation modelled
Aubert et al. [143]
2001
Functional
activation
Neuronal energy metabolism,
brainhaemodynamics and blood-brain
barrier exchange, sodium mebrane
transport and Na/K ATPase.
Function imaging by fMRI and MRS
obtained during prolonged
stimulations.
Korzeniewski and
Zoladz [144] 2001
Oxidative
phosphoryla-
tion
Oxidative phosphorylation in
mammalian skeletal muscle.
Extension of previous models
including the creatine kinase system.
Used to demonstrate that CK does not
significantly affect the kinetics
oxidative phosphorylation. Suggests
parallel activation of different steps of
oxidative phosphorylation at higher
work intensities.
Gjedde [145] 2002 Oxygen
delivery
Oxygen tension in mitochondria and
capillaries, oxygen diffusion, blood
flow and oxygen consumption.
Regional cerebral blood flow and
metabolism as functions of arterial
oxygen saturation.
Table 2.1: A summary of some of the models of brain circulation and metabolism
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Paper and year Main Aspect Summary Situation modelled
Cortassa et al. [146]
2003
Metabolism ODE model of cardiac mitochondrial
energy metabolism including TCA
cycle, oxidative phosphorylation and
Ca2+.
Mitochondrial bioenergetic data, Ca2+
dynamic and respiratory control.
Aubert and Costalat
[147] 2005
Astrocytes &
neurons
Model of compartmentalised energy
metabolism in neurons and astrocytes.
Theoretical testing of the ANLS
hypothesis.
Jung et al. [148]
2005
Circulation Cerebral circulation and oxygen
supply and autoregulation
Relationship between blood pressure
and CSF production. Correlation
between arterial oxygen concentration
and blood pressure with impaired
autoregulation.
Beard [149] 2006 Oxygen
transport and
metabolism
Oxygen transport and metabolism
including ATP, ADP, PCr and
oxidative phosphorylation and ATP
synthase.
Based on data from isolated
mitochondria. Compared with ATP,
ADP, PCr and Pi data at different
workloads during coronary
hypoperfusion.
Table 2.1: A summary of some of the models of brain circulation and metabolism
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Paper and year Main Aspect Summary Situation modelled
Vatov et al. [150]
2006
Metabolism Cerebral blood flow, oxygen pressure,
mitochondrial NADH redox state and
extracellular potassium.
Pathological conditions including
complete and partial ischaemia and
cortical spreading depression.
Simpson et al. [36]
2007
Astrocytes &
neurons
Brain glucose and lactate levels during
neuronal activation, including kinetic
description of transporter proteins.
Concludes neurons are primarily
responsible for glucose uptake and the
generation of lactate transients.
Alastruey et al.
[151] 2008
Circulation One dimensional non-linear model of
pulsatile blood flow and arterial
haemodynamics and autoregulation.
Effects of anatomical variation in the
circle of Willis on blood flow after
sudden carotid artery occlusion.
Cloutier et al. [152]
2009
Astrocytes &
neurons
Based on Aubert and Costolat [147]
but including glutamate cycling, an
expanded description of glycolysis,
and glycogen dynamics.
Calibrated from in vivo data from
freely moving rats. Verified by data
from a restraint simulation.
Table 2.1: A summary of some of the models of brain circulation and metabolism
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Paper and year Main Aspect Summary Situation modelled
Linninger et al.
[153] 2009
Circulation Blood, CSF, parenchyma and spinal
canal model to predict intracranial
pressure gradients and blood and CSF
flow.
CSF flow velocities in normal subjects
and subjects with hydrocepahlus.
DiNuzzo et al. [154]
2010
Astrocytes &
neurons
Unification of models by Aubert and
Costolat [147] Simpson et al. [36] and
Mangia et al. [155].
Modelling of metabolite trafficking in
the brain during functional activation.
Concludes neuronal metabolism is
controlled through glucose uptake.
Orlowski et al.
[156] 2011
Metabolism Addition of pH dynamics to the model
of Cloutier et al. [152], including pH
buffering and proton transport
channels.
pH changes following ischaemic
stroke to help understand tissue
damage.
Table 2.1: A summary of some of the models of brain circulation and metabolism
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2.2.1 Models of circulation
Many compartment models of cerebral circulation have been published since the work
of Monro and Kellie [157]. These models are made up of several compartments, usu-
ally including the arteries and veins. Other commonly modelled compartments include
capillaries, CSF and venous sinuses. In general, this type of models aim to predict vari-
ables such as CBF or intracranial pressure (ICP) from measurements such as arterial
blood pressure and PaCO2. They assume laminar flow of incompressible fluid along
the cerebral blood vessels, and use a variety of different methods to relate changes in
the resistance and volumes of the vessels, and the flow through them to changes in
pressure. A common way of representing such models is as an electrical circuit. Flow
is analogous to current, perfusion pressure to voltage, resistance of the vessel walls to
electrical resistance and changes in volume of the vessels are related to capacitance. An
example is shown in Figure 2.2.
These types of models do not, in general, involve spatial resolution or modelling of
flow in individual vessels. This would increase the complexity of the model and make
it more computationally intensive to solve. Models of this kind do exist [158, 159] and
it would be helpful to use this kind of model if comparing with measurements from
modalities offering spatial information such as MRI.
An aspect of particular importance in models of cerebral circulation is autoregulation.
Most mathematical analyses of autoregulation fall into two categories: transfer function
analysis and physiological models. The former involves formulating functions which
map the input (in this case the arterial blood pressure) to the output (in this case some
measure of CBF such as Vmca) [160, 161]. Transfer function analysis assumes a linear,
time invariant system. Therefore, if a system cannot be approximated well by these
assumptions, a physiological approach is often used. This involves creating a math-
ematical representation of the autoregulatory system. The two approaches have also
been combined [162].
One well-established model that takes a physiological approach is the model by Ursino
and Lodi [142] which has been used to investigate autoregulation and CO2 response.
Another model with a similar approach is that of Jung et al. [148]. This model was de-
veloped specifically to investigate measurements from patients in neurosurgical inten-
sive care, and it also includes a model of oxygen diffusion from the capillaries. These
models concentrate on changes in steady state, or changes over relatively long time
scales, but other models focus on pulsatile flow. Examples include the models by Alas-
truey et al. [151] and Linninger et al. [153] and the model by Czosnyka et al. [140]
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which investigates the relationship between cerebral perfusion pressure and CO2 levels
with the pulse wave of CBF. The models of circulation used in this work are based on
the model by Ursino and Lodi [142] and this is therefore described in more detail below.
Model by Ursino and Lodi
P1 P12 P2 Pc Pv Pvs2G1 2G1 2G2
q
2G2 Gpv Gvs
q f
G f
qo
Go
C1 C2 Cvi
Cic
Cve
Gve
Pa
Pic Ii
Pcv
Figure 2.2: Electrical circuit analog from Ursino and Lodi [142]
The model by Ursino and Lodi [142] is a model of cerebral blood flow, intracranial
pressure and volume, and CSF, illustrated by an analgous electrical circuit in Figure
2.2. The total intracranial volume V is related to the intracranial pressure Pic by the
compliance Cic. The compliance itself is inversely proportional to the intracranial pres-
sure and a constant kE.
Cic
(
dPic
dt
)
=
dV
dt
, Cic =
1
kEPic
(2.10)
There are four compartments with variable volume: the large pial arteries, small pial
arteries, veins and CSF. The arteries are modelled as a parallel arrangement of vessels
with equal (inner) radius r. Blood volume is proportional to r2 and the conductance
of the vessels to r4. The radius is determined by intravascular pressure P, intracranial
pressure, and the tension T in the arterial walls.
Par − Pic(r + h) = Te + Tm + Tv (2.11)
Te, Tm and Tv are the elastic, muscular and viscous tensions, which are summed to give
the total tension. The wall thickness h is calculated from the inner radius, assuming that
the vessel wall is incompressible. The elastic and viscous tensions are functions of r.
Muscular tension is also a function of r, but additionally depends on a parameter that
changes in response to CO2 levels and to represent autoregulation.
The venous part of the model is divided into three compartments. The first represents
vessels from the capillary venules to the large cerebral veins, and the second represents
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the final part of the large cerebral veins up to the dural sinuses. The pressure in the first
compartment is always higher than the ICP, and therefore this compartment does not
collapse. Its conductance is considered to be constant i.e. the effect of small changes in
diameter are ignored. The second compartment is assumed to collapse before entering
the dural sinuses, where the pressure in the vessels equals the ICP. The total volume of
these two venous compartments (Vv) varies according to
Pv − Pic = Pv0 exp (Kv (Vv − Vv0)) + Pv1 (2.12)
where Pv is the venous pressure, Pic is the intracranial pressure and Pv0, Pv1, Kv and Vv0
are constants. The final venous compartment represents the dural sinuses to the heart
and has a fixed conductance and compliance.
CSF is produced from the capillaries, and drains into the venous sinuses. The rates of
these processes are proportional to the transmural pressure differences. However, they
are assumed to only occur in one direction, and their rates become zero if the pressure
gradient changes direction.
2.2.2 Models of oxygen delivery
Other models concentrate on oxygen delivery and the relationship between flow and
oxygen consumption. One such model is that by Gjedde et al. [145]. It was used
to investigate oxygen delivery during neuronal activation and show that experimental
results could be consistent with a negligible reserve of oxygen in brain mitochondria.
Another model of this sort was developed by Hyder et al. [141]. It was created to
investigate the relationship between CBF and CMRO2 seen in data from a range of
experiments. It differs from an earlier model by Buxton and Frank [163] by allowing
a variable diffusivity of the capillary bed. Although these models have been successful
at reproducing data from experiments such as functional activation, they do not model
cellular metabolism and therefore cannot, in general, model concentration changes of
metabolites.
2.2.3 Models of metabolism
The scope of models of energy metabolism ranges from the whole process of energy
metabolism to modelling oxygen binding with CCO [164]. The models in this thesis
need to cover the whole of energy metabolism in order to simulate the necessary ex-
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perimental signals. However, to limit the complexity of the model, most stages are
represented by a single reaction. More detailed models are useful for helping to de-
velop simplified expressions, and in the future could be included in a modular way into
a larger model.
There are several models of glycolysis which include all the reactions and stages. Gly-
colysis has particularly been modelled in yeast [165, 166] and red blood cells [167,
168]. There is a large amount of experimental data available for these cell types and
the biochemical pathways are well know. In yeast, models have been able to repro-
duce glycolytic oscillations seen in these cells [166]. Detailed models of the TCA cycle
also exist [169]. A comprehensive model of the TCA cycle was developed by Wu et
al. [170]. The model includes 42 flux expressions, of which 11 are TCA cycle fluxes
and most of the remaining fluxes are related to transport. It draws on the earlier work
of Kohn et al. [171] and it can simulate the concentrations of 34 biochemical reac-
tants. The rate constants were taken from experimental values where possible and the
rest were estimated based on data from isolated mitochondria. The model was used to
predict how the TCA cycle is regulated. The authors concluded that the most impor-
tant regulator is the mitochondrial redox state i.e. the NAD/NADH ratio, but that ADP
concentration is also an important factor.
Models concentrating on oxidative phosphorylation include the models by Korzeniew-
ski in isolated mitochondria and in muscle, and the model of cardiac metabolism by
Cortassa et al. [146]. The Korzeniewski models are discussed in more detail below,
since aspects of the models in this thesis are taken from them. The Cortassa model, in
addition to oxidative phosphorylation, describes the TCA cycle and other processes in
the mitochondrial matrix. The form of the equation describing ATP synthesis is based
on a model by Magnus and Keizer [172]. The rate equation is derived from a six stage
cycle. Different paths around this cycle are evaluated and combined to give an overall
rate. Some of these paths represent incomplete coupling; i.e. transfer of protons can
occur without ATP synthesis or vice versa. This also leads to the rate depending differ-
ently on the two components of the protonmotive force. The constants in the expression
are derived by fitting to data from isolated mitochondria.
Models by Korzeniewski
Korzeniewski and co-workers have developed dynamic models of oxidative phospho-
rylation, initially for mitochondria in cellular suspensions [32], and then extended to
muscle [144].
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The models include the main reactions involving ATP, ADP, Pi and phosphocreatine.
The total exchangeable phosphate pool is a constant and equal to
3[ATP] + 2[ADP] + [AMP] + [Pi] + [PCr]. (2.13)
ATP and ADP exist in free and magnesium bound forms. The relative concentrations
of these forms depends on the Mg2+ concentration and the relevant dissociation con-
stant. In addition, ATP and ADP are considered separately in the mitochondria and in
the cytosol. The rate of transfer between these is dependent on the mitochondrial and
cytoplasmic concentrations of free ATP and ADP, and on the protonmotive force. The
form of the kinetics is complex and was derived from experimental data.
The ATP synthesis rate is calculated by assuming the rate limiting step is the disso-
ciation of ATP from the enzyme ATPase. ATPase exists in two states: bound to the
substrate, and bound to the product. The dissociation rates of these two states are equal.
The ratio between the concentrations of substrate-enzyme state and product-enzyme
state is equal to the displacement of the synthesis reaction from equilibrium. With these
assumptions, ATP synthesis rate νs,ATP can be calculated as
νs,ATP = ks
e∆G − 1
e∆G + 1
(2.14)
where ks is a constant and ∆G is the Gibbs free energy change for the reaction resulting
in the synthesis of one molecule of ATP in the mitochondria. Hydrolysis of ATP takes
place in the cytoplasm and is modelled as a single Michaelis-Menten process. The con-
stant kM is set so that ATP use is almost saturated at physiological ATP concentrations.
The reactions catalysed by creatine kinase and adenylate kinase are modelled as mass
action reactions.
2.3 Models combining circulation and metabolism
Below, several models are described that aim to represent multiple aspects of energy
metabolism, circulation and oxygen delivery in a number of compartments or cell types.
All are models of the brain except that of Beard [149]. This models cardiomyocytes and
focuses on mitochondrial metabolism which is similar between cell types.
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2.3.1 Models by Aubert et al.
The models of brain energy metabolism by Aubert et al. have been widely used and
adapted since the first model was published in 2001 [143]. This is a model of electri-
cal activity, energy metabolism and haemodynamics made up of 17 variables and 49
parameters and is illustrated in Figure 2.3.
Figure 2.3: Schematic diagram of the 2001 model by Aubert et al. [143]
There are two compartments representing the capillaries and the intracellular contents
of the neurons. ATP is consumed mainly by the Na+/K+ pumps, and this process is
modelled with a Michaelis-Menten relationship to ATP. It is also consumed by other
ATPases which are grouped into a single process occurring at a constant rate. ATP
is regenerated by glycolysis, oxidative phosphorylation and by phosphocreatine. The
creatine kinase reaction is modelled as a mass action reaction, with no dependence on
pH. The description of glycolysis is taken from a model of metabolism in erythrocytes
by Heinrich and Rapoport [173], and parameter values are also taken from the model
of erythrocyte metabolism by Joshi and Palsson [168]. The description of glycolysis
involves four stages. Conversion between pyruvate and lactate is modelled as a mass
action reaction. Lactate, glucose and oxygen are all transported between the blood
and the intracellular space: lactate and glucose by facilitated diffusion, and oxygen by
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simple diffusion.
Mitochondrial respiration is modelled as a single step, which means this model cannot
simulate CCO redox state. Two different rates are given based on alternative hypothe-
ses. In the first, the rate is dependent on pyruvate concentration and oxygen concen-
tration following the Michaelis-Menten relation, and on the ATP/ADP ratio following
the Hill equation. In the second, the rate depends on the oxygen concentration, and
on a second messenger which is proposed to be present during activation. The rate of
mitochondrial respiration is directly proportional to the rate of ATP transport out of the
mitochondria (and this also determines the rate of transport of ADP into the mitochon-
dria). The rate of oxygen consumption is also directly proportional to the respiration
rate.
The model was created to investigate the BOLD response seen during activation in
fMRI. It does not attempt to model blood flow, and activation is represented by an
increase in blood flow (as an input) and an increase in sodium ions entering the intra-
cellular compartment.
An updated version of the model was published in 2002 [174], this time made up of
15 variables and 51 parameters. The main difference in this version of the model was
the introduction of a venous compartment based on the balloon model of Buxton et al.
[175].
Figure 2.4: Schematic diagram of the 2005 model by Aubert and Costalat [176]
This model was later adapted to investigate the ANLS by adding more compartments to
differentiate between the astrocytes, neurons and extracellular space [147] as illustrated
in Figure 2.4. Five compartments are included: the intracellular spaces of the astrocytes
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and neurons, the extracellular space, and capillaries and veins. The intracellular reac-
tions in the neurons and astrocytes were taken from the previous homogeneous models,
and most of the parameters have the same value in the two compartments. The main dif-
ference between them is that a lactate eﬄux from astrocytes at rest was assumed, whilst
for neurons there was neither production or consumption. The model has 20 differential
equations and around 85 parameters.
2.3.2 Model by Simpson et al.
Figure 2.5: Schematic diagram of the model by Simpson et al. [36]
The model by Simpson et al. [36] concentrates on glucose and lactate transport be-
tween six compartments: serum, endothelial cells, basal lamina, interstitium, astrocytes
and neurons. The flows of lactate and glucose between these compartments are illus-
trated in Figure 2.5. It was created with the aim of helping to test the ANLS hypothesis
and differs from other models with this aim by considering the transport of substrates
across the blood brain barrier. As it concentrates on transport, it does not contain a
detailed description of oxidative metabolism. It instead contains one equation repre-
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senting conversion of glucose to lactate, and another representing conversion of lactate
to CO2. There are several parameters controlling the rate of the flows shown in Fig-
ure 2.5, whose values are set from a knowledge of the properties of the different MCT
and GLUT proteins expressed in the different cell types (see Section 1.2.3). The model
has 10 variables, representing the concentrations of glucose and lactate in each of the
compartments except the serum, and around 50 parameters.
The model simulations did not demonstrate the ANLS, but instead suggested that neu-
rons are the main site of glucose uptake and use. The same model was later used to
demonstrate a neuron-to-astrocyte lactate shuttle (the opposite of the ANLS) [155].
2.3.3 Model by Cloutier et al.
Figure 2.6: Schematic diagram of the model by Cloutier et al. [152]
The compartmentalised model by Aubert and Costalat [147] was modified and used by
Cloutier et al. [152], again to investigate the ANLS, but this time comparing with in
vivo data from freely moving rats under different stimuli. A schematic diagram of this
model is shown in Figure 2.6.
The model includes several modifications with the aim of better simulating the meta-
bolic response to stimulation. Firstly, the model of glycolysis was expanded to contain
five reactions rather than three. Secondly, the cycling of the neurotransmitter glutamate
between astrocytes and neurons was added to the model. The cycle is represented by
three equations, and glutamate has the effect of influencing astrocyte metabolism dur-
69
ing stimulation. Thirdly, simulation of glycogen dynamics in astrocytes was added,
with glycogen acting as an additional substrate supply. Finally, the single equation rep-
resenting mitochondrial metabolism was altered to include inhibition at high ATP/ADP
ratios.
The model has 34 differential equations, 89 parameters, and an additional 9 parameters
describing the stimulation input. The parameter values were set by comparison with
steady state data, and dynamic data from a tail pinch experiment in rats. The model was
then validated by comparing with a restraint stimulus in rats, and was found to match
the experimentally measured glucose and lactate concentrations well.
The model has also been further extended by Orlowski et al. [156] to simulate pH with
the aim of understanding pH changes during stroke. This model was itself expanded
to include cellular oedema and diffusion in the extracellular space, which allows three-
dimensional simulations of stroke damage [177].
Figure 2.7 shows a simulation with the model by Cloutier et al., downloaded in SBML
format from the Biomodels database [178], and carried out using the BRAINCIRC
modelling environment (see Section 3.1). Hypoxia-ischaemia was simulated by halving
the arterial oxygen concentration from 8.34 mM to 4.17 mM after 100 s for 300 s. At
the same time, blood flow entering the capillaries was also halved from 0.012 s−1 to
0.006 s−1. All other parameter values were left unchanged. The model shows a fall
in ATP and PCr concentration in neurons, and a much smaller drop in the astrocytes.
The difference is likely to be caused by the higher rate of oxygen consumption in the
neurons. Both astrocytes and neurons display a drop in glucose concentration and a rise
in lactate concentration, with the astrocytes being slower to recover. The overall rate of
glucose transport into the cells vGLC and lactate transport out of the cells vLAC are shown
in the bottom two graphs of Figure 2.7. At rest, lactate flows out of the astrocytes and
into neurons, indicative of the ANLS. When oxygen levels are low, the rate of glycolysis
in the neurons increases leading to lactate flowing out and more glucose entering.
2.3.4 Model by Beard
Beard developed a model to represent oxidative phosphorylation and oxygen transport
in cardiac muscle [149] which is shown in Figure 2.8. The model is made up of five
compartments: the capillaries, interstitial space, and the cellular cytoplasm, mitochon-
drial matrix and mitochondrial intermembrane space. Unlike the other models described
here, this model uses a distributed one dimensional representation of oxygen transport
i.e. the oxygen concentration of the compartments varies along the length of the capil-
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Figure 2.7: Simulation of hypoxia-ischaemia using the model by Cloutier et al. [152].
The top two graphs show the inputs and the other graphs show the model predictions
for concentration and flow rate changes in the neurons and astrocytes.
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Figure 2.8: Schematic diagram of the 2006 model by Beard [149]. The diagram on the
right is taken from Wu et al. [179] which uses a slightly changed version of the same
model.
lary. There are 34 variables in the model and around 65 parameters.
The aim of this model was to investigate how mitochondrial metabolism is regulated,
and it therefore contains more detail in the mitochondrial part of the model. Glycolysis
and the TCA cycle are not explicitly modelled, instead there is a modelled rate of NAD
reduction which is dependent on Pi concentration. The fluxes through complexes I,
III and IV of the electron transport chain are modelled separately. The expressions
for these fluxes have a similar form to one another which is derived by considering
thermodynamic equilibrium. The flux through complex IV (CCO) includes a factor of
1
1 + k/[O2]
(2.15)
where k is a constant that is present to account for the observed dependence of the rate
of oxygen consumption on oxygen concentration. This factor is relevant to the oxi-
dation state of CCO which is discussed in Chapter 5. ATP synthesis is also modelled
and depends on the concentrations of Pi and magnesium bound ATP and ADP. Mag-
nesium binding of ATP and ADP is modelled in both the mitochondrial matrix and the
intermembrane space.
Simulations were compared with data from canine hearts and the model predicted that
cytoplasmic inorganic phosphate is an important regulator of mitochondrial respiration,
allowing ATP rates in cardiac muscle to remain almost constant despite large variations
of metabolic rate.
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2.3.5 Model by Vatov et al.
The model by Vatov et al. [150] was created in order to use measurable variables to
estimate variables that are not measured, in a clinical setting in real time. The model
is simpler than many of the others discussed here, because speed of solution was a
primary concern. It is made up of six differential equations, and its variables include
extracellular potassium concentration and measurable NADH concentration. It is not
explicitly separated into compartments, but it includes simulation of blood flow and a
simple representation of autoregulation. It has been used to simulate ischaemia and
cortical spreading depression.
2.3.6 BrainCirc
The BrainCirc model (Banaji et al. [180]) published in 2005 was developed in con-
junction with the BRAINCIRC modelling environment (see Section 3.1) with which it
consequently shares its name. The primary aim in its development was to investigate
autoregulation. An overview of the main sites and processes is shown in Figure 2.9.
The ten compartments of the model can be grouped into blood vessels, brain tissue and
vascular smooth muscle (VSM).
The circulatory part of the model is similar to the model by Ursino and Lodi [142]
(Section 2.2.1). The blood vessels are subdivided into five compartments: proximal
arteries, distal arteries, capillaries, veins and venous sinuses. Venous volume depends
on transmural pressure, and intracranial pressure is variable.
The radius of the arterial compartments is controlled by the VSM. There are two VSM
sites, corresponding to the proximal and distal arteries. The response of the VSM to
signalling molecules is important for autoregulation. Contraction is determined by the
concentrations of Ca2+, and of NO. Ca2+ concentration depends on the conductance of
potassium ion channels. Four types of these channels are modelled. Their combined
conductance is a function of the concentrations of Ca2+, K+, ATP, H+, adenosine and
NO, and also of the membrane potential.
Brain tissue is divided into three compartments: extracellular space, cytoplasm, and
mitochondrial matrix. It is the extracellular space that exchanges substances with the
VSM. It also exchanges substances with the blood in the capillaries, and with the cyto-
plasm. The most important chemicals exchanged are oxygen and glucose.
The cytoplasm is the site of energy usage. During neural activity K+ is expelled from
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Figure 2.9: The main processes and sites of the BrainCirc model reproduced from
Banaji et al. [180]. The sites are 1. Vascular system 2. Vascular smooth muscle
3. Extracellular space 4. cytoplasm and 5. mitochondrial matrix.
the cytoplasm and Na+ enters. ATP is needed to restore the balance. ATP is also used
for other processes, which are combined into a single Michaelis-Menten process. The
phosphocreatine system and adenylate kinase system are also modelled. These reactions
are treated as mass action reactions, with rate constants set such that they are nearly
always at equilibrium. Glycolysis in the cytoplasm is modelled as a one step irreversible
Michaelis-Menten process. It involves the production of four protons. The vmax of the
reaction is regulated by the AMP/ATP ratio. Pyruvate can be converted to lactate, and
lactate is transported into the extracellular space, and then into the blood.
The cytoplasm exchanges substances with the mitochondrial matrix. Oxygen and CO2
diffuse across the membrane, whilst NADH, ATP/ADP, Pi and pyruvate are associ-
ated with specific transport processes. The most important mitochondrial process is the
TCA cycle. This is modelled as a three stage process. The electron transport chain
is modelled in a single step. The return of three protons to the matrix is coupled to
the phosphorylation of one ADP molecule. The rate of ATP synthesis is taken from
the model by Korzeniewski [144] (see 2.2.3). Some protons return to the matrix via
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leak channels, and the size of the leak current has an exponential dependence on the
protonmotive force.
2.3.7 BrainSignals
The BrainSignals model [12] is a model of cerebral blood flow and metabolism in the
adult human brain. It was developed with the intention of helping to predict, interpret
and validate NIRS measurements, in particular the oxidation of CCO. A schematic
diagram of the model showing the four compartments and the main processes modelled
within them is shown in Figure 2.10. The model is described here in detail, since it
forms the basis for all the modelling in this thesis.
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Figure 2.10: Schematic diagram of the BrainSignals model
Circulation
The circulatory part of the model is based on the model by Ursino and Lodi [142], but
has been simplified. There are three circulation compartments representing the arteries
and arterioles, the capillaries and the veins. The volumes of the veins is assumed to be
constant, and the volume of the capillaries is considered negligible. The arterial volume
Va is proportional to the square of the arterial compartment radius r, which along with
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blood pressure determines CBF by
CBF = G (Pa − Pv) , G = KGr4 (2.16)
where G is the conductance of the cerebral artery compartment, KG is a constant, and
Pa and Pv are the blood pressures at the start of the arterial and venous compartments
respectively.
The arterial radius r, and therefore the conductance G is determined by the balance
of pressure, and elastic wall tension Te and muscular wall tension Tm (force per unit
length) generated in the artery walls
Te + Tm =
(
Pa + Pv
2
− Pic
)
r (2.17)
where Pic is the intracranial pressure which is assumed to be constant. The elastic
tension depends only on r.
Te = h
σe0 exp (Kσ (r − r0)r0
)
− 1
 − σcoll (2.18)
where σe0, Kσ, r0 and σcoll are constants and h is the vessel wall thickness, which is
given by
h = −r +
√
r2 + 2r0h0 + h02 (2.19)
The muscular tension is also a function of r
Tm = Tmaxexp
− ∣∣∣∣∣∣ r − rmrt − rm
∣∣∣∣∣∣nm
 (2.20)
where Tmax is the maximum tension, rm is the radius at which this occurs and rt and
nm determine the shape of the function. Autoregulation is represented in the model by
having Tmax vary with arterial pressure Pa: an increase in arterial pressure leads to an
increase in Tmax and so a decrease in r. Tmax also depends on three other parameters
in the same way, SaO2, PaCO2 and energy demand (u). These four parameters are
combined to give a single parameter η
η = RP
(
νPa
νPa,n
− 1
)
+ RO
(
νO2
νO2,n
− 1
)
+ Ru
(
1 − νu
νu,n
)
+ RC
(
1 − νCO2
νCO2,n
)
(2.21)
where Rx is a sensitivity constant associated with parameter x, and νx is a time filtered
version of the parameter x
dνx
dt
=
1
τx
(x − νx) (2.22)
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where τx is a time constant. The variable η determines Tmax by a sigmoidal relationship
Tmax = Tmax0(1 + kautµ), µ =
µmin + µmaxeη
1 + eη
(2.23)
where kaut is a parameter to allow for simulation of loss of autoregulation, and µmin and
µmax are the lower and upper limits of µ. The steady state relationship between CBF and
Pa with autoregulation present (kaut = 1) and absent (kaut = 0) is shown in Figure 2.11.
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Figure 2.11: Steady state relationship between arterial pressure and blood flow in the
circulation part of the BrainSignals model with and without autoregulation
Oxygen transport
The blood compartments in the model contain oxyhaemoglobin (HbO2) and deoxy-
haemoglobin (HHb). The sum of their concentrations ([Hbtot]) is fixed, and equal in all
compartments, i.e.
[HbO2,a] + [HHba] = [Hbtot] (2.24)
[HbO2,v] + [HHbv] = [Hbtot] (2.25)
where a subscript a or v indicates haemoglobin in the arterial or venous compartment.
Arterial oxygen saturation (SaO2) is often measured, and so is an important input pa-
rameter. Arterial haemoglobin concentration can be calculated from it by
[HbO2,a] = SaO2[Hbtot]. (2.26)
Capillary oxygen saturation ScO2 is an average of the arterial and venous saturations.
Dissolved oxygen concentration in the capillaries ([O2,c]) depends only on the capillary
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saturation and is calculated by
[O2,c] = φ
(
ScO2
1 − ScO2
) 1
nh
(2.27)
where φ is the concentration of oxygen at half maximal saturation and nh is the Hill
coefficient for the dissociation of oxygen from haemoglobin which is assumed to be
constant, i.e. the Bohr effect is ignored.
Transport of oxygen from the capillaries to the mitochondria is a simple diffusion pro-
cess which takes place at rate
JO2,min = DO2([O2,c] − [O2]) (2.28)
where [O2] and [O2,c] are the oxygen concentrations in the mitochondria and the cap-
illary, and DO2 is a diffusion constant set so that, under normal conditions, the rate of
oxygen delivery to the mitochondria equals the rate of oxygen usage (CMRO2). The
oxygen transfer rate must also satisfy
JO2,min = CBF([HbO2,a] − [HbO2,v]). (2.29)
By combining the above equations, the oxygen saturations in veins and capillaries and
JO2,min can be calculated.
Metabolism
The metabolic part of the model concentrates on oxidative phosphorylation in the mi-
tochondria. This involves the pumping of protons into the mitochondria, which then
return to the cytoplasm via ATP synthase. The electrochemical potential for protons is
∆p = ∆Ψ + Z
(
pHm − pHo) , (2.30)
where ∆Ψ is the membrane potential, pHm is the mitochondrial pH, pHo is the cytoplas-
mic pH and the constant Z is given by
Z =
RT
log10 (e)F
, (2.31)
where R is the ideal gas constant, T is the temperature and F is the Faraday constant.
The modelled cytoplasmic pH is fixed and the mitochondrial pH is calculated from the
proton concentration. However, in order to simulate buffers, an effective mitochondrial
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volume for protons is modelled as RHiVmit where Vmit is the mitochondrial volume and
the scaling factor RHi is
RHi =
Cbuffi
(10−pHm − 10(−pHm−dpH))/dpH (2.32)
where Cbuffi and dpH are constants.
The proton pumping occurs by the electron transport chain, which is modelled as three
reactions summarised in Figure 2.12.
CuA,r
CuA,o
cyt a3,r
cyt a3,o
O2
NADH
∆p
f1 f2 f3
Figure 2.12: Electron transfer chain and proton pumping in the BrainSignals model
The first reaction combines Complexes I–III and describes the transfer of four electrons
from NADH to the CuA centre of CCO. This reaction is coupled to the transport of p1
protons across the membrane. It is considered to be reversible, and its rate is given by
f1 = k1CuA,o − k−1CuA,r (2.33)
The forward rate k1 is given by
k1 = k1,0 exp
(
−ck1 (∆p − ∆pn)) (2.34)
where k1,0 depends on the ratio of NAD to NADH, ∆pn is the normal value of ∆p and
ck1 is a constant. The ratio of the rate constants is given by
k1
k−1
= Keq1 =
CuA,req
CuA,oeq
(2.35)
The free energy for this reaction is
∆G1 = −4
E1 + Z log (CuA,oCuA,r
) + p1∆p. (2.36)
When the reducing substrate is NADH
E1 = E0(CuA) − E0(NADH) + Z2 log
(
1
[NAD]/[NADH]
)
(2.37)
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where E0 refers to a standard redox potential. At equilibrium, ∆G1 = 0, which can be
used to give an expression for the equilibrium constant.
Keq1 = 10−(p1∆p/4−E1)/Z (2.38)
The second reaction describes the transfer of the four electrons to the haem a3/CuB
centre, and the pumping of p2 protons. Again, it is considered reversible and its rate is
given by
f2 = k2CuA,rcyt a3,o − k−2CuA,ocyt a3,r. (2.39)
The forward rate is
k2 = k2,n exp
(
−ck2 (∆p − ∆pn)) (2.40)
where k2,n and ck2 are constants. Their ratio is set in the same way as for the first
reaction, with the free energy given by
∆G2 = −4
E0(cyt a3) − E0(CuA) + Z log (CuA,rcyt a3,oCuA,ocyt a3,r
) + p2∆p (2.41)
and equilibrium constant
k2
k−2
= Keq2 = 10−(p2∆p/4−E0(cyt a3)+E0(CuA))/Z. (2.42)
The final reaction describes the reduction of oxygen by cytochrome a3, and the pumping
of p3 protons. This reaction is modelled as irreversible, and its rate is given by
f3 = k3[O2]cyt a3,r
 e−c3(∆p−∆p30)1 + e−c3(∆p−∆p30)
 (2.43)
where ∆p30, c3 and k3 are constants. This reaction sets the rate of oxygen consumption
CMRO2 = Vmit f3. (2.44)
The rates of the three reactions ( f1, f2 and f3) are equal under normal conditions. When
they differ there is a change in the oxidation state of the redox centres. The membrane
potential ∆Ψ varies according to
d∆Ψ
dt
=
p1 f1 + p2 f2 + p3 f3
Cim
, (2.45)
where Cim is the capacitance of the inner mitochondrial membrane. The potential ∆p is
used to drive ATP synthesis, although this is not explicitly modelled. The flow rate of
80
protons through Complex V is
LCV = LCV,max
 1 − e−θ1 + rCVe−θ
 , θ = kCV (∆p + Z log (u) − ∆pCV0) (2.46)
The parameter rCV accounts for a bias between the forward and backward reaction rates,
and ∆pCV0 is the protonmotive force at which there would be no net flow of protons.
LCV,max is the maximum rate of proton flow through the membrane. It is set from the
normal rate of proton flow which is determined by the normal CMRO2. Any different
effects of ∆Ψ and ∆pHn are ignored. Under normal conditions, 25 % of protons return
through leak channels. This percentage varies with ∆p according to
Llk = kuncLlk0
(
exp(klk2∆p) − 1) (2.47)
where Llk0 and klk2 are constants and kunc is a parameter representing uncouplers, which
under normal conditions is set to one.
2.3.8 Comparison between models
The models described in Section 2.3 have many aspects in common. One way in which
to compare models is by their level of complexity. The number of compartments, vari-
ables or equations and parameters of the different models are compared in Table 2.2.
Two models stand out in this table. The model by Vatov et al. [150] has fewer vari-
ables and parameters than the other models, and it is not explicitly divided into com-
partments. This makes it suitable only for simulating particular signals, and limits its
flexibility and its similarity to the underlying physiology. The BrainCirc model (Banaji
et al.2005 [180]) stands out for the opposite reason: it has many more parameters, and
variables than the other models. This can make it difficult to understand the behaviour
of the model and also means it takes longer to solve the model equations.
The models also concentrate on different aspects of physiology. The model by Simpson
et al. [36] is specifically a model of glucose and lactate transport between compartments
and is therefore unsuitable for modelling other aspects of metabolism. However parts
of the model and its parameter values may be included in other models, for example,
the model by Cloutier et al. takes some parameter values from this model. It has also
been combined with the model by Aubert and Costalat [154].
In order to simulate both the NIRS and MRS signals, the circulation, the cellular cy-
toplasm and mitochondria must be modelled. None of these existing models contain
enough detail in all these areas. The models by Beard [149] and the BrainSignals model
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Paper and Year Number of
compartments
Number of
equations /
variables
Number of
parameters
(approx for
some models)
Aubert et al.[143] 2001 2 17 49
Aubert et al.[174] 2002 3 15 51
Aubert and Costalat [147] 2005 5 20 85
Banaji et al.[180] 2005 10 168 237
Beard [149] 2006 5 34 65
Vatov et al.[150] 2006 6 10
Simpson et al.[36] 2007 6 10 50
Banaji et al.[12] 2008 4 12 80
Cloutier et al.[152] 2009 4 34 89
Table 2.2: Number of compartments, variables and parameters in models of energy
metabolism and circulation
(Banaji et al. 2008 [12]) have more detail relating to mitochondrial metabolism and ox-
idative phosphorylation, whilst the others concentrate on cytoplasmic metabolism. Only
the two models by Banaji et al. have sufficient detail in the circulatory part of the model
to simulate the NIRS haemoglobin signals. Many of the models differentiate between
astrocytes and neurons. This significantly increases the complexity of the model and is
not essential if the differences between these compartments are not of particular interest.
It may, however, lead to improved simulations of lactate concentration.
None of these models is specialised to the neonatal brain. The majority of the metabolic
processes occurring are the same in neonates as in adults. However, the appropriate
values for model parameters may differ, and processes may have different levels of
importance.
2.4 Summary
There is a long history of both compartment models of cerebral circulation, and mod-
els of cellular energy metabolism. Integrative, multi-scale models combining the two
have only begun to be developed recently. In particular, the models by Aubert and co-
workers [143, 147] are early examples of this type, and have been the starting point
for several other models. Since 2005, a major application of this type of modelling
has been to investigate the ANLS, thus requiring the compartmentalisation of the mod-
els into astrocytes and neurons. The Braincirc model [180] takes a similar approach
to these models, but is focused on autoregulation, and contains a large number of pa-
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rameters and variables, and is therefore more complex. The BrainSignals model [12]
is smaller and was developed to simulate NIRS signals, and so contains more detail
relating to mitochondrial metabolism to allow simulation of the ∆oxCCO signal.
The aim of this thesis is to simulate signals from both NIRS and MRS. The Brain-
Signals model is therefore a good starting point, but it must be expanded to include
more reactions occurring in the cytoplasm, to allow simulation of MRS measured vari-
ables. In addition, none of these existing models are specialised to the neonatal brain,
which is necessary for this work. A new model has been developed, starting from the
BrainSignals model, to simulate HI in newborn piglets. This new model (referred to as
the BrainPiglet model) is described in Chapter 5 and it is applied to experimental data
in Chapters 5 and 6. The computational and mathematical techniques used to carry out
this modelling are the subject of the next chapter.
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Chapter 3
Methods
This chapter describes the methods used in the modelling process, which begins with
specifying the model equations and using them to run simulations. Subsequent steps
include comparison of the model output with measured data, sensitivity analysis and
parameter optimisation. A flow diagram illustrating the process is shown in Figure 3.1
and the steps are described in the following sections.
3.1 The BRAINCIRC modelling environment
All the simulations were carried out using the open source BRAINCIRC modelling
environment [181] developed by Banaji. The model specification, generation, and the
solving of the resulting differential algebraic equations (DAEs) have been used un-
changed in this work. New methods for output and analysis of the results have been
developed and used.
3.1.1 Describing the model
Models in the BRAINCIRC environment are specified in several plain text files. Before
describing these files, the terminology used throughout this thesis to describe different
types of quantities in the model is clarified.
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Figure 3.1: Flow diagram illustrating the modelling process. Red arrows represent the
path followed during sensitivity analysis, and blue arrows represent the path followed
during optimisation. The diagram illustrates the process in general: the specific pro-
cesses followed in each chapter are described within the chapter.
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Model quantities
The term parameter is used to describe any quantity in the model that has a given nu-
merical value, and is therefore an input to the model. A parameter’s value will only
change throughout a simulation if it (or a parameter on which it depends) is explicitly
changed in a model input file (see Section 3.1.2). Parameters are further divided into
those that are settable i.e. those for which a numerical value must be given, and those
that are derived i.e. those calculated from settable and/or other derived parameters.
The term variable is used to describe any quantity in the model whose value is deter-
mined by solving the model, and is therefore an output. Variables are divided into true
variables and temporary variables. True variables are those that are explicitly solved for
in the model, whereas temporary variables are functions of true variables and parame-
ters.
Temporary variables and derived parameters are used in order to allow the model equa-
tions to be expressed more naturally, and thus make them more readable. In many
cases, the outputs of interest are temporary variables rather than true variables. The use
of temporary variables therefore makes it easier to compare model outputs with data.
Model files
A model is made up of three types of files. Examples of these are available to download
with the software.
Module files These are the files in which the equations and processes of the model are
specified. A model can include any number of module files. Each file is split into sev-
eral sections, including those which define parameters, variables, temporary variables
and chemical reactions. Expressions describing derived parameters and temporary vari-
ables are given in C syntax using the names of the appropriate parameters/variables.
Chemical reactions can be written in a particular format by declaring the reactants and
products and the stoichiometry. If the reaction is declared to be of a Michaelis-Menten
or mass action type, the rate expression is automatically generated from given constants.
Alternatively the rate expression can be defined explicitly. Differential equation terms
are then generated for the reactants and products from the reaction rate and stoichiome-
try. An example of a chemical reaction definition with explanatory comments is shown
below
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\\Name to use as identifier
name: PCrtoATP
\\Reaction type is two-way Mass Action
type: MA2
\\reactants and their stoichiometry
left: 1.0, _PCr, 1.0, _ADP, 1.0, _Hy
\\products and their stoichiometry
right: 1.0, _ATP, 1.0, _Cr
\\number of compartments in the reaction
comps: 2
\\compartment volume for each reactant
compsleft: 1.0, 1.0, R_Hic
\\compartment volume for each reactant
compsright: 1.0, 1.0
\\required rates, for reaction type MA2 these are
\\rate constants for the forward and backward reactions
rates: k_PCrATP, k_nPCrATP
Module files also have sections for specifying algebraic relations, differential equations,
and individual terms in differential equations.
Descriptor files These files state which processes are used in the model. They allow
different reactions or equations to be included without rewriting the whole model. A
BRAINCIRC ‘model’ can therefore be thought of as a family of models, with each
different descriptor file specifying an individual model.
Parameter files These are the files which contain the values for the settable param-
eters. All settable parameters used in the model must have a value given in a single
parameter file which is specified when a simulation is run.
3.1.2 Running a simulation
Running a simulation requires an input file. These files specify changes in parameter
values over time. They can be used to input experimental data. They also usually
contain, for convenience, the experimental data which will be compared with simulation
outputs.
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The DAEs are solved with the RADAU5 fortran solver, which uses a Runga-Kutta
method of order 5 with step size control and continuous output. The time between
the output points therefore depends on the time step that is chosen by the solver which
can vary throughout the simulation. The BRAINCIRC program outputs the results in
plain text files. However, these files are large, and writing them limits the speed of
simulations, and therefore this has been replaced with files in the HDF5 format [182] in
order to speed up running large numbers of simulations for optimisation and sensitivity
analysis.
3.1.3 Markup languages for modelling
Markup languages are popular formats for exchanging information. The two commonly
used markup languages for biological modelling are Systems Biology Markup Lan-
guage (SBML) and CellML. SBML is a XML based format for representing reaction
networks [183, 184]. CellML [185] is a similar project, but has less of a focus on chem-
ical reactions, and concentrates more on reusing models in a modular way. Other XML
based formats exist for exchanging different types of information, including FieldML
for representing mathematical fields such as the distribution of biochemical compounds,
and Simulation Experiment Description Markup Language (SED-ML) for encoding
simulation details. Only SBML and CellML will be further discussed here, since these
are the most well-established, and the most relevant to the BRAINCIRC software.
Online databases exist to share models in both the SBML and CellML formats. The
BioModels database [178] is the largest of these, the latest version (June 2013) contains
143 013 models, however only 963 of these are published models with the remain-
der generated from reaction pathways. The database accepts models in both SBML
and CellML formats. The CellML model repository [186] is specifically for CellML
models and (accessed August 2013) contains 458 models. Both of these repositories
consist mainly of models concentrating on specific aspects of biochemistry, although
they also contain larger and organ scale models. The CellML model repository is di-
vided into categories; there are 33 models in the ‘Neurobiology’ category. Only one of
these, the model by Cloutier et al. [152] is a general model of brain metabolism. The
‘Metabolism’ category contains 78 models, including several of the models mentioned
in Chapter 2 [152, 146, 166, 144, 170]. The BioModels database is not divided into
categories in a similar way, however a search for ‘brain’ returns 144 models including,
again the model by Cloutier et al. [152] and also the Braincirc model by Banaji et al.
[180] described in Section 2.2.
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There are many different pieces of software for creation, analysis and use of SBML
and CellML models. The SBML website [187] contains a software matrix to compare
different software tools, of which there are currently 254 listed including BRAINCIRC.
The CellML website lists around 40 software tools, including two main multi-purpose
modelling environments, OpenCell [188] and OpenCOR [189].
Given the popularity of these two XML formats, it is important that the BRAINCIRC
environment is capable of importing and exporting models encoded in SBML and
CellML. BRAINCIRC can import SBML models and convert them to the BRAIN-
CIRC format, however it has no export facilities. Therefore, an SBML exporter for
models in the BRAINCIRC format has been developed. The details of this, and the
differences between the two formats is discussed in the following section. Adding sim-
ilar capabilities for CellML is a future priority. There are tools that allow conversion
between CellML and SBML in both directions. However, these currently have limited
functionality, although they are likely to be improved in the future.
Comparison between BRAINCIRC format and SBML
The SBML exporter is written in python using the libSBML python API [190]. There
are several differences in the way SBML and BRAINCIRC specify models that can
render the import and export processes imperfect; the main problem being that chemical
reactions are not preserved. The current export method translates all BRAINCIRC
parameters and variables into SBML ‘parameters’. Reactions are translated into terms
in the differential equations that govern the rate of change of these SBML parameters,
rather than into SBML reactions. This reason for this arises from the different way in
which chemical reactions are represented in the two formats, which may stem from the
fact that SBML is more oriented towards reaction networks than BRAINCIRC.
In SBML, quantities taking part in reactions must be defined as species. Each species
must reside within a defined compartment. The rate of chemical reactions must be
given per amount of species, rather than (as is more usual) per change in concentration.
This is so that reactions between species in different compartments, such as transport
reactions, are handled correctly. To illustrate this, consider the reaction R1 described by
S 1 −−→ S 2 (3.1)
where S 1 and S 2 are species in the same compartment. The rate of the reaction is given
by
d[S 2]
dt
= −d[S 1]
dt
= k[S 1] (3.2)
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where k is a constant. In SBML, the reaction would be represented as
<reaction id="R_1">
<listOfReactants>
<speciesReference species="S_1" stoichiometry="1" />
</listOfReactants>
<listOfProducts>
<speciesReference species="S_2" stoichiometry="1" />
</listOfProducts>
<kineticLaw>
<math xmlns="http://www.w3.org/1998/Math/MathML">
<apply>
<times /> <ci> k </ci> <ci> S_2 </ci> <ci> c_1 </ci>
</apply>
</math>
</kineticLaw>
</reaction>
where c1 is the volume of the compartment containing S 1 and S 2. The kineticLaw
element describes the rate of change of the amount of S 1 and S 2 in moles (AS 1 and AS 2)
and it is then assumed that
dAS 2
dt
= − dAS 1
dt
= kc1[S 1] (3.3)
d(c1[S 2])
dt
= − d(c1[S 1])
dt
= kc1[S 1] (3.4)
which is equivalent to Equation 3.2. If S 2 is instead defined to reside in a different
compartment from S 1 which has a volume c2, Equation 3.2 is no longer valid. The
above SBML reaction definition does remain valid however, because the rates are now
considered to be
d(c2[S 2])
dt
= −d(c1[S 1])
dt
= kc1[S 1]. (3.5)
BRAINCIRC does not have a global concept of compartments, and neither does it dis-
tinguish between a species, and a non-chemical variable. Reaction rates are specified
in the more usual way, as relative to concentrations of the chemicals involved. The
reaction above, with the two substances in one compartment, would be represented in
BRAINCIRC as
name: R_1
type: MA1
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left: 1.0, S_1
right: 1.0, S_2
rates: k
and the rate terms in Equation 3.2 would be automatically generated when the model is
compiled. If a reaction includes chemicals in more than one compartment, this must be
made explicit in its definition by specifying, for each chemical involved, the volume of
the compartment relative to the volume of the native compartment of the reaction. In the
second case therefore, with the two substances in different compartments, the reaction
definition must be changed to
name: R_1
type: MA1
left: 1.0, S_1
right: 1.0, S_2
rates: k
comps: 2
compsleft: 1.0
compsright: (c_2 / c_1)
in order for the correct rate equations to be generated.
The BRAINCIRC method is simpler than the SBML method for models with only one
compartment. It also gives greater flexibility; but in practice this flexibility is rarely
taken advantage of, and can lead to mistakes. In its current form therefore, the method
for specifying chemical reactions in BRAINCIRC is better thought of as a short-cut for
writing differential equations rather than a comprehensive specification of reactions. An
improvement would be to adopt a system more similar to SBML in which the compart-
ment of a chemical is defined.
Also, currently in BRAINCIRC, every variable involved in a chemical reaction is taken
to be a true variable, even if (as is commonly the case) some can be expressed in terms of
others as temporary variables. Identifying sets of true variables and temporary variables,
would simplify the simulation process. This is not straightforward however, because
the stoichiometry may be expressed in terms of parameters, the values of which are
not defined until runtime. A proper analysis of the reactions would therefore require
symbolic mathematics.
Another difficulty in translating BRAINCIRC models into SBML models is the feature
of BRAINCIRC that allows a parameter to be defined using a function written in C.
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Mathematical expressions in SBML are defined using a restricted subset of Content
MathML. MathML is a recommendation of the W3C group for describing mathematics
[191]. It can be used for describing both the presentation of displayed mathematics, and
the content of mathematical expressions. It is not possible to translate any C function
which can be used in BRAINCIRC into MathML. For example, reading and writing to
files is possible in BRAINCIRC parameter functions. There is currently very limited
support for translating these explicitly defined C functions into MathML (where this
is possible) and this could be improved. However, the BrainPiglet model does not use
these functions at all, and BrainSignals uses them only for very simple conditional
statements, which can be translated by the exporter.
The final difference between SBML and BRAINCIRC that will be discussed is units.
The use of units in SBML is optional. However, if a model involves quantities with
units, describing them is useful for avoiding mistakes, and vital if the model is to be
understood by others. BRAINCIRC does not have any methods of dimensional analy-
sis, but does allow for optional descriptions of each model quantity, which can include
units. The exporter has an option to include SBML units.
The libSBML library has functions to check the consistency of models, which can in-
clude checking units are dimensionally consistent. To make it easier to achieve consis-
tent dimensions, SBML allows a unit attribute to be added to numbers in mathematical
expressions. This is useful for numbers in expressions which are not dimensionless,
such as multiplying by 100 to convert between metres and centimetres. The alternative,
to define these numbers as parameters, would in general overcomplicate the model.
There is no equivalent to this in BRAINCIRC, and so these units must be added manu-
ally to an exported SBML model to create a model with consistent units. This was car-
ried out for both the BrainSignals and BrainPiglet models, and the units were checked
for consistency.
3.1.4 Reasons for using BRAINCIRC
Using the BRAINCIRC environment was the natural choice for this work, since the
BrainSignals model was created in BRAINCIRC format, and the environment was be-
ing used by others in the group. But the software also offers advantages over other pop-
ular alternatives. MATLAB R©[192] or packages based on MATLAB (e.g. PottersWheel
[193] and SimBiology [194]) are often used. BRAINCIRC has a major advantage over
these packages in that it is free software [195] available to be used and modified by any-
one, and only depends on other software available without charge. The plain text format
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in which BRAINCIRC stores models is easy to read and edit directly, whereas XML
files are more difficult to read and edit. Software packages that store models in SBML
and CellML formats therefore usually require an interface to edit and examine models.
The flexibility of using different descriptor files and parameter files as described above
is another strength of BRAINCIRC. Finally, many software packages for systems bi-
ology have limited or no support for solving DAEs, for example the Systems Biology
Workbench does not support DAEs and OpenCell has only experimental support.
In general, although maintaining custom software is time-consuming, it allows greater
control of the modelling process. Provided adequate import and export functionality
to and from SBML and CellML formats exists, models can still be shared with others
using different software.
3.2 Comparison of model with data
Both measured and modelled signals are resampled to one point per second before
comparison. All analysis is carried out using NumPy [196]. In most cases, comparison
involves calculating the mean square error (MSE) between the measured signal and the
(potentially modified) modelled signal. Four types of comparisons are used, depending
on how the modelled signal is modified. For a modelled signal X and a measured
signal Y with N equally spaced data points, the four types are (using the notation A =∑
i Ai/N):
Unmodified The MSE between the measured and unmodified modelled signal
MSEu =
1
N
∑
i
(Xi − Yi)2. (3.6)
Offset The modelled signal is offset such that its mean matches that of of the measured
signal
MSEo =
1
N
∑
i
(
Xi −
(
X − Y
)
− Yi
)2
. (3.7)
Scale The modelled signal is scaled
MSEs =
1
N
∑
i
Xi (XY)(X2) − Yi

2
. (3.8)
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Scale and Offset Both a scaling factor and an offset are applied to the modelled signal
MSEso =
1
N
∑
i
(
aXi −
(
aX − Y
)
− Yi
)2
a =
(XY) − X · Y(
X2
) − X2 . (3.9)
For each case, the offset and scaling factors are calculated to give the minimum possible
error. A derivation of these factors can be found in Appendix B. The root mean square
(rms) error (
√
MSE) may also be calculated for each of the four forms above.
Although the offset and scaling factors are used because the measurement may contain
an arbitrary offset or scaling, it is the modelled signal that is altered in all cases. This
is because the magnitude of the modelled signal may depend on the model parameters.
Therefore, modifying the measured signal to match it would have unintended conse-
quences when performing parameter optimisation.
3.3 Optimisation
The goal of optimisation is to minimise some aspect of the model output. Usually, this
is the rms distance between a modelled signal and a measured signal across part or all
of the trace. A new graphical interface has been developed to perform optimisation for
a BRAINCIRC model of any number of settable parameters (subject to the constraints
of the particular optimisation algorithm used). Any aspect of the model output can be
minimised that can be written as an expression in NumPy [196] , and there are short-
cuts for generating expressions which minimise the four errors between a modelled and
a measured signal described in Section 3.2. The program allows plotting of the results
as the optimisation is running to follow its progress. Alternatively, optimisations can
be run without using the interface, in which case multiple optimisations can be run
simultaneously, provided they use the same module and descriptor files. The details of
the optimisation, and the results, are saved in the javascript object notation (JSON): a
plain text format which is supported by many different programming languages.
The optimisation itself is performed using OpenOpt [197]. This is an open-source op-
timisation framework that has many features. Here, it is used because it provides a
common interface to many different open-source optimisation algorithms. Optimisa-
tion methods can be broadly divided into global and local methods. Local methods
attempt to find any minimum point, and the minimum found can often depend on the
starting position or details of the algorithm.
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Local methods usually require many fewer evaluations of the objective function, and
may also have more reliable convergence properties. There are many different meth-
ods, some make use of function derivatives and some do not. Local methods can be
used where it is known that there is only one minimum point, or if there is more than
one, but it does not matter which is found. However, for functions resulting from com-
plex models such as those used in this thesis, there may be multiple minima, and the
possibility of converging to one which is not the overall minimum cannot be ignored.
Global methods attempt to find the overall minimum over the whole of a given param-
eter space. Methods of global optimisation are often based on natural phenomena. Ex-
amples include simulated annealing, inspired by the thermodynamics of cooling [198],
evolutionary algorithms such as the genetic algorithm, inspired by natural selection
[199] and particle swarm methods, inspired by the flocking of animals such as birds or
fish [200]. Of course, it can never be guaranteed that the overall minimum has been
found, unless every possible point is tested.
Two methods have been used in this thesis: one local and one global. The local method
chosen was the modified Powell’s method implemented in SciPy [201]. The global
method used was the PSwarm solver [202] developed by Vaz and Vicente [203]. These
methods were chosen because they are linked to the OpenOpt framework and were
found to give good results in preliminary optimisations. They are described below.
3.3.1 Powell’s method
This algorithm for finding a local minimum was originally proposed by Powell [204]. It
is a popular method because it is efficient, and since it does not make use of derivatives,
it can be used for complex functions. The implementation described here is that of the
SciPy package [201] which is a modified version of the original method.
To minimise a function f (x), a starting point x0 is chosen, and f (x0) is evaluated. For
all optimisations in this thesis, the starting point is chosen at the default parameter
values. The function is then minimised in the direction of change of the first parameter,
starting from x0. Brent’s method [205] is used for the one-dimensional minimisations.
This is a commonly used method which is both efficient and reliable. The resulting
best position in this direction is denoted x1, and the decrease in the objective function
( f (x0) − f (x1)) is recorded as ∆1. The function is then minimised in the direction of
change of the second parameter starting from x1, the resulting best position denoted x2,
and the decrease f (x1)− f (x2) recorded as ∆2. This process is then repeated for each of
the N parameters, giving a final position xN .
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The search direction which gave rise to the largest ∆ is then replaced with the direction
from x0 to xN provided two conditions are met. Firstly, fE = f (2xN − x0) must be
smaller than f (x0). This condition indicates that further improvements in the direction
xN −x0 may be possible. Secondly, the ∆ in the direction of greatest decrease (∆?) must
account for a large enough proportion of the total decrease, assessed by
2
(
f (x0) − 2 f (xN) + fE) ( f (x0) − f (xN) − ∆?)2 < ∆? ( f (x0) − fE)2 . (3.10)
If these conditions are satisfied, and the direction set is therefore updated, a further
one-dimensional minimisation is carried out in the new search direction (x0 − xN).
Another iteration is then carried out by setting x0 to xN , and again searching for a
minimum consecutively in each of the set of search directions. The algorithm continues
until the required accuracy of the function value has been reached (or the maximum
number of permitted function evaluations is reached). An example of the progress of
the algorithm whilst minimising a simple function of two parameters
f (p1, p2) =
√
4.0
(
p1 − p2)2 + (1 − p1 − p2)2 (3.11)
starting from p1 = p2 = 0 is shown in Figure 3.2.
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Figure 3.2: An example of the trajectory followed by the modified Powell’s method for
the simple function given in Equation 3.11
3.3.2 PSwarm
This is a derivative-free global optimisation method which combines a pattern search
and a particle swarm. It attempts to find the minimum of functions subject to simple
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bounds (i.e. each parameter can vary between an upper and a lower bound). The devel-
opers of the method compared its performance with other global optimisation methods
using extensive numerical experiments. PSwarm was found to perform well, and to be
more robust to different types of function than the others tested. Another advantage is
that the method can be parallelised, however this has not been implemented here.
The particle swarm part of the method involves a swarm of a given number of particles,
which was set in this work to the default value suggested by the software developers
of 42 for all optimisations. Each particle is randomly assigned a starting position and
starting velocity. The position of the ith particle at time step t is then updated according
to
xi(t + 1) = xi(t) + vi(t + 1) (3.12)
where vi is the velocity of the ith particle updated by
vi, j(t + 1) = I(t)vi, j(t) +
ω1, j
2
(
yi, j(t) − xi, j(t)
)
+
ω2, j
2
(
yˆ j(t) − xi, j(t)
)
(3.13)
for each direction j = 1, . . . , n where n is the number of parameters. The values ω1, j
and ω2, j are random numbers drawn from a uniform distribution between 0 and 1. The
weighting I(t) is known as the inertial factor. It has a value of 0.9 at t = 0 which is
decreased linearly at each time step such that it would reach 0.4 when the maximum
number of permitted time steps is reached. The positions yi(t) and yˆ(t) are the best
positions of the ith particle and of the whole swarm respectively, found up to time t.
Equation 3.13 therefore represents reducing the magnitude of the previous velocity, and
adding a random combination of the directions from the particle to its best position, and
to the swarm’s best position, for each parameter.
The PSwarm algorithm proceeds by implementing a particle swarm as above. An iter-
ation is considered successful if the overall best position of the swarm yˆ is improved
upon by any of the particles at that time step. Following a successful iteration, another
particle swarm step is carried out. However, if the iteration is unsuccessful, i.e. no im-
provement upon yˆ is found, a poll step is executed. This is the pattern search part of the
method, which is included to help achieve convergence.
In the poll step, the objective function is evaluated at points surrounding the overall
best position yˆ, generated by increasing and decreasing each parameter by a step length
α. Initially, α is set to one fifth of the distance between the upper and lower bounds
of the parameter for which this distance is a minimum. If an improvement is found in
the poll step, the best particle is moved to this position, and the iteration is considered
successful. If no improvement is found, the iteration is considered unsuccessful, and
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the step length parameter α is halved. Following the poll step, another swarm step is
executed. If there are two successful poll steps at consecutive iterations in the same
direction, α is doubled.
The process continues until α and all the particle velocities are smaller than their given
tolerance values. Particles which are too close to the best particle are removed from the
simulation to reduce the number of function evaluations required.
3.3.3 Bayesian methods
Another way of inferring parameters is to use Bayesian methods. These aim to de-
termine the posterior probability distribution for a set of parameters by multiplying a
likelihood function by the prior probability distribution of the parameters. The likeli-
hood can be thought of as the probability of the observed data given the model and the
parameter values. The advantage of Bayesian methods is that they result in a proba-
bility distribution rather than a single point in parameter space. However, their main
disadvantage is that they require a much greater number of function evaluations, and
therefore often cannot be used due to constraints on time and computational power. For
this reason, Bayesian methods have not been used in this work, but they are discussed
further in Chapter 7.
3.4 Sensitivity analysis
Techniques for sensitivity analysis can be thought of as either local or global. Local
techniques usually involve calculating derivatives at a given point in parameter space.
Global techniques aim to evalue the effects of a parameter over the whole of parameter
space, i.e. all parameters are varied simultaneously within their given ranges. This is
important when the model is non-linear and involves significant interactions between
parameters, which is usually the case for large complex models such as the ones used
in this work. The difficulty with global methods, is that they require a large number
of model evaluations, and are therefore computationally expensive compared with local
methods. Techniques have been developed which aim to estimate global effects with a
minimal number of function evaluations. One of these techniques is explained below.
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Morris’ method
The method of Morris [206] is a widely used method in situations where there are a
large number of parameters and the cost of model evaluation is high. It is a simple
method, but effective as a tool for screening parameters. For a function of k parameters
f (p), p = (p1, p2, . . . , pk) (3.14)
a maximum (pi,max) and minimum (pi,min) are defined for each parameter. The parameter
space is divided into a grid such that each parameter can take n possible values given
by
pi,min + m
pi,max − pi,min
n − 1 (3.15)
where m is an integer between 0 and n − 1. The jump ∆ is defined as an integer number
of steps on the parameter grid i.e.
∆i = m∆
pi,max − pi,min
n − 1 (3.16)
where m∆ is a fixed integer between 0 and n − 1. An elementary effect is defined as
di(p) =
f (p1, . . . , pi + ∆i, . . . , pk) − f (p)
∆i
(3.17)
i.e. it is the overall gradient of f between pi and pi + ∆i with all the other parameters
held constant. There are a total of n(k−1)(n −m∆) elementary effects. If n is chosen to be
even, and m∆ to be n/2 (as they are in the implementations in this thesis) the number of
elementary effects becomes nk/2.
The Morris method consists of sampling from these elementary effects, and calculating
the sample mean µ (or more commonly the mean of the absolutes µ?) and the standard
deviation σ for each parameter. To implement the method, a base point p0 is chosen
at random. From these base points, a sequence of k + 1 values of p are generated by
incrementing each parameter pi by ±∆i in turn. For the case of m∆ = n/2 the step ∆i
can only be taken in one direction from each point whilst still remaining in the allowed
parameter range. Since each value of p differs from the previous value in only one
parameter, the method is known as the Morris one at a time (OAT) method. The k + 1
values of p define a trajectory in parameter space with k steps of length ∆. The value
of the function at these points is used to calculate the elementary effects. Each point
(except the first and last) is involved in the calculation of two elementary effects. This
is then repeated r times, requiring a total of r(k + 1) function evaluations. Although the
points within the trajectory are dependent, each sample contains only one elementary
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effect from each of the r trajectories, and is therefore made up of independent points.
The calculated values µ, µ? and σ can be used to assess the importance of the parame-
ters on the output. The mean of the absolutes µ? is used to allow for parameters which
have non-linear effects, or strong interactions with other parameters. To make it easier
to compare these values, the parameters are scaled to lie between 0 and 1 before cal-
culating the elementary effects. Parameters with a large µ? can be considered to have
an important effect on the output, whilst those with a small µ? are unimportant. The
standard deviation σ can be used to distinguish between parameters which have a linear
independent effect (small σ) and those which have a non-linear effect or interact with
other parameters (large σ). The main limitation of this method is that it only gives
qualitative results.
Other methods
Techniques for quantitative global sensitivity analysis are usually based on the variance
of the model output. These requires a greater number of model evaluations. However,
there are methods (for example the Sobol’ method [207]) which can estimate quantita-
tive sensitivity indices with fewer computations. These methods generally require that
the input parameters are independent, and that the function is solvable over the whole of
the parameter space defined by the inner product of the individual parameter intervals.
This is not the case in the BrainPiglet model; at many points in this space, the model
fails to give a solution. For the Morris method, undefined results are simply excluded
from the calculations of µ? and σ.
Implementation
Sensitivity analyses were carried out using the R sensitivity package [208]. Firstly,
the R functions are used to generate the complete list of parameter values for which
simulations should be run. These values are saved in a simple database. Multiple
simulations are then run in parallel, until all the simulations are completed. Around
200 000 simulations are run for each of the sensitivity analyses in this work. The results
of each simulation are saved to an HDF5 file, which can be used by the R algorithm to
calculate the relevant sensitivity indices.
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3.5 Summary
The BRAINCIRC modelling environment has been used to implement the model. This
software was developed to simulate biological systems and it was previously used to
develop the BrainSignals model. BRAINCIRC allows a model to be specified in an
easy to read text format, and can simulate systems of DAEs. A new SBML exporter has
been developed, which can be used to export the BrainPiglet model. This allowed the
libSBML library to be used to check the consistency of the units.
Several improvements have been made to the BRAINCIRC environment to increase the
speed of simulations, and extensions have been added using the Python programming
language to perform parameter optimisation and sensitivity analysis. The SciPy Pow-
ell’s method and the PSwarm method were used for parameter optimisations to attempt
to minimise the mean square error or root mean square error between measured and (po-
tentially scaled and/or offset) modelled data. Sensitivity analyses to determine the most
influential parameters were carried out using the Morris method, implemented with the
R sensitivity package.
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Chapter 4
Hypercapnia in healthy adults
This chapter describes the application of the BrainSignals model to simulate a study
involving healthy adults breathing increased levels of CO2 gas. Much of this work
has been published in Moroz et al. [209] which is reproduced at the end of this thesis.
CO2 is used clinically to treat increased intracranial pressure and cerebral ischaemia
[210]. Changes in CO2 levels are also used as a safe way to alter CBF in experiments.
The BrainSignals model was used to investigate the changes in the NIRS signal TOI in
response to a CO2 challenge by considering some of the physiological effects of CO2
which are described below.
4.1 CO2 and brain physiology
Typical PaCO2 is around 40 mmHg. A greater than average PaCO2 is known as hyper-
capnia, and the opposite, hypocapnia. They are usually caused by hypo- or hyperven-
tilation respectively. Most of the CO2 in the blood is in the form of bicarbonate ions
(HCO−3 ). CO2 levels therefore influence blood pH. Hypercapnia can lead to acidosis
(pH lower than 7.35) whilst hypocapnia can cause alkalosis (pH greater than 7.45).
A well known effect of hypercapnia is an increase in CBF [25]. This is accompanied by
an increase in CBV, although to a lesser extent. Ito et al. [211] used positron emission
tomography (PET) to determine a CBF increase of 6 % mmHg−1 and a CBV increase
of 2 % mmHg−1. Hypocapnia has the opposite effect, and so decreases CBF and CBV.
However, the changes measured are usually smaller: the same study found a CBF de-
crease of −3.5 % mmHg−1 and CBV decrease of −1 % mmHg−1. These changes are due
to dilation or constriction of the cerebral arteries, thought to be caused by extracellular
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pH levels [212, 213]. Dilation occurs in vitro even after removal of extravascular cells
and endothelium [214], suggesting the response originates in the vessel wall itself. The
blood brain barrier allows free diffusion of CO2 but is fairly impermeable to HCO−3 .
The effects of CO2 on metabolism however are less well known. During hypercapnia,
there is a decrease in pH. Most studies have also found a decrease in PCr and pyruvate,
and an increase in Pi [26]. Some studies also report changes in ATP [215]. A decrease
in PCr concentration and an increase in the lactate/pyruvate ratio typically indicates that
energy demand is exceeding supply. However, these equilibria are sensitive to pH, and
it is possible that the changes seen during hypercapnia are caused solely by pH changes.
The reduced pyruvate concentration is thought to be caused by a reduction in glucose
metabolism as a result of a decrease in the rate of glycolysis [216]. It has been sug-
gested that oxygen metabolism can be maintained by recruiting substrates, leading to a
‘substrate depletion’ [217]. In experiments carried out over longer periods in animals,
recovery from some of the effects of CO2 has been observed. For example, Arieff et
al. [218] investigated pH in the brain of anaesthetised dogs and found that for moderate
hypercapnia and hypocapnia, changes in intracellular pH were no longer present after
three hours. The majority of studies on the metabolic effects of CO2 have used anaes-
thetised animals. It is possible that different effects would be seen in concious animals
or in humans. Friedman et al. [99] studied hypocapnia in healthy adults with MRS, and
found smaller changes in metabolites than those seen in similar animal studies.
There is disagreement over the effects of CO2 on the rate of oxygen metabolism [219].
Examples can be found reporting an increase [220, 221], a decrease [222, 223], and no
change [51] in cerebral oxygen metabolism during hypercapnia. It is generally accepted
in the fMRI literature that CMRO2 is unchanged. This allows CO2 breathing protocols
to separate flow and metabolic components of the BOLD signal [224]. Recently Zappe
et al. [225] have studied anaesthetised macaque monkeys using EEG. They found that
during inhalation of 6 % CO2, spontaneous neural activity was reduced by 15 %. Sim-
ilar findings were reported in conscious humans by Xu et al. [226]. In addition, they
used an MRI technique to measure CMRO2 and found a decrease of 13 % during mild
hypercapnia.
4.2 Previous NIRS studies
A number of studies have used NIRS to investigate the effects of altering CO2 levels
in humans. They are summarised in Table 4.1. All the studies except one (Cho et
al. [227]) involved periods of both hypocapnia and hypercapnia and monitored either
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Vmca or CBF. The flow changes seen were in the expected direction and ranged from
2.4 % mmHg−1 to 4.8 % mmHg−1, the largest changes being seen in the Vmca of the
anaesthetised patients studied by Yoshitani et al.[87]. The study with by far the largest
number of subjects (Smielewski et al. [228]) observed a Vmca change of 3.2 % mmHg−1.
The NIRS measurements obtained depend on the instruments that were used. The rSO2
(INVOS 4100 and 3100A) and TOI (NIRO 300) are both estimates of the physio-
logical quantity TOS (see 1.3.1). Both the mentioned INVOS spectrometers use two
wavelengths of around 730 nm and 810 nm and detect light at two distances from the
source, which allows a subtraction algorithm to be used to reduce extracranial con-
tamination of the signal. The NIRO 300 uses four wavelengths (775 nm, 825 nm,
850 nm and 904 nm). Spatially resolved spectroscopy is used to calculate TOI from
three differently spaced detectors. Two of the studies in Table 4.1 measured rSO2
[227, 87] and the latter also measured TOI. The first study recorded an increase in
rSO2 of 0.5 % mmHg−1 during hyperoxic hypercapnia. The second recorded an increase
in rSO2 of 0.83 % mmHg−1 during hypercapnia and a decrease of −0.75 % mmHg−1
during hypocapnia in anaesthetised patients. The corresponding changes in TOI were
0.42 % mmHg−1 and −0.88 % mmHg−1. Although the rSO2 and TOI changes were of a
similar size, Yoshitani et al. concluded there was unacceptable disagreement between
the two measurements.
Absolute changes in HbO2 and HHb can be measured by the NIRO instruments. The
earlier NIRO models, NIRO 500 and NIRO 1000, use four and six wavelengths re-
spectively in the range 700–910 nm but do not use spatially resolved spectroscopy
and therefore cannot calculate TOI. Changes in ∆HbO2 and ∆HHb were measured in
four of the studies. Germon et al. [229] do not report absolute concentrations, but
that the change seen in ∆HHb was 34 % larger for the farther spaced optodes (55 mm
compared with 27 mm). Smielewski et al. observed changes of 0.27 µM mmHg−1 in
∆HbO2 and −0.08 µM mmHg−1 in ∆HHb between hypocapnia and hypercapnia in 50
healthy volunteers using an optode spacing of 60 mm. Despite a smaller optode spac-
ing averaging 41 mm, Rostrup et al. [230] found larger changes of 0.47 µM mmHg−1
in ∆HbO2 and −0.11 µM mmHg−1 in ∆HHb. The changes observed by Cho et al.
[227] were much larger, ∆HbO2 increased by 0.79 µM mmHg−1 and ∆HHb decreased
by −0.46 µM mmHg−1. However in this study, hypercapnia was also accompanied by
hyperoxia and an increase in blood pressure.
Overall, the studies show similar patterns in the changes of NIRS measurements during
PaCO2 changes. There is not good numerical agreement between the studies, but this
would be expected considering the range of experimental protocols and measurement
instruments, and the small number of subjects included in some of the studies.
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Paper and
year
Subjects System used Optode
position and
spacing (mm)
PaCO2 (mmHg) Conc. Change (µM mmHg−1) TOI/rSO2
(%)
Vmca (cm s−1)
∆HbO2 ∆HHb
Smielewski et
al. [228] 1995
50 healthy
volunteers
NIRO 1000 One side of
forehead
baseline 35 58
change of 7.5–30 3.2 % mmHg−1
DPF - 5.93 60 0.27 ± 0.01 −0.08 ± 0.01
Germon et al.
[229] 1998
10 healthy
males
prototype NIR
spectrometer
Top left
forehead
oligaemia 34% greater
change
55 from 48.8 ± 3 for 55 mm
spacing
38.7 ± 7
27 to 31.2 ± 3 69.1 ± 9 (2.4 % mmHg−1)
Cho et al.
[227] 2000
5 healthy
volunteers
Comparison One on each
side of
forehead
baseline 42 ± 2
to 56 ± 3 +7.3 ± 0.2
INVOS 3100A 30 and 40
NIRO 500 0.79 ± 0.2 −0.46 ± 0.3
Rostrup et al.
[230] 2002
5 healthy
volunteers
NIRO 500 Left forehead baseline 32–44 (mean 38) hypocapnia - hypercapnia CBF and CBV
0.47 -0.11 measured by PET
DPF - 5.98 mean 41
range 35-47
38–55 (mean 48) CBF – 1.9
ml 100 gbrain−1 min−1 mmHg−1
23–36 (mean 29) CBV –
0.08 ml 100 gbrain−1 mmHg−1
Table 4.1: A summary of NIRS studies of CO2 challenges
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Paper and
year
Subjects System used Optode
position and
spacing (mm)
PaCO2 (mmHg) Conc. Change (µM mmHg−1) TOI/rSO2
(%)
Vmca (cm s−1)
∆HbO2 ∆HHb
Yoshitani et
al. [87] 2002
19
anaesthetised
patients
Comparison Right
forehead
INVOS 4100 30 and 40 baseline 40 ± 4 66 ± 8 48 ± 15
32 ± 4 60 ± 8 34 ± 11 (−4.1 % mmHg−1)
52 ± 5 75 ± 8 80 ± 25 (4.8 % mmHg−1)
NIRO 300 40 or 50 baseline 40 ± 4 66 ± 7
32 ± 4 59 ± 7
52 ± 5 71 ± 6
Table 4.1: A summary of NIRS studies of CO2 challenges
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4.3 Method and results
4.3.1 Experimental protocol
Data were taken from a hypercapnia study carried out by Tachtsidis et al. [83]. The
study was approved by the Joint Research Ethics Committee of the National Hospital
for Neurology and Neurosurgery and the Institute of Neurology, University College
London. The experiment involved 14 subjects breathing normal air for five minutes
to establish a baseline. The inspired CO2 was then increased to about 6 % to increase
EtCO2 by 11 mmHg. This was maintained for ten minutes and followed by a further
five minutes at baseline. Throughout the study, the subjects’ heart rate, MABP and
SaO2 were monitored. The Vmca was also monitored, using transcranial Doppler. The
TOI was measured using the NIRO 300 (Hamamatsu Photonics KK), and ∆oxCCO was
measured with a NIRS broadband system [77].
4.3.2 Data analysis and modelling
All signals were smoothed and filtered. In a few cases, breaks in the signal caused by
instrumentation error were identified manually and replaced by a linear interpolation.
This was necessary in six of the signals, all from different subjects: the SaO2 signal
from one subject (a total of 150 s replaced in 6 places); the MABP signal from another
subject (a total of 27 s replaced in 7 places); and the EtCO2 signal from four of the
subjects (8–12 s removed from a single place in each subject). An example of one of
these is shown in Figure 4.1.
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Figure 4.1: Example of instrumentation error in the EtCO2 signal from one subject
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SaO2, EtCO2 and MABP were input to the model, and its outputs of TOS (TOSm), Vmca
(Vmcam) and ∆oxCCO (∆oxCCOm) were compared to their measured equivalents TOId,
Vmcad and ∆oxCCOd.
To calculate the response, a period of hypercapnia and a subsequent baseline period
were identified by inspection of the EtCO2 trace for each subject. The baseline period
was chosen at the end of the study because, for most subjects, there was a longer, more
stable baseline here than at the beginning. The response ρ was calculated from the
means during these periods, after resampling to 1 Hz, as follows
ρTOS = TOS(hypercapnia) − TOS(baseline) (4.1)
ρVmca =
Vmca(hypercapnia) − Vmca(baseline)
Vmca(baseline)
× 100 % (4.2)
ρ∆oxCCO = CCO(hypercapnia) − CCO(baseline) (4.3)
The Vmca response is given as a percentage because the absolute value of Vmca can
vary but it is assumed to be proportional to CBF (see Section 1.3.3) so it is the relative
change that is of interest.
The measured data are summarised in Table 4.2. There were significant differences
between normocapnia and hypercapnia for both TOI and Vmca with mean responses of
(1.1 ± 0.8) % and (26 ± 11) % respectively. There was no significant difference between
the mean values of ∆oxCCOd during hypercapnia and baseline; the mean ∆oxCCOd
response was (0.02 ± 0.16) µM. Using 10 subjects from the same study, Tachtsidis et
al. [83] found a significant difference of (0.25 ± 0.17) µM between ∆oxCCO during
hypercapnia and at baseline. The analysis was different from the one used here, most
importantly the baseline value was taken at a different time and some subjects with poor
∆oxCCO data were excluded.
Normocapnia Hypercapnia
Duration (s) 240 ± 20 500 ± 50
EtCO2 (mmHg) 39 ± 2 52 ± 2
TOId (%) 69 ± 6 70 ± 6
Vmcad (cm s−1) 42 ± 11 52 ± 13
∆oxCCOd (µM) 0.11 ± 0.30 0.13 ± 0.30
Table 4.2: Summary of the measured hypercapnia data, mean ± SD across the 14 sub-
jects
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4.3.3 Initial optimisations
Methods
Optimisations were carried out as described in Section 3.3 to minimise the mean square
error (MSE) between the measured and simulated signals. Each optimisation was per-
formed with both the SciPy Powell’s method and the PSwarm method. An overview of
the modelling and optimisation process is illustrated in Figure 4.2.
Solve model equations
MABPSaO2 EtCO2
Preprocessing
Set other
parameters
Outputs
Compare
Measured
TOS
Measured
Vmca
Modelled
TOS
Modelled
Vmca
Figure 4.2: Modelling and optimisation process for TOS and Vmca
For each simulation, the following errors were calculated:
ETOS The MSE between TOSm and TOId (see Equation 3.6),
EVmca The MSE between the scaled Vmcam and Vmcad (see Equation 3.8),
ECCO The MSE between the offset ∆oxCCOm and ∆oxCCOd (see Equation 3.7).
Optimisations were performed per subject to minimise either ETOS, EVmca or a combi-
nation of the two. ECCO was not minimised, but its values resulting from the TOS and
Vmca optimisations were compared.
Six optimisations were performed in total, the first two being
1. Minimise ETOS with respect to two parameters: concentration of blood haemo-
globin oxygen binding sites (four times blood haemoglobin conentration) [Hbtot],
chosen for its influence on the absolute TOS value, and RC which represents the
sensitivity of the flow response to PaCO2 changes.
2. Minimise EVmca with respect to RC. [Hbtot] was not included in this optimisation
109
since it was included in Optimisation 1 specifically for its effect on the TOS base-
line value, and it does not have this effect on Vmca. There is no need to optimise
a parameter to match the Vmca baseline, because the modelled signal is scaled to
match the measured data. [Hbtot] was instead set to its value from optimisation 1
to allow a better comparison of ETOS values between optimisations 1 and 2.
The results of these optimisations were used to define two further error functions.
ETOS = ETOS −
1ETOS
2ETOS − 1ETOS
(4.4)
EVmca = EVmca −
2EVmca
1EVmca − 2EVmca
(4.5)
where 1ETOS and 2ETOS are the ETOS values after optimisations 1 and 2 as listed above
and similarly 1EVmca and 2EVmca are the values of EVmca. These expressions were used
in order to assess the ability to fit TOS and Vmca simultaneously, compared with the
ability to fit them alone. The third optimisation was
3. Minimise the sum of ETOS and EVmca by varying parameters [Hbtot] and RC. The
resulting errors 3ETOS and 3EVmca would be expected to lie between 0 and 1, with 0
meaning the fit is as good as for optimisation to that signal alone, and 1 meaning
the fit is as poor as for optimisation to the other signal.
Results
With no optimisation, mean ρTOSm was (7.2 ± 1.2) %, much larger than the measured
value of (1.1 ± 0.8) %. Vmca changes were better predicted, with a mean ρVmcam of
(32 ± 6) %, closer to the measured response of (26 ± 11) %. The resulting errors from
the three initial optimisations are shown in Table 4.3. The errors with no optimisation
(Optimisation 0) are also shown. There were no difference between the two optimisa-
tion methods.
Optimisation ETOS EVmca
0 12 ± 15 2 ± 5
1 0 1
2 1 0
3 0.22 ± 0.03 0.13 ± 0.08
Table 4.3: Initial optimisation results for CO2 studies
As expected, optimising to both the TOI and Vmca signals simultaneously produced er-
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rors larger than when optimising to that signal alone. The differences between the mea-
sured and modelled responses in TOS and Vmca are shown in Figure 4.3. Comparing
the responses of the individual subjects gives further information on how the optimisa-
tions differ, and why the simultaneous optimisation was less successful. The responses
of both signals could be matched well when optimising to that signal alone. However,
the value of RC resulting from optimisation 2 was larger than that from optimisation 1
for every subject; i.e. a greater sensitivity of blood flow to CO2 was required to explain
the changes in Vmcad, than that required to explain the changes in TOId. Consequently,
when optimising to both signals, in every case, the modelled TOS response was larger
than measured, whilst the modelled Vmca response was smaller.
By considering the physiology and measurements, three possible reasons for this dis-
crepancy were proposed and amendments were made to the model to investigate their
consequences.
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Figure 4.3: Error in response ρTOSm − ρTOId vs ρVmcam − ρVmcad for all fourteen subjects for
no optimisation (0) and for optimisations 1–3 as described in the text.
4.3.4 Model extensions
Methods
Three new mechanisms were added to the model in turn and three further optimisations
were performed to minimise the sum of ETOS and EVmca.
4. The TOI measurement may be contaminated by an extracranial component. If
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it is assumed than the TOS value of this component does not change with CO2
levels, the measured change in TOI will be smaller that the TOS change occur-
ring in the brain.
To simulate an extracerebral contribution to TOI, TOS(corrected) was calculated
as the weighted sum of intra and extracerebral compartments
TOSm(corrected) = (1 − α)TOSm(ic) + αTOSm(ec) (4.6)
where α is the fractional contribution of the extracerebral compartment, and
TOSm(ec) its fixed TOS value. TOSm(ic), the intracerebral TOS, was calculated
as before (see Equation C.68). TOSm(ec) and α were optimised together with
RC.
5. Venous volume in the BrainSignals model is fixed at 0.75 (as a fraction of nor-
mal total blood volume Vblood,n). If venous volume were to increase during hy-
percapnia, deoxyheamoglobin concentration would be increased to a greater
extent than oxyhaemoglobin, leading to a lower TOS during hypercapnia and
thus a lower TOS response.
To simulate this possibility, venous volume (Vv) was varied with CO2 levels.
Previously, it was fixed at 0.75 (as a fraction of the normal total blood volume
Vblood,n). This was changed to
Vv = (0.75 + ν(PaCO2 − PaCO2,n)) (4.7)
where PaCO2,n is the model’s normal value of PaCO2. The constant ν was in-
cluded as an optimisation parameter. No limit was imposed on total blood vol-
ume, and the effect of volume changes on ICP was not taken into account. For
many purposes this would be an oversimplification, but it is sufficient to deter-
mine whether a venous volume change could reconcile the discrepancy between
TOS and Vmca response and estimate how large this change would need to be.
6. An increase in cerebral metabolic rate during hypercapnia would lead to a great-
er oxygen extraction fraction, and therefore to a reduced TOS and lower re-
sponse.
To investigate this, a change linking metabolic rate to CO2 levels was intro-
duced, via the parameter u representing the demand. This was varied in a similar
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way to venous volume
u = 1 + d(PaCO2 − PaCO2,n) (4.8)
and d was optimised. Demand affects metabolic rate by altering the rate of ADP
phosphorylation (see Equation C.64) and it also effects the [NAD]/[NADH]
ratio (see Equation C.120) Changes in demand also have a direct effect on the
blood flow (see Equation C.33); but this was removed here by setting the rele-
vant parameter Ru to zero.
In these optimisations, [Hbtot] was again set to its value from optimisation 1. This was
done because inclusion of [Hbtot] led to problems in identifying the parameters. The
additional mechanisms affected the baseline TOS value, however it was their effect on
changes in TOS that was of interest.
Results
The six differently optimised datasets are summarised in Table 4.4. Parameter values
not given in the table were set at their defaults, except for [Hbtot] which was fixed at
its value from optimisation 1 as explained previously. The two optimisation methods
produced the same results to the accuracy given in the table for every simulation.
113
Optimisation 1 2 3 4 5 6
Parameters
Optimised
RC 0.3 ± 0.2 1.5 ± 0.6 1.1 ± 0.4 1.5 ± 0.6 1.4 ± 0.5 1.2 ± 0.4
[Hbtot] (mM) 8.5 ± 3.0 7.8 ± 2.7
α 0.78 ± 0.14
TOSm(ec)(%) 69 ± 6
ν (mmHg−1) 0.06 ± 0.05
d (mmHg−1) 0.16 ± 0.16
Signals
optimised to
TOId X X X X X
Vmcad X X X X X
Errors
ETOS 0 1 0.22 ± 0.03 −0.32 ± 0.31 0.02 ± 0.04 0.01 ± 0.05
EVmca 1 0 0.13 ± 0.08 0.001 ± 0.003 0.01 ± 0.01 0.00 ± 0.06
Table 4.4: Details of the optimisation methods and results. The first row contains the mean ± SD of the optimised parameter values. No value
given indicates that a parameter was fixed.
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The errors in TOS and Vmca response for each subject in each of these optimisation sets,
and for no optimisation, are shown in Figure 4.4.
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Figure 4.4: Error in response ρTOSm − ρTOId vs ρVmcam − ρVmcad for all fourteen subjects in
each optimisation method. The legend refers to the six optimisation methods described
in Table 4.4. Series 0 represents no optimisation. The box at the origin surrounds all
the points from optimisations 4–6, where new mechanisms were introduced.
All three new model mechanisms were capable of reducing the discrepancy between
TOS and Vmca response:
1. The additional compartment for TOSm was the most successful, leading to a
mean ρTOSm of (1.1 ± 0.7) % and a mean ρVmcam of (22 ± 9) %. The mean opti-
mum weight of the extracerebral compartment was 0.8 (range 0.45–0.95). The
negative value of ETOS for this optimisation was a consequence of the reduction
in the size of the modelled fluctuations in TOS.
2. With a varying venous volume, mean ρTOSm was reduced to (1.6 ± 1.0) % and
mean ρVmcam to (20 ± 7) %, which therefore matched better the measured signals.
However, this corresponded to a mean venous volume change of 100 %, (range
20–230 %).
3. When optimising the change in oxygen metabolism, the mean resulting CMRO2
increase was (18.0 ± 8.4) %. The mean ρTOSm and ρVmcam were (1.5 ± 1.0) % and
(21 ± 8) % respectively, which matched well with the measured signals.
An example of the CMRO2 change in one subject, along with TOSm, TOId, Vmcam and
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Vmcad, is shown in Figure 4.5. The plausibility of these changes and their consequences
are considered in the discussion.
∆oxCCO
A plot of the response of ∆oxCCOd vs the response of ∆oxCCOm for the seven differ-
ently optimised datasets is shown in Figure 4.6. It is clear from the graph, that there is
a much greater variation in ρ∆oxCCOd than in ρ∆oxCCOm . The model shows an increase of
∆oxCCO during hypercapnia for all subjects, whereas in the data, some subjects show
a decrease. There is no clear correlation between ρ∆oxCCOm and ρ∆oxCCOd for any of the
optimisation sets. From Figure 4.7 it can be seen that there is little difference between
the mean E(∆oxCCO) for any of the optimisations, except optimisation 6, where there
was a change in demand. The model predicts an increase in demand during hypercapnia
to cause an increased change in ∆oxCCOm. However, the difference in the mean error
is small compared with the variation between subjects.
One of the difficulties with analysing ∆oxCCO data, is that there is a lot of noise in the
signal. A more thorough analysis would require looking at the data on an individual
basis. Figure 4.8 shows ∆oxCCOm and ∆oxCCOd after optimisation 6 for two sub-
jects: one where the models prediction compared well with the data, and one where it
compared poorly. Optimisation of the model to the ∆oxCCO signal would give further
information. However it is unlikely that the model could fit closely the data from the
second example subject shown, even with optimisation.
4.4 Discussion
As expected, Vmcad and TOId increased during hypercapnia. The model behaviour was
qualitatively correct, but there were several differences between the modelled and mea-
sured data. Also, the fluctuations seen in TOSm were greater than the fluctuations in
TOId. These fluctuations originate from blood pressure changes. Therefore, the model
predicts TOI to be more sensitive to changes in blood pressure than what is seen. This
will require more investigation but is not discussed further here.
The fact that both optimisation methods gave the same results increases confidence in
the results of the optimisations, and the performance of the optimisation algorithms.
It also suggests, since the SciPy Powell’s method is a local method, that there were
not multiple minima in the functions investigated. Fewer function evaluations were
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Figure 4.5: Examples of TOS, Vmca and from one volunteer. The graphs show the
measured signal, the modelled signal after optimisation 3, and the modelled signal after
optimisation 6 as described by Table 4.4.
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Figure 4.6: Response ρ∆oxCCOm vs ρ∆oxCCOd for all fourteen subjects in each optimisation
method. The legend refers to the six optimisation methods described in Table 4.4. Series
0 represents no optimisation.
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Figure 4.7: MSE for CCO across all subjects after optimising according to Table 4.4
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Figure 4.8: Comparison of modelled and measured ∆oxCCO for two subjects. The
period of hypercapnia is indicated by the dashed lines.
required for Powell’s method, on average 3 times fewer than for PSwarm (ranging from
1.5–6) However, using the global PSwarm method provides more confidence that the
overall minimum has been found.
The particular aspect of the model investigated here was the ratio of TOSm response to
Vmcam response, which was consistently higher than that seen in the measured data. All
three additional mechanisms improved the simulations; however the changes required
for optimum fitting suggested that no single mechanism is likely to be successful in its
own right.
The method used here of changing venous volume was very simplistic. A more real-
istic method could be incorporated, for example as in the model by Ursino and Lodi
[142]. However, a large change in venous volume would still be required to model
TOId response accurately. Since it is well known that hypercapnia increases CBV, it is
reasonable to suppose there might be an increase in cerebral venous volume. However,
when Ito et al. [231] attempted to measure this using PET they found no change in
combined capillary and venous volume i.e. the CBV change was attributed solely to
arterial volume changes. A study in anaesthetised rats did find a small increase in ve-
nous volume with increased CO2 levels [232]. A linear relationship was found between
venous volume and CBF changes, such that a doubling of CBF caused a 15 % increase
in venous volume. Assuming a CBF change of 2 % mmHg−1 (as seen in Vmca in this
study) this is equivalent to a ν of 0.002 in Equation 4.7, which would therefore predict
a venous volume increase of 3.5 % in this study. The model optimisations suggest a
ν of 0.06 (corresponding to a doubling of the venous volume during the hypercapnia
challenge) would be required to reconcile the observed TOS and Vmca responses. This
is an extremely large change and therefore venous volume change is unlikely to be an
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important factor.
Linking of CMRO2 to CO2 levels allowed improved fits to Vmcad and TOId. But as
before, the 18 % increase in CMRO2 was unexpectedly large. The direction of the
change also disagreed with some recent studies on hypercapnia using EEG and MRI
[225, 226]. These studies suggest CMRO2 should decrease with increasing CO2. If
a mechanism to implement this were added to the model, it would increase the ratio
of the TOIm response to the Vmcam response, leading to a greater discrepancy with the
measured responses.
The measured ∆oxCCO signal could potentially be used with the model to further in-
vestigate CMRO2 changes. However, the relationship between CMRO2 and ∆oxCCO is
complex, and in addition, some of the ∆oxCCO measurements from this study have high
levels of noise. Although this analysis did not show a significant change in ∆oxCCO
during hypercapnia, Tachtsidis et al. [83] found a significant increase in ∆oxCCO us-
ing a different analysis and a slightly smaller set of subjects from the same experiment.
The authors found that this increase could not be attributed exclusively to the increase
in oxygen delivery, which suggests an increase in CMRO2. However, any changes in
CMRO2 which may occur with changing CO2 levels must be small and will therefore
only have a small effect on TOS.
Finally, this analysis suggested that an 80:20 extracerebral to intracerebral weighting
was required to optimise the fit to the TOId datasets. Monte Carlo simulations of
photons travelling through tissue have shown that the sensitivity of NIRS oxygenation
measurements to changes in scalp and skin oxygenation is dependent on the distance
between the source and detectors [233]. It is therefore likely that a different extrac-
erebral to intracerebral weighting would have been required to optimise the fit if the
measurement had originated from a different instrument or used a different algorithm
(see Section 1.3.1). TOI has been shown to have a high sensitivity and specificity to
intracerebral changes [92]. However, the consistency of NIRS measurements of the
cerebral effects of PaCO2 changes has previously been questioned [234].
4.5 Conclusions
The use of a physiological model has shown that there is a discrepancy between the
modelled and measured TOI and Vmca responses to hypercapnia i.e. the measurements
obtained are not compatible with the assumptions about brain physiology incorporated
in the model. This is not obvious from a more simple numerical analysis. The model has
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also been used to show that changes in venous volume or in CMRO2 during hypercapnia
would have to be implausibly large to account for this discrepancy, and it therefore
suggests the origin of the TOI measurement should be questioned. The conclusions
are dependent on the accuracy of the model. However, additional validation of the
model is provided by its use to study data from hypoxia challenges [235]. Also, the
magnitude of the changes required to correct the discrepancy here were large and they
are therefore likely to remain despite small changes in model parameters or equations.
In this analysis, the additional model mechanisms have been considered in turn, since
the data is not sufficient to distinguish between them. Combining the mechanisms and
considering more data could help to refine the model’s predictions. Addition of the
∆HbT signal to the analysis would give further information on volume changes, and
consideration of the ∆oxCCO signal may help with investigating CMRO2 changes.
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Chapter 5
The BrainPiglet model and anoxia in
piglets
This chapter describes the BrainPiglet model, and shows its behaviour during steady
state simulations. The model is then applied to measurements from a study in which
newborn piglets were subjected to brief anoxia. This work has been published using an
earlier version of the model very similar to the one described here [236]. The anoxic
insults are shorter and less severe than hypoxic-ischaemic insults, and are not expected
to cause any cellular damage. The data can therefore be used as an initial test of the
applicability of the model to neonatal piglets. The model is used to simulate both NIRS
and MRS measurements, allowing evaluation of the model as a tool for multimodal data
integration.
5.1 The BrainPiglet model
The BrainPiglet model was created by extending and adapting the BrainSignals model
(see Section 2.3.7). The model was adapted by changing several parameters to values
appropriate to newborn piglets. These parameters were chosen by considering which
physiological quantities represented by the parameters were likely to differ between
piglets and adult humans. These are shown in Table 5.1, and their use is described in
the text below. The model was extended firstly in order to simulate variables measured
by MRS in addition to NIRS, and secondly to allow simulation of HI induced by carotid
artery occlusion, described in Chapter 6. The first of these involves extensive expansion
of the metabolic part of the model, in particular the metabolic processes occurring in the
cytoplasm. The BrainPiglet model has 24 variables and 114 parameters (see Appendix
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Parameter Description Units BrainSignals Piglet Source
CBFn Normal CBF ml 100 gbrain−1 min−1 61 46 [59]
[CCO]tis Total CCO
concentration in tissue
µM 5.5 2.2 [75, 237]
CuA,frac,n Normal fraction of
CCO oxidised
0.8 0.67 [237]
CMRO2,n Normal CMRO2 µM 100 gbrain−1 min−1 194 114 [59, 238]
Pa and
Pa,n
Mean arterial blood
pressure
mmHg 100 50 [59]
[Hbtot]
and
[Hbtot]n
Total blood
haemoglobin O2
binding site
concentration
mM 9.1 5.4 [239]
Vblood,n Normal brain blood
fraction
0.04 0.0325 [238]
Pic and
Pic,n
Intracranial pressure mmHg 9.5 4.5 [240]
Table 5.1: Parameters that were changed from their BrainSignals values in the Brain-
Piglet model
D), whereas BrainSignals has 12 variables and 80 parameters (see Appendix C). A
schematic diagram of the BrainPiglet model is shown in Figure 5.1, and the aspects of
the model which are additional to or changed from BrainSignals are described below.
5.1.1 Circulation
The circulatory part of the model was altered by introducing a changing venous vol-
ume, and adding a supplying arterial compartment to allow simulation of carotid artery
occlusion. A diagram showing the circulation of the BrainPiglet model in electrical
circuit form is shown in Figure 5.2.
The conductances G0, G and Gv are the conductances of the supplying arterial, cere-
bral arterial and venous compartments respectively. Pa, Pa2 and Pv are the pressures
at the start of these compartments. P1 is the pressure at the midpoint of the arterial
compartment, Pvs is the pressure at the venous sinuses, Pic is the intracranial pressure
and Pv,n is the normal venous pressure. The capacitors in the diagram are included to
represent the volume changes of the arterial and venous compartments. However, the
circulatory part of the model is considered to be always at steady state, and therefore
no differential equations related to capacitance are included. The validity of this as-
sumption is explored in the following section. The volume of the arterial compartment
is represented by the charge on the variable capacitor labelled Ca. However, this is for
illustrative purposes only, as arterial compliance is not included directly in the model
and Ca is not a parameter or variable in the model. Arterial volume is calculated from
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Figure 5.1: Schematic diagram of the BrainPiglet model. CA and VA represent the
carotid and vertebral arteries
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Ca Cv
Figure 5.2: A diagram showing the circulation part of the BrainPiglet model in electrical
circuit form
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the arterial radius r by
Va = Va,n
(
r
rn
)2
(5.1)
where Va,n is the arterial volume and rn the arterial radius under normal conditions. The
radius is determined by the algebraic equation
Te + Tm − (P1 − Pic) r = 0 (5.2)
where the muscular and elastic tensions Te and Tm vary as described in Section 2.3.7.
The difference in venous volume from its normal value (Vv - Vv,n) is represented by the
charge on the capacitor labelled Cv. The venous volume is therefore given by
Vv = Vv,n + Cv
(
Pv − Pv,n
)
(5.3)
where Cv is the compliance of the venous compartment which is a constant. The con-
ductance of the veins Gv is assumed to be constant, following Ursino and Lodi [142]
who assign a constant conductance to the proximal venous compartment in their model.
To simulate carotid artery occlusion, an extra compartment representing the arteries
supplying the brain was added to the model. Reducing the conductance G0 of the sup-
plying artery compartment represents occluding the carotid arteries, and causes a de-
crease in pressure of the blood entering the brain. The pressure at the cerebral arteries
Pa2 is calculated by equating the blood flow through the two arterial compartments
Pa2 =
G0Pa + GPv
G + G0
(5.4)
The pressure at the veins is calculated from Gv as a fraction of the total conductance Gt
Pv =
Gt
Gv
(Pa − Pvs) + Pvs (5.5)
where Pvs is the constant pressure at the venous sinuses, and Gt is given by
Gt =
GG0Gv
GG0 + GGv + GvG0
. (5.6)
Steady state approximation
As in BrainSignals, the circulation part of the BrainPiglet model is assumed to be al-
ways at steady state. This was done for simplicity, since the model is not intended to
study short time scale responses. The effect of changes in input parameters on the ar-
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terial wall tension are subject to time delays and represented with differential equations
(see Equations D.18 to D.21). However, no other differential equations are used in the
circulation part of the model, and therefore a steady state is assumed.
In order to investigate this assumption, two submodels were created, comprising of just
the circulatory part of the BrainPiglet model, with a fixed blood oxygen concentration.
One of these submodels was altered so that a steady state was not assumed. To do
this, two model equations were replaced with differential equations. First, to represent
the time course of changes in arterial radius, Equation D.97 (P1 = (Pa2 + Pv) /2) was
replaced with
dr
dt
=
G (Pa2 − 2P1 + Pv)
Krr
(5.7)
where Kr is a constant of proportionality between arterial volume and radius
Kr =
Va,nVblood,n
rn2
(5.8)
where Va,n is the normal arterial volume as a fraction of total blood volume, and Vblood,n
is the fraction of brain volume which is blood. The second differential equation de-
scribes how venous pressure changes with time
dPv
dt
=
2G (P1 − Pv) −Gv (Pv − Pvs)
CvVblood,n
(5.9)
and replaces Equation D.103:
Pv =
Gt
Gv
(Pa − Pvs) + Pvs. (5.10)
The change in arterial radius for both submodels in response to a step change in pressure
is shown in Figure 5.3. There is a small difference between the two, however, since the
changes in pressure and other inputs in the data occur over longer time periods, the
assumption that the circulation is at steady state is reasonable. However, it should also
be noted that the response of the model to changes in pressure also depends on how
autoregulation is modelled.
5.1.2 Metabolism
In order to simulate measurements from MRS, several metabolic processes were added
to the model. The processes that relate to glycolysis, lactate and the TCA cycle are
summarized in Figure 5.4. Glycolysis is modelled as a single stage Michaelis-Menten
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Figure 5.3: Difference in the change in arterial radius between submodels using dif-
ferential equations (dashed) and the steady state assumption (solid) caused by the step
change in arterial pressure shown on the left.
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Figure 5.4: Metabolic processes relating to glycolysis, lactate and the TCA cycle
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process with a maximum rate vglyc which depends on the energy state of the cell and
varies as
vglyc =
vglyc,n (I + 1)
1 + I
[ATP]
[ATP]n
[AMP]n
[AMP]
(5.11)
where vglyc,n is the normal maximum rate, and I is a parameter which determines how
much the rate of glycolysis can change depending on the ATP and AMP concentrations.
The normal rate of glycolysis is set to match the normal rate of glucose consumption
CMRgluc,n. The net rate of glucose transport between the cell and capillaries is given by
TGlucin − TGlucout = vglut
 [glucc][glucc] + kglut − [gluc][gluc] + kglut
 (5.12)
where [gluc] is the cytoplasm glucose concentration and [glucc] is the capillary glucose
concentration which is assumed to be constant. The maximum rate vglut is set such that
the net rate of glucose transport into the cell is equal to CMRgluc,n when the glucose
concentration is at its normal value. The parameter kglut is an average of the different
GLUT transporters found in the brain and is set from [241].
Lactate transport into and out of the cell is modelled in the same way, but also involves
the transport of a proton, so that the net rate is
TLacin − TLacout = vMCT
 [lacc][H+]n(kMCT + [lacc]) ([H+]n + kMCT,H+)
− [lac][H
+
cyt](
[lac] + kMCT
) (
[H+cyt] + kMCT,H+
)
 (5.13)
where the lactate concentration in the capillaries [lacc] is also assumed to be constant.
Transport of lactate between brain cells has been the subject of much recent modelling,
owing to the interest in the ANLS [147, 154, 152]. Neurons and astrocytes have dif-
ferent expression of the MCT family members, leading to different kMCT [36]. In the
BrainPiglet model however, there is no distinction between the two cell types and an
intermediate value for kMCT is used. The maximum rate of lactate transport vMCT is cal-
culated from the normal cerebral rate of lactate consumption CMRlac. For the model to
be at a steady state under normal conditions, the stoichiometry of the reactions requires
that
1
6
CMRO2,n − CMRgluc,n = 12CMRlac,n. (5.14)
Satisfying this equation with the chosen values for CMRgluc,n and CMRO2,n results in a
negative value of CMRlacn i.e. lactate is produced in the cytoplasm at baseline conditions
and transported into the blood.
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The interconversion between pyruvate and lactate is modelled as a mass action reaction,
which is fast, and therefore effectively always at equilibrium and has a rate given by
TPytoLac = kpl[Py][H+cyt] − k−pl[lac][NADcyt] (5.15)
where k−pl is a constant and kpl depends on [NADHcyt]. The ratio of the rate constants is
set so that under normal conditions the net rate of the reaction is equal to CMRlac,n.
The processes relating to ADP and ATP occurring in the cytoplasm (and mitochondria)
are shown in Figure 5.5. The ATP hydrolysis rate has a Michaelis Menten form de-
ATP
ADP
ATP
synthesis
ATP
use
glycolysis
PCr
Cr
Creatine
Kinase
Adenylate
Kinase
AMP
Figure 5.5: Metabolic processes in the cytoplasm and mitochondria relating to ATP use,
synthesis and buffering
pending only on ATP concentration. It has a small kM so that the rate of hydrolysis does
not decrease significantly until ATP levels are low. The maximum rate of ATP use is
proportional to the demand u. ATP is buffered by the creatine kinase reaction and the
adenylate kinase reaction which are both modelled as mass action reactions and have
rates
TCK = kPCr[PCr][ADP][H+cyt] − k−PCr[ATP][Cr] (5.16)
and
TAK = kAK[ADP]2 − k−AK[ATP][AMP] (5.17)
respectively. Both of these reactions are assumed to be fast compared to other processes
and therefore to be effectively at equilibrium at all times.
The malate aspartate shuttle is modelled as a mass action process with a rate given by
TMAshuttle = kMAshut[H+cyt][NAD] − k−MAshut[NADcyt][H+m] (5.18)
where, again, the concentrations of cytoplasmic and mitochondrial NADH are included
within the rate parameters.
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Unlike the BrainSignals model, the BrainPiglet model simulates cytoplasmic pH. Buff-
ering of H+ ions in the cytoplasm is modelled in an analogous way to that of the mito-
chondria (see Equation 2.32) with the same value for dpH and a slightly higher value
for Cbuffi,c following Korzeniewski and Zoladz [144].
The mitochondrial part of the model has been expanded to include the TCA cycle. The
transformation of pyruvate to acetyl-CoA and the whole TCA cycle are combined into
a single reaction that consumes one molecule of pyruvate and produces five reducing
equivalents which are all assumed to be NADH for simplicity. The rate is given by
TTCA =
vTCA[Py][NAD](
km,tcaN + [NAD]
) (
km,tcaP + [Py]
) . (5.19)
The km values were estimated from the detailed model of the TCA cycle by Wu et al.
[170]. The km for pyruvate is small, since this model suggests that the TCA cycle rate
is not sensitive to pyruvate concentration unless it falls very low. The rate of the TCA
cycle is also influenced by ATP and ADP concentrations. However, the main controlling
factor is thought to be the NAD/NADH ratio [242].
ATP synthesis takes place in the mitochondria. The transport of ATP and ADP into and
out of the mitochondria is not explicitly modelled. The rate of return of protons through
Complex V is adjusted from BrainSignals (Equation 2.46) so that
θ = kCV
∆p + Zna log
 gpgp,n
 − ∆pCV0 (5.20)
where na is the number of protons required to phosphorylate one ATP, including the
proton used in the exchange of ADP and ATP across the mitochondrial membrane, and
gp is the phosphorylation potential
gp =
([ADP]/c	)([Pi]/c	)
([ATP]/c	)
. (5.21)
This is the equilibrium constant for the hydrolysis of ATP. Equilibrium constants are
calculated from thermodynamic activities, which are considered to be dimensionless. If
the concentration of a solute is low (as they are in this case) the activity is given by the
solute concentration divided by a standard concentration c	 (1 M). Therefore, gp is a
dimensionless quantity, and is calculated in the BrainPiglet model by
gp =
[ADP][Pi]
(1000 mM) [ATP]
. (5.22)
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where the factor of 1000 arises because the concentrations are given in units of mM
rather than M. The Gibbs free energy of ATP hydrolysis ∆G is calculated by
∆G = ∆G◦ + ZF log
(
gp
)
(5.23)
where ∆G◦ is the standard Gibbs free energy of ATP hydrolysis and F is the Faraday
constant. The protonmotive force at which there would be no net flow of protons is
given by
∆pCV0 =
−∆Gn
naF
(5.24)
where ∆Gn is the normal value of ∆G. Finally, ATP is synthesised in the mitochondria
by Complex V at a rate of
TADPtoATP =
LCVVmit
na
. (5.25)
5.2 Steady state simulations
Figure 5.6 shows the results of steady state simulations for a varying oxygen saturation
in the model, with all other parameters at their default values. As expected, as SaO2
decreases, both CBF and CBV (shown as total blood volume as a fraction of its normal
value Vt/Vt,n) increase. There is a slight decrease in CMRO2 and a drop in ∆oxCCO.
The concentration of PCr decreases whilst the concentration of ATP remains constant,
showing the expected buffering relationship. Lactate concentration increases as SaO2
decreases. SaO2 is not reduced below 50 % because at lower SaO2 lactate continues to
build up in the cells and no steady state is reached. This is because the rate of lactate
production exceeds the maximum rate at which it can be transported out of the cells.
The points on the plots are experimental values taken from Tsuji et al. [125] showing
how CCO oxidation and PCr and ATP concentrations change with SaO2. These should
be compared with the model predictions with caution since the piglets were one month
old, and the periods of hypoxia used were only brief. Also PaCO2 and MABP were not
held constant. Each of the eight piglets were subjected to brief hypoxic periods with
increasing severity. The PCr and ATP concentrations (measured by MRS) are given as
percentage decreases, and here are multiplied by the normal model concentrations for
comparison. The ∆oxCCO changes were given in µM multiplied by the differential path
length factor (DPF). Here they have been converted to µM by using the DPF for human
infant brains of 4.39 quoted in the paper. The experimental values show a different
shape than the model prediction, with CCO not becoming reduced until SaO2 is around
60 %. This difference is discussed further in the following section.
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Figure 5.6: Steady state plots vs arterial oxygen saturation for the BrainPiglet model.
The points show experimental values taken from Tsuji et al. [125].
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Modelled CBF and CBV as a function of Pa are shown in Figure 5.7. The shape of the
autoregulation curve is not significantly changed from the BrainSignals model, but the
position of the plateau is shifted to the normal blood pressure of the piglet. Experiments
investigating autoregulation in piglets have found CBF remains constant in the range
50–80 mmHg [243, 244, 245]. The model shows a smaller range of blood pressure over
which constant CBF is maintained.
The points in Figure 5.7 are experimental data taken from Chemtob et al. [244] showing
the variation of CBF with MABP. Eight newborn piglets were subjected to one episode
of hypertension and one of hypotension. CBF was measured using microspheres. The
results show a similar pattern to that predicted by the model, but the position and value
of the plateau are different. The piglets in this experiment had significantly higher
baseline MABP (73 mmHg) and CBF (92 ml 100 gbrain−1 min−1) than the model values
(see Table 5.1) making it hard to compare with the model. Differences may be caused
by differences in experimental protocol and anaesthesia.
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Figure 5.7: CBF and Vt/Vt,n vs Pa for steady state simulations. It should be noted that the
piglets in the experiment from which the data in the left plot were taken had a higher
baseline blood pressure than the model and in the experimental data with which it is
later compared in detail.
Figure 5.8 shows modelled CBF and CBV as a function of PaCO2. The points show
experimental values taken from Brown et al. [246]. Six newborn piglets were subjected
to either one period of hypercapnia, one of hypocapnia, or one of each. CBF was
measured using NIRS methods. A mean reactivity of 1.4 ml 100 gbrain−1 min−1 mmHg−1
was found. This is higher than the 0.75 ml 100 gbrain−1 min−1 mmHg−1 predicted by the
model. The baseline CBF of the piglets in this experiment was lower than the value
chosen for the model. The experimental datasets compared with the model in detail in
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the next two chapters do not include PaCO2 changes, and therefore CO2 reactivity is
not considered further.
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Figure 5.8: CBF and Vt/Vt,n vs PaCO2 for steady state simulations.
In general, comparison of steady state simulations with experimental data is difficult,
since there are limited data available for newborn piglets. Also, it is difficult to keep
other systemic values constant when performing this type of experiment, and anaesthe-
sia may affect the results.
5.3 Modelling anoxia
The application of the model to data from an anoxia study in newborn piglets is now
described.
5.3.1 Methods
The experimental data were taken from a publication in 2000 by Springett et al. [247].
The experiment involved subjecting six newborn piglets to brief periods of anoxia. The
piglets were anaesthetised with isoflurane and artificially ventilated. Their FiO2 was re-
duced from 40 % to 0 % for 105 s. After returning FiO2 to 40 % for 10 min, the anoxia
was repeated six times for each piglet. MABP was monitored throughout, and continu-
ous NIRS and 31P-MRS measurements were recorded.
The data were presented in the publication [247] as plots which are shown in Figure
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5.9. The left figure (Figure 1 in the paper) shows the results from one piglet, described
by the authors as typical, averaged over all anoxias. The right figure (Figure 2 in the
paper) shows the results averaged over all anoxias for all piglets. The average MABP
was extracted from the left figure, since the MABP averaged over all piglets was not
available, and this was used an input to the model. SaO2 was also used as an input. This
was estimated from the experimental protocol as no measurements were available. CO2
levels were not reported during the challenge, and were assumed to remain constant.
The model inputs are shown in Figure 5.10. The NIRS and MRS measurements were
extracted from the plots on the right of Figure 5.9 and compared with the model outputs.
Figure 5.9: Plots from Springett et al. [247] showing results averaged over six anoxias
from left: one piglet and right: six piglets. The periods marked are defined by the
authors as A) anoxia R) reoxygenation F) fast recovery phase and S) slow recovery
phase. In the top graphs HbT is offset for clarity.
The experimental results showed a decrease in ∆HbO2 and an increase in ∆HHb during
anoxia. Immediately after anoxia, there was an increase in ∆HbT indicating an increase
in CBF. There was a reduction of CuA (a drop in ∆oxCCO) during anoxia and a small
hyperoxidation upon reoxygenation. The MRS results showed a decrease in PCr con-
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Figure 5.10: Arterial blood pressure and arterial oxygen saturation used as model inputs
to simulate anoxia [247]. Blood pressure was taken from the measurements from one
typical piglet (see Figure 5.9). SaO2 was estimated from the experimental protocol.
centration and an increase in Pi concentration, but no changes in ATP concentration
were seen.
5.3.2 Results
The results of the simulations, with all the parameters set to their default values, are
compared with the measured results in Figure 5.11. The model matches the direction of
change for all the measurements, however there are some differences between the mag-
nitudes of the changes, particularly for PCr and Pi. From a knowledge of the model,
and the relevant physiology, four model parameters were changed to improve the sim-
ulations: these are listed in Table 5.2. Each was chosen to improve a specific aspect of
the simulations.
Parameter Default Value Changed Value
[PCr]n/[Pi]n 1.5 2.7
I 3 50
kaut 1.0 0.5
[NAD]n/[NADH]n 9.0 1.5
Table 5.2: Parameters that were changed to improve the simulations of anoxia.
• To improve the simulation of the overshoot of ∆HbO2 following anoxia, the au-
toregulation capacity in the model was decreased by reducing the parameter kaut
from 1.0 to 0.5. After this change, the maximum venous volume increase was
approximately 45 %. The improvement in the simulation of ∆HbT is shown in
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Figure 5.11: Model simulations (solid line) compared with measurements (dashed line)
from (left) NIRS and (right) 31P-MRS during anoxia in piglets. The measured results
are taken from Springett et al. [247] and the simulations were carried out with all model
parameters set to their default values
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Figure 5.12. The effect of changing kaut on autoregulation in the model is also
shown.
• To reduce the magnitude of the drop in simulated [PCr], the glycolysis rate was
made more sensitive to changes in AMP and ATP concentration by increasing the
parameter I from 3 to 50. This resulted in an approximately sevenfold increase
in glycolysis rate during anoxia which reduced the drop in [PCr] during anoxia
from 75 % to 45 %
• To correctly simulate the magnitude of the change in [Pi], the ratio of normal
concentrations [PCr]n/[Pi]n was increased from 1.5 to 2.7. In the model, if [ATP]
is constant, changes in [PCr] and [Pi] are equal and opposite (ignoring AMP
which is present only at small concentrations). The experimental results therefore
require the ratio [PCr]n/[Pi]n to be 2.7. With this ratio, the model will accurately
simulate the Pi measurement, providing PCr is accurately simulated.
• To decrease the rate of reduction of CCO, the normal ratio [NAD]n/[NADH]n was
decreased from 9 to 1.5. This resulted in a slower drop of simulated ∆oxCCO.
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Figure 5.12: Effect of varying kaut with other parameters set to the values show in Table
5.2. Left: Modelled and measured ∆HbT vs time and right: Modelled steady state CBF
vs arterial blood pressure.
The comparison between modelled and measured results after these parameter changes
is shown in Figure 5.13. It can be seen that the modelled results matched the measured
results more closely, and there are improvements in the aspects listed above. The plausi-
bility of these parameter changes based on evidence from the literature is considered in
the discussion. The modelled lactate concentration is shown in Figure 5.14 and shows
a rise in lactate during anoxia as expected.
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Figure 5.13: Model simulations (solid line) compared with measurements (dashed line)
from (left) NIRS and (right) 31P-MRS during anoxia in piglets. The measured results
are taken from Springett et al. [247] and the simulations were carried out with the
parameter changes shown in Table 5.2
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Figure 5.14: Modelled lactate concentration during anoxia with parameter values shown
in Table 5.2
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The effect of the parameter changes on the steady state behaviour of the model is shown
in Figures 5.15, 5.16 and 5.17. The reduction in autoregulation causes a reduced in-
crease in CBF and CBV as SaO2 drops. It also leads to smaller changes in CBF and
CBV with changing CO2, but larger changes with changing arterial pressure. A re-
duction in SaO2 causes CMRO2 to fall. This fall is greater for the changed parameter
values. This is partly caused by the reduced oxygen delivery from the lower autoreg-
ulation and consequently smaller CBF. However, there is a greater effect from the
reduction in [NAD]n/[NADH]n. As SaO2 falls, the reduced oxygen concentration at the
mitochondria causes CMRO2 to fall. This is somewhat counteracted by the build-up
of electrons in the transport chain and build-up of NADH giving an increased concen-
tration of cyt a3,r. The effect is smaller when [NAD]n/[NADH]n is lower because the
increase in NADH has a smaller effect on the first reaction in the electron transport
chain (Equation D.28) and therefore, the drop in CMRO2 is greater. For the same rea-
son, CCO becomes less reduced when [NAD]n/[NADH]n is lower. A larger drop in
CMRO2 also causes a larger drop in PCr concentration and a larger increase in lactate
concentration. Increasing the parameter I leads to a smaller drop in PCr concentration
in the dynamic simulation by increasing the rate of glycolysis. However, this only has
an effect once PCr is depleted enough for the ATP concentration to begin to fall, at
arterial saturations lower than 50 %.
Following these parameter changes, the model’s simulations of changes in ∆oxCCO
were further investigated. The model did not replicate the delay between the onset of
anoxia and the reduction of CuA which was seen in the measurements. In order to
investigate this, and also to explore the hyperoxidation seen following anoxia, which
is seen in the measurements but is not well understood, the model was further altered.
Initially, the equation representing the transfer of electrons to oxygen was changed from
its original form (Equation 2.43) to
f3 = k3cyt a3,r
[O2]
[O2] + k
(k + [O2]n)
 e−c3(∆p−∆p30)
1 + e−c3(∆p−∆p30)
 . (5.26)
This form was chosen to create a Michaelis-Menten relationship between oxygen and
CMRO2. This is a simplification because the reaction is not a single enzyme-catalysed
reaction. The effective kM for oxygen k was set to 5 µM. By choosing this value for k,
which is much lower than the normal value for [O2] of 0.0240 mM, the rate of the reac-
tion remains high until [O2] is low. This would therefore be predicted to delay the drop
in ∆oxCCO. The model was then further changed such that there was no dependence
of ATP synthesis rate on the phosphorylation potential by replacing gp with its normal
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Figure 5.15: Steady state plots vs arterial oxygen saturation for the BrainPiglet model
with default parameter values as in Figure 5.6 (dashed) and parameter changes as in
Table 5.2 (solid).
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Figure 5.16: CBF and Vt/Vt,n vs Pa for steady state simulations with the BrainPiglet
model using default parameter values as in Figure 5.7 (dashed) and parameter changes
as in Table 5.2 (solid).
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Figure 5.17: CBF and Vt/Vt,n vs PaCO2 for steady state simulations with the BrainPiglet
model using default parameter values as in Figure 5.8 (dashed) and parameter changes
as in Table 5.2 (solid).
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value in Equation 5.20 such that
θ = kCV
(
∆p − ∆pCV0) . (5.27)
The results of these changes are shown in Figure 5.18. When Equation 5.26 is used,
the simulation of CuA is significantly improved as SaO2 begins to drop (although the
simulation is slightly worse at lower SaO2). Also, the magnitude of hyperoxidation of
CuA during recovery is decreased. When, in addition, the dependence of ATP synthesis
rate on phosphorylation potential is removed, no hyperoxidation is seen.
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Figure 5.18: (a) Comparison of measured ∆oxCCO and modelled ∆oxCCO vs time. (b)
Comparison of measured and modelled ∆oxCCO vs oxygen saturation at the onset of
anoxia. (c) Modelled CMRO2
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5.3.3 Discussion
The model was applied successfully to simulate oxygenation and metabolic changes
in the brains of newborn piglets during anoxia. It correctly predicted no significant
changes in ATP concentration throughout the experiments. To simulate the other mea-
sured signals, changes to the original model were required. These changes offer an
insight into the physiological interpretation of the experimental results as discussed be-
low. In addition, the model allows predictions of variables that are more difficult to
measure, including CMRO2 and lactate concentration.
During recovery from anoxia, a large increase in MABP accompanied by an increase in
∆HbO2 was measured. As there was not a corresponding reduction in ∆HHb, this im-
plies an increase in CBV. The model suggests that this hyperaemia cannot be attributed
to changes in the arterial volume alone. A dilation of the cerebral arteries to this extent
would be predicted to cause a several-fold increase in CBF, which, unless accompa-
nied by a corresponding increase in CMRO2, would lead to a decrease in ∆HHb via a
washout effect. It is more likely, therefore, that the increased blood volume following
anoxia has a significant venous contribution, which is driven by the increase in blood
pressure. However, the autoregulation behaviour of the model causes changes in arterial
pressure of this magnitude to be damped by changes in arterial resistance before they
are felt at the veins. A reduction of the parameter kaut from 1.0 to 0.5 reduces this can-
celling effect, and so led to a better replication of the observed hyperaemia. Previous
studies in piglets have found that CBF does not change in the range of 50–80 mmHg
[243, 244, 245]. However, these studies used piglets older than 24 h. In one study in-
volving piglets of different ages, it was found that for piglets less than 4 days old, the
average change in CBF as blood pressure was varied was 1.0 % mmHg−1, whereas for
piglets older than 4 d it was 0 % mmHg−1 [248]. The interpretation of the anoxia mea-
surements using our model suggests that cerebral autoregulation was impaired or not
fully developed in these newborn piglets.
The relationship between PCr and ATP concentrations in the model as oxygen saturation
falls shows the expected buffering of ATP by PCr, with ATP not decreasing until PCr
is low. The model predicts that ATP concentration will begin to decrease when SaO2
falls below 40 %. However, the model predicted a drop in PCr concentration during
anoxia larger than that observed. Increasing the parameter I allowed a greater increase
in glycolysis rate, and therefore a greater rate of ATP synthesis during anoxia. This
glycolysis rate could not be sustained for longer anoxias, because the model predicts
that glucose is used faster than its maximum rate of transport into the cell. The value
of I was increased from 3 to 50. Above this value, there is almost no further change
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in glycolysis rate, because changes in ATP and AMP concentrations become limiting.
For large I, the glycolysis rate in the model increased approximately sevenfold. This
is greater than the fivefold increase calculated to occur in foetal rats during ischaemia
[249]. It should be noted that the extent of PCr concentration decrease in the model is
also sensitive to the normal PCr concentration ([PCr]n).
There are two features of particular interest in the ∆oxCCO experimental results: (i)
the delay between the drop in ∆HbO2, and the reduction of CuA, and (ii) the hyper-
oxidation of CuA during recovery. The former was not reproduced by the model in its
original form, but the latter was. It has been observed previously in piglets that CuA re-
dox state is not affected by mild hypoxia [125]. A similar effect has also been observed
in adult rats [67, 250], but not in adult humans [95, 83]. The mechanisms for this effect
are unknown, and it does not emerge from the alteration of the BrainSignals model to
simulate the neonatal piglet brain. But, when it was introduced directly through the use
of Equation 5.26, it improved the simulation of CuA reduction at the onset of anoxia.
As expected, it also decreased the magnitude of CuA hyperoxidation following anoxia,
since this is partly caused by the increased oxygen tension at the mitochondria as a con-
sequence of the increased oxygen delivery. An oxidation is still seen however, because
the increased concentrations of ADP and Pi during and following anoxia increase the
rate of ATP synthesis via Equations 2.46 and 5.22. The proton motive force across the
mitochondrial membrane is decreased which increases CMRO2 and, with the parame-
ter values used, results in an oxidation of CuA. If this dependency on phosphorylation
potential is removed, no oxidation is seen. This supports the suggestion of Springett
et al. [247] when reporting the experimental results, that the hyperoxidation follow-
ing anoxia was a result of increased CMRO2. A CuA hyperoxidation following anoxia
was also observed in an earlier study [251]. The authors suggest that a pH drop could
be partly responsible for the oxidation via a direct effect of pH on CuA. There is no
mechanism for this effect in the BrainPiglet model, although a small change in pH was
observed following anoxia, as measured by MRS.
Another possible explanation for the oxidation is a decrease in the substrate supply to
the TCA cycle. Our model suggests the opposite is true for pyruvate, whose concentra-
tion increased during anoxia, and takes several minutes to return to normal (see Figure
5.19). However, there is an decrease in NAD/NADH ratio (also shown in Figure 5.19)
which will tend to decrease the rate of the TCA cycle; but this appears to have only a
small effect on the oxidation of CuA. The normal NAD/NADH ratio does however have
a significant effect on the rate of reduction of CuA as illustrated in Figure 5.20. Although
changes in mitochondrial NADH concentration can be measured by fluorescence, the
NAD/NADH ratio is difficult to measure in vivo [252]. Estimates of this ratio differ, for
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example in rat liver cells a ratio of 5–10 was measured [253], but in myocytes isolated
from newborn piglets a ratio of 1.2 was found [254]. A decrease in the model’s normal
NAD/NADH ratio from 9 to 1.5 led to the simulated rate of ∆oxCCO fall matching the
experimental rate. However, there are other factors that affect this rate, including the
form of the TCA cycle rate dependence on NAD/NADH ratio, and the sensitivity of the
reactions of the electron transport chain to changes in the proton gradient.
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Figure 5.19: Modelled pyruvate concentration and [NAD]/[NADH] during anoxia.
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Figure 5.20: Reduction of modelled ∆oxCCO during anoxia with parameter values as
in Table 5.2 (except [NAD]n/[NADH]n with values as shown).
5.4 Conclusions
This work was the first step towards modelling oxygen deprivation in the neonatal piglet
brain, and has been published [236]. The model was able to reproduce the experimen-
tal data well. This required assuming a reduced autoregulation capacity, a hypothesis
which could be tested experimentally. The model was also used to confirm that an in-
creased ADP concentration could lead to hyperoxidation of CCO following anoxia. In
this chapter, model parameters were chosen and altered based on consideration of the
model structure and the physiological quantities represented by the parameters. Nu-
merical parameter optimisation was not used because only one averaged dataset was
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available, and the SaO2 measurement used as an input was only an estimate. In the
following chapter, datasets from individual piglets subjected to HI are modelled, and
sensitivity analysis and parameter optimisation are carried out. This is the next step in
validating the model for simulating oxygenation and blood flow changes in newborn
piglets.
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Chapter 6
Hypoxia-ischaemia in piglets
This chapter concentrates on the modelling of HI. Some of this work has been pub-
lished [255]. First, the results of a Morris sensitivity analysis on the BrainPiglet model
are presented. Then the steady-state behaviour of the model when simulating carotid
artery occlusion is reported. The model is then applied to data from individual piglets
subjected to HI. The model is compared to data from NIRS and both H-MRS and 31P-
MRS. The fit of the model to the data is investigated and improved by using sensitivity
analysis and parameter optimisation tools. Finally, failure of some of the piglets to
recover is investigated by simulating cell death.
6.1 Sensitivity analysis
Sensitivity analysis was used to identify the settable parameters that have the most im-
portant effect on the model outputs. A Morris sensitivity analysis was carried out using
an 8 level grid with an m∆ of 4 (see Section 3.4). The parameter ranges were set at ±
20 % of the model value for all parameters. This range was then increased as appro-
priate in cases where the parameter had been set heuristically, or was known to have a
large uncertainty. The ranges of some parameters were also adjusted because they were
intended to fall within a specific range e.g. 0–1. Several parameters were excluded, ei-
ther because they are accurately known physical constants such as the Faraday constant
F, or because their sensitivity index was not of interest, such as the offset of the NIRS
signals. In total, 99 parameters were included in the sensitivity analysis. The ranges
used for each parameter are given in Section D.6. The number of repeats used was
2000 which gave a total of 200 000 simulations.
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Simulations were run using the BrainPiglet model as described in the previous chapter.
The parameters were set to their chosen values, and the model run for 1000 s. The
outputs were taken at the final point of the simulation and used to calculate the µ?
values. This gives a measure of the sensitivity of the steady state of the model to the
parameter values. It should be noted that there are several parameters which do not
affect the steady state of the model, for example the rates of the mass action reactions
which are at equilibrium (e.g. t1/2,PCr) and the time constants controlling the delay
between changes in input parameters and their effect on circulation (e.g. τO2). The
sensitivity of the dynamics of the model to parameter values can be investigated in many
different ways, and the results will depend on the particular aspect being investigated.
Some aspects will affect the fit of the model to HI data, and will therefore influence the
sensitivity analysis in Section 6.4.2. But in this section, the steady states of the model
are investigated. This is of interest since most aspects of the model reach steady state
fairly quickly relative to the time scales of interest in the simulations, although lactate
dynamics is a notable exception to this.
Figure 6.1 shows the results of this sensitivity analysis for the model output of [ATP].
It can be seen that many of the parameters have small µ? values. The normal ATP
concentration [ATP]n has a much larger µ? value than the other parameters. Around
70 % of the parameters have a µ? of less than 1 % and 97 % have µ? less than 10 % of
that of [ATP]n. This parameter also has a smaller σ value relative to its µ? compared
with the other parameters, and therefore has a more linear effect on the value of ATP.
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Figure 6.1: µ? vs σ for [ATP] in steady state simulations.
The µ? values were normalised for each variable, and those parameters with normalised
µ? greater than 0.2 are shown in Table 6.1. It can be seen that the parameters which
are generally used as inputs have the largest effects on the outputs. The two parameters
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∆HbO2 ∆HHb ∆oxCCO [lac] [ATP] [PCr] [Pi]
SaO2 1.00 1.00 1.00 0.55 0.34
Pa 0.96 0.46 0.29 0.49 0.20 0.38
[Hbtot]n 0.60 0.60 0.29 0.24
kaut 0.72 0.23
rocc 0.59
rn 0.48
Pa,n 0.31
Vblood,n 0.28 0.25
rm 0.28
r0 0.22
occfrac 0.21
CuA,frac,n 0.86
[CCO]tis 0.62
SaO2,n 0.23
[lac]n 1.00
[ATP]n 1.00
[PCr]n 1.00 0.78
[PCr]n/[Pi]n 1.00
Table 6.1: Grid showing the normalised µ? values of most influential parameters in the
BrainPiglet model at steady state for each output that can be compared with a measured
signal.
most commonly used as inputs, SaO2 and Pa, have a strong influence on many of the
variables, and are most influential overall. The normal concentration of haemoglobin
O2 binding sites in the blood [Hbtot]n also has a strong influence on several of the pa-
rameters. Besides these parameters, there is not much overlap between the parameters
which have the largest effect on the different variables. The ∆HbO2 variable has the
largest number of parameters (11) with a normalised µ? greater than 0.2. For this vari-
able, 20 % of parameters have a normalised µ? of greater than 0.1, but still only 37 %
of parameters have a normalised µ? of greater than 0.01. Overall, about one third of the
parameters have a normalised µ? of less than 0.01 and two thirds have a normalised µ?
of less than 0.1 for all 7 variables. As expected, the parameters which affect only the
dynamic behaviour of the model (such as the time constants for the input parameters
τO2 , τPa τCO2 and τu) have very small µ
? values.
6.2 Modelling carotid artery occlusion
Figure 6.2 shows the relationship between the steady state CBF as a fraction of its nor-
mal value, and the conductance of the supplying arterial compartment. The parameter
determining the shape of this curve is the normal conductance of the supplying artery
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compartment G0,n. This is set as a fraction (G0,frac) of the normal conductance of the
cerebral arterial compartment. If G0,frac is large, CBF remains high until G0 is low. If
G0,frac is small the relationship becomes more linear, however this situation is unlikely
since the large supplying vessels offer less resistance to blood flow than the smaller
cerebral vessels. G0 is modified by changing the (normalised) radius of the supplying
artery compartment
G0 = G0,n (1 − rfracrocc)4 (6.1)
The control parameter rocc represents the extent to which the carotid arteries are oc-
cluded, and rfrac is the fraction by which the radius would be reduced if the carotid
arteries were completely occluded.
rfrac = 1 −
(
(G0)occluded
G0,n
)1/4
= 1 − (1 − occfrac)1/4 (6.2)
where occfrac is the fraction of total CBF which normally passes through the carotid
arteries.
In man, approximately 40% of blood supplying the brain flows through each carotid
artery [13]. This is assumed to apply to the piglet also (occfrac = 0.8). A few studies
have reported CBF measurements in piglets when one or both of the carotid arteries
were occluded, and oxygen levels were normal. The occlusion of just one carotid artery
did not significantly reduce CBF. With both carotid arteries occluded, Kurth et al. [256]
found that CBF fell to (74 ± 22) % of its baseline value, whereas Oriot et al. [257]
reported (46 ± 20) %. However, in both experiments there were changes in the systemic
arterial pressure, and in the latter case, the baseline CBF was about twice the normal
reported value for piglets. A value for G0,frac of 5 was chosen so that the curve lay
between these two values at a G0 of 20 % its baseline value.
The pressure drop through the model compartments is illustrated in Figure 6.3 for dif-
ferent levels of occlusion.
6.3 Experimental protocol
The data were provided by collaborators carrying out experiments at UCL Institute of
Neurology. Some data from these experiments have been published [258] and a full
description of the experimental protocol can be found there. This thesis uses data
from 14 male piglets aged less than 24 h. All experiments were performed under
UK Home Office Guidelines. The piglets were sedated with intramuscular midazo-
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Figure 6.2: CBF vs G0 in the BrainPiglet model with G0,frac = 10.0 (dotted) G0,frac =
5.0 (solid) and G0,frac = 0.1 (dashed). Complete occlusion of the carotid arteries is
equivalent to reducing G0 to 0.2 of its normal value.
lam (0.2 mg kg−1) and isoflurane anaesthesia (3 % during surgery, otherwise 2 %) was
maintained. The piglets were mechanically ventilated with settings adjusted to main-
tain PaO2 and PaCO2 in the ranges 8–13 kPa and 4.5–6.5 kPa. SaO2 was monitored
continuously. Both common carotid arteries were surgically isolated at the level of the
fourth cervical vertebra and encircled by remotely controlled vascular occluders. An
umbilical arterial catheter was inserted to monitor heart rate and blood pressure, and to
take blood samples to measure PaO2, PaCO2, pH, electrolytes, glucose, and lactate. An
umbilical venous catheter was inserted for infusion of maintenance fluids (10 % dex-
trose, 60 ml kg−1 d−1), fentanyl (3–6 µg kg−1 h−1), and antibiotics. Bolus infusions of
colloid and inotropes maintained the mean arterial blood pressure above 40 mmHg. Af-
ter surgery, the piglets were positioned prone in a plastic pod and the head immobilised
in a stereotactic frame.
For all 14 piglets, NIRS data was acquired using an in house developed broadband spec-
trometer. Optodes were placed on either side of the piglet head, and secured using the
stereotactic frame. NIR spectra in the range 650–980 nm were collected at 1 min inter-
vals throughout the experiment. The NIRS measurements ∆HbO2 ∆HHb and ∆oxCCO
were determined from the attenuation spectra between 780 and 900 nm using the UCLn
algorithm [259] after correction for wavelength dependence of path-length [260].
For 5 of the piglets, whole brain 1H-MRS was acquired using a 9.4 T spectrometer and a
60 mm diameter MRS surface coil. The acquired voxel was a cube of side length 19 mm
contained entirely within the brain. The repetition time was 5 s, with an echo time of
288 ms; data from 12 averages was used resulting in an acquisition time of 1 min per
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Figure 6.3: Diagram illustrating the drop in pressure through the compartments at dif-
ferent levels of occlusion
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spectrum. The spectra were accquired continuously and analysed using the AMARES
algorithm [261] to calculate the Lac/Naa peak area ratio (along with other ratios that
are not used in this thesis).
In these piglet, after 10 min of baseline measurements, HI was induced by occluding the
common carotid arteries and reducing the FiO2 in steps to 8 %. FiO2 was then increased
again after around 12 min in steps to its baseline value, after which the occluders were
deflated. A further 60 min of measurements were collected.
For another 8 of the piglets, whole brain 31P-MRS was acquired every minute using a
9.4 T spectrometer and a 70 mm × 50 mm surface coil. The data were analysed with the
AMARES algorithm to calculate the NTP/EPP, PCr/EPP, and Pi/EPP peak area ratios.
Baseline data were recorded for 10 min, followed by inflation of the occluders and re-
duction of FiO2 to 12 %. This was maintained until the height of the β-NTP peak had
fallen to 50 % of its baseline value. FiO2 was then adjusted to maintain this peak be-
tween 30 % and 50 % of its baseline height for 12.5 min. The occluders were then
deflated and FiO2 returned to normal.
6.4 Methods and results
6.4.1 Experimental results
Examples of results from two piglets, one measured with H-MRS and one with 31P-
MRS, are shown in Figures 6.4 and 6.5. The results from all the piglets are shown
in Appendix A. All piglets show a drop in ∆HbO2 and a rise in ∆HHb which both
return close to their baseline values after the insult. Piglet LWP168 (monitored with
H-MRS) shows an overshoot of ∆HbO2 lasting approximately 10 min. This pattern is
seen clearly in 4 of the 6 piglets monitored with H-MRS (see also Figures A.1, A.2 and
A.6), but none of those monitored with 31P-MRS. For the 4 piglets with an overshoot,
the maximum ∆HbO2 within the 10 min following the insult is (21 ± 4) µM (averaged
across the 4 piglets). For the other 10 piglets the maximum is (−1 ± 3) µM. All piglets
show a reduction of CCO as expected. There is an increase in Lac/NAA ratio which
recovers slowly after the insult. There is also a decrease in NTP/EPP and PCr/EPP and
an increase in Pi/EPP.
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Figure 6.4: Measured results from one piglet (LWP168) with H-MRS
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6.4.2 Data analysis
Each dataset was resampled to 1 point every six seconds. The beginning and end of
the carotid artery occlusion were identified by examining the ∆Hbdiff signal. The SaO2
and mean arterial blood pressure measurements were used as inputs. An input for the
carotid artery occlusion was created by varying the control parameter rocc (see Equation
6.1) between 0 and 1 over a minute period at the onset of occlusion, and then back to
0 again at the end of the occlusion. Ideally this would happen instantaneously, but this
caused the model to be unstable.
Before optimisation was performed, Morris sensitivity analysis was carried out for each
piglet on the rms error between the modelled and measured signals. This was done to
see which parameters had the most important effects on the fitting of the model to the
data and so help decide which parameters should be optimised to improve the fit. The
NIRS variables (∆HbO2, ∆HHb and ∆oxCCO) were offset before comparing them with
their measured equivalents. The 31P-MRS measured variables (NTP/EPP, PCr/EPP
and Pi/EPP) were compared with no scaling or offsets, and [lac] was both scaled and
offset before being compared with the Lac/Naa ratio measured by proton MRS.
For each parameter and variable, the mean of the µ? and σ values was calculated across
all the piglets for which the relevant signal was measured. These values are shown in
Figure 6.6. These mean µ? values were then normalised for each variable. Parameters
with a normalised µ?≥ 0.2 are shown in Table 6.2.
The parameters representing the normal concentrations of the variables were found to
be the most influential. Overall, 28 % of the parameters had normalised µ? values less
than 0.01 and 57 % of the parameters had normalised µ? values less than 0.1 for all
signals. The most influential parameters were different for all the signals, except for the
related signals ∆HbO2 and ∆HHb, and [ATP], [PCr] and [PCr]n/[Pi]n. This was used to
help to carry out parameter optimisation.
6.4.3 Parameter optimisation
Parameters identified by the sensitivity analysis were optimised for each of the piglets.
Only those parameters with a normalised µ? ≥ 0.5 were included, to limit the number of
parameters and therefore help prevent overfitting and increase parameter identifiability.
The parameters were split into four groups based on the variables for which they were
influential.
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Figure 6.6: Mean σ vs mean µ? across all piglets from a Morris sensitivity analysis of
the rms error between measured and modelled variables.
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∆HbO2 ∆HHb ∆oxCCO [lac] [ATP] [PCr] [Pi]
[Hbtot]n 1.00 1.00 0.21
r0 0.52 0.20
Vblood,n 0.49 0.34
kaut 0.45 0.31
rn 0.45 0.22
rt 0.45
RO 0.36
rm 0.34
occfrac 0.28 0.43 0.24
Kσ 0.28
SaO2,n 0.26
Pa,n 0.24 0.34 0.27
RC 0.24
RP 0.24
[CCO]tis 1.00
CuA,frac,n 0.91 0.25
[lac]n 1.00
CMRgluc,n 0.53
[ATP]n 1.00 1.00 0.46
[PCr]n 0.30 0.99 0.48 0.47
[PCr]n/[Pi]n 0.22 0.83 0.52 1.00
CVinh 0.23 0.22
Table 6.2: Normalised µ?values from a sensitivity analysis for the rms error between
modelled and measured signals. Only parameters with a normalised µ?≥ 0.2 are shown.
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Group 1 The parameters [Hbtot]n, PaCO2 and r0 were optimised to minimise the sum
of the rms error between the measured and modelled ∆HbO2 and ∆HHb signals.
Group 2 The parameters [CCO]tis and CuA,frac,n were optimised to minimise the rms
difference between the measured and offset modelled ∆oxCCO. ∆oxCCO was
only compared up to the nadir of the insult (the point where SaO2 began to in-
crease), since some piglets did not show recovery of the CCO redox state and the
model was not able to replicate this.
Group 3 For those piglets which were monitored with H-MRS the parameters [lac]n
and CMRgluc,n were optimised to minimise the sum of the rms difference between
the measured and modelled Lac/NAA. Simulated Lac/NAA was estimated by
both scaling and offsetting the modelled lactate concentration.
Group 4 For the piglets which were monitored with 31P-MRS the parameters [ATP]n,
[PCr]n and [PCr]n/[Pi]n were optimised to minimise the rms difference between
the modelled and measured NTP/EPP, PCr/EPP and Pi/EPP signals. The signals
were also only optimised to the nadir of the insult.
The optimisations were carried out with both the PSwarm and Powell methods. The re-
sulting optimised parameter values are summarised in Table 6.3. Examples of modelled
and measured signals before and after optimisation are shown in Figures 6.7 and 6.8.
In the majority of cases, the parameters found by the two optimisation methods were the
same. In most cases, when they differed it was the point found by the PSwarm method
that gave the lower error, however the difference was small. For the parameters used to
optimise the MRS signals ([ATP]n, [PCr]n, [PCr]n/[Pi]n, CMRgluc,n and [lac]n) the values
were the same for all piglets to the accuracy given. For the parameters used to optimise
the NIRS haemoglobin signals ([Hbtot]n, PaCO2 and r0) there were differences in 4 of
the piglets of between 1 and 3 in the least significant figure to the accuracy given in the
table. Finally, for the parameters used to optimise the ∆oxCCO signal, 3 piglets had
small differences between the optimised parameter values, and 1 piglet (LWP158) had
a large difference (1.0 µM for [CCO]tis and 0.22 for CuA,frac,n). However, the product of
the two parameters (CuA,frac,n[CCO]tis) was the same for both methods in all cases. In 11
of the 14 piglets, the optimised value of [CCO]tis reached the maximum allowed value
(7 µM). The variation of the rms error between the modelled and measured ∆oxCCO
signals up to the nadir of the insult with the two parameters in one piglet (LWP180) is
shown in Figure 6.9. This shows that the product of the two parameters, which is what
determines the magnitude of the fall in ∆oxCCO, is much better defined by the data
than the individual parameter values.
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Although the same values of [ATP]n and [PCr]n were found by both optimisation meth-
ods, there is a similar relationship between these parameters and the sum of the errors
between the measured and modelled 31P-MRS signals up to the nadir of the insult.
This time it is the ratio between the parameters ([ATP]n/[PCr]n) which is more clearly
defined than the parameters themselves as shown in Figure 6.10. This relationship is
not surprising, since the variables are expressed as fractions of the total exchangeable
phosphate pool (2[ATP]n + [PCr]n + [Pi]), and therefore the baseline values of the three
variables depend only on the ratios of [ATP]n, [PCr] and [P]n.
Parameter Units Default
Value
Optimised Value(SD)
PSwarm Powell
[Hbtot]n mM 5.4 6.3(1.5) 6.2(1.5)
PaCO2 mmHg 40 39(12) 40(12)
r0 cm 1.26 ×10−2 1.22(0.08) ×10−2 1.23(0.08) ×10−2
[CCO]tis mM 2.2 ×10−2 6.3(1.5) ×10−3 6.2(1.7) ×10−3
CuA,frac,n (dimensionless) 0.67 0.50(0.16) 0.52(0.17)
[lac]n mM 3.0 3.3(1.6) 3.3(1.6)
CMRgluc,n mM s−1 4.4 ×10−3 4.2(1.0) ×10−3 4.2(1.0) ×10−3
[ATP]n mM 1.2 3.5(1.7) 3.5(1.7)
[PCr]n mM 2.6 4.4(1.8) 4.4(1.8)
[PCr]n/[Pi]n (dimensionless) 2.73 1.1(0.3) 1.1(0.3)
Table 6.3: Mean(SD) parameter values across all piglets after individual optimisations
6.4.4 Effect of total haemoglobin concentration
It is clear from the previous results that the total blood haemoglobin concentration
(proportional to [Hbtot]) has an important effect on the modelled NIRS outputs. This
parameter is assumed to remain constant throughout the experiment. However, this
concentration was measured several times throughout the experiment. In each piglet,
haemoglobin concentration ([Hb]) was measured at least twice, and up to 13 times over
a period ranging from 2–48 h. These measurements are shown for each piglet in Figure
6.11. There were large variations in [Hb], with a range across all 14 piglets of 3.4–
20.4 g dl−1. The range in an individual piglet varied from 1.7 g dl−1 to 10.5 g dl−1 and on
average was 4.9 g dl−1. These changes arose from the taking of blood and giving of fluid
to the piglets throughout the experiment for various reasons. The fluctuation may have
caused significant changes in the NIRS signal; the direction of which depends on the
arterial oxygen saturation, as illustrated by the simulations shown in Figure 6.12. The
haemoglobin concentration was not measured frequently enough during the modelled
period to investigate whether changes in the haematocrit were responsible for changes
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Figure 6.7: Plots comparing the modelled and measured NIRS and MRS signals before
and after optimisation for a piglet monitored with H-MRS (piglet LWP168)
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Figure 6.8: Plots comparing the modelled and measured NIRS and MRS signals before
and after optimisation for a piglet monitored with 31P-MRS (piglet LWP180)
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Figure 6.9: rms error between modelled and measured ∆oxCCO as a function of
[CCO]tis and CuA,frac,n for piglet LWP180. The line shows CuA,frac,n[CCO]tis = 2.85 µM
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in the NIRS signals, although such an analysis may be possible over longer timescales.
It is therefore important to consider possible haematocrit changes when interpreting the
results.
6.4.5 Cell death
Relationship between signals following HI
Several of the piglets showed incomplete recovery of ∆oxCCO and the 31P-MRS signals
following HI i.e. these signals did not return to close to their baseline values after the
insult and for the duration of the experiment. This was investigated by calculating a
recovery fraction for each signal. Three periods during the signal were identified, and
means were calculated as follows:
baseline Mean of the first 500 s of data
nadir Mean of the 200 s before the nadir of the insult, taken as the point at which the
SaO2 began to be increased.
recovery Mean of the last 500 s of data ((100 ± 20) min after nadir)
These periods are illustrated for the ∆oxCCO signal of a piglet which did not fully
recover in Figure 6.13
The recovery fractions for CCO, NTP and PCr were then calculated as follows
CCO recovery fraction =
recovery − nadir
baseline − nadir (6.3)
NTP and PCr recovery fraction =
recovery
baseline
(6.4)
Figure 6.14 shows the relationship between the CCO recovery fraction and the NTP and
PCr recovery fractions for each piglet. The graphs show a clear relationship between
these fractions. However, with only three piglets having a low recovery fraction, there
is not enough data for a quantitative statistical analysis.
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Figure 6.11: Measured blood haemoglobin concentration for each piglet over the full
experiment for up to 48 h
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Figure 6.14: Relationship between recovery of CCO and NTP and PCr following HI
Modelling cell death
One hypothesis for explaining these results is that a fraction of the cells in the brain have
died during HI. This was modelled by assuming that during HI, CCO becomes fully
reduced, and remains so in the dead cells. It was also assumed that in the dead cells, all
the exchangeable phosphate was in the form of Pi. A parameter d f was introduced to
represent the fraction of cells which were considered to be dead. This parameter was
set to 0 until the nadir of HI and to the value of parameter d following the nadir, using
an input parameter ∆nadir functioning as a switch.
It was assumed that no oxygen consumption was taking place in the dead cells, and that
their oxygen concentration would quickly equilibrate with that of the capillaries. The
modelled rate of oxygen transfer from the capillaries to the mitochondria was therefore
reduced to (1−d f ) of its normal rate. This was the only change to the model, other than
an alteration of some output variables (i.e. variables which have no effect on any other
part of the model). The following model outputs were changed:
output NTP/EPP =
(
1 − d f
)
[ATP]
EPP
(6.5)
output PCr/EPP =
(
1 − d f
)
[PCr]
EPP
(6.6)
output Pi/EPP =
(
1 − d f
)
[Pi]
EPP
+ d f (6.7)
output ∆oxCCO = (1 − d f )∆oxCCO − d f oxCCOn (6.8)
output CMRO2 = (1 − d f )CMRO2. (6.9)
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Parameter Units Default
Value
Optimised Value(SD)
PSwarm Powell
[CCO]tis mM 2.2 ×10−2 5.8(1.0) ×10−3 5.1(1.2) ×10−3
CuA,frac,n (dimensionless) 0.67 0.69(0.10) 0.78(0.09)
[ATP]n mM 1.2 3.1(1.0) 2.3(1.2)
[PCr]n mM 2.6 4.4(1.6) 3.4(1.9)
[PCr]n/[Pi]n (dimensionless) 2.73 1.7(0.9) 1.7(0.9)
d (dimensionless) 0.0 0.31(0.29) 0.31(0.29)
Table 6.4: Results of optimisations of ∆oxCCO and 31P-MRS variables including a
fraction of dead cells
In order to investigate the effect of simulated cell death, the 6 parameters d f , [CCO]tis,
CuA,frac,n, [ATP]n, [PCr]n and [PCr]n/[Pi]n were optimised to minimise the rms differ-
ence between the measured and modelled ∆oxCCO, NTP/EPP, PCr/EPP and Pi/EPP
signals during the baseline, nadir and recovery periods as defined in Figure 6.13. The
signals were fitted during only these periods, rather than over the whole signal, to pre-
vent inaccuracies in modelling the time course of the changes from affecting the results.
The parameters [Hbtot]n, PaCO2 and r0 were set to the values previously optimised to
the NIRS haemoglobin signals.
The results of these optimisations are shown in Table 6.4. The mean optimised value
of d across the 8 piglets was 0.31 ± 0.29 with a range of 0.01 to 0.87. Figure 6.15
shows the results from one piglet comparing d = 0 and the optimised value of d = 0.37.
With d = 0.37 the means of the simulated ∆HbO2 and ∆HHb during recovery were
−1.0 µM and −2.2 µM compared with −6.3 µM and 8.5 µM for d = 0. The correspond-
ing measured values were -7.0 µM and 10.6 µM. Therefore, whilst adding a dead com-
partment to the model improved the simulation of ∆oxCCO and the 31P-MRS variables,
the haemoglobin simulations were further from the measured data.
Again, the optimisations were carried out with both the PSwarm and modified Powell
methods. There were no differences between the two methods in the optimised values
of the parameters d and [PCr]n/[Pi]n. However, the values of [CCO]tis, CuA,frac,n, [ATP]n
and [PCr]n found were different. But the values of CuA,frac,n[CCO]tis and [ATP]n/[PCr]n
were again the same for all piglets. This can be explained by the landscapes of the rms
errors illustrated in Figures 6.9 and 6.10. The PSwarm method found a point with a
lower error for four of the piglets, whilst for the other four piglets the Powell method
found a better point.
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Figure 6.15: Comparison between measured (dashed) and modelled (solid) results from
a piglet which did not recover using (left) d = 0 and (right) d = 0.37
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6.5 Discussion
The model has been used to simulate data from individual piglets subjected to HI. NIRS
and MRS measurements have been simulated, and sensitivity analysis and optimisation
techniques have been used to investigate and improve the results.
6.5.1 Sensitivity analysis
A systematic method of sensitivity analysis is important for a model as large and as
complex as the BrainPiglet model. The Morris method is a useful way of exploring the
whole of the given parameter space and screening for influential parameters. However,
the results of the method are heavily dependent on the input parameter distributions. It
is therefore important that these distributions are set with sufficient consideration. For
the results presented here, the majority of the parameters had their ranges set to ±20 %
of their default value, and all parameters were given uniform distributions. In the future
this could be improved by, as far as possible, deriving parameter distributions from the
available experimental data and allowing other types of distribution, such as normal
distributions.
Despite this reservation, the results of this sensitivity analysis are still valuable. They
show that the most influential parameters are the ones which are generally used as in-
puts. They also show that the normal concentrations of the variables representing the
measured signals are important, which is to be expected. It is also encouraging, since
these parameters are most likely to vary between individuals and could potentially be
optimised for each individual.
Two sensitivity analyses were carried out: one investigating the steady state of the
model, and the other investigating the rms error between the modelled and measured
signals during HI. The was a lot of similarity between the results of these two. The pa-
rameters with very small µ? values for all signals were the same for both the sensitivity
analyses. Parameters which only effect the dynamic behaviour of the model therefore
did not have a strong influence on the rms error between the measured and modelled
data. The fairly large proportion of parameters with small µ? values across all signals
and both sensitivity analyses confirms the Morris method is a good screening tool to
distinguish between influential and non-influential parameters. The parameters found
to be most influential were also the same between the two analyses (aside from the input
parameters which were fixed at their measured values in the second analysis).
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However, there were differences between the two analyses. For example, PaCO2 had
the second highest normalised µ? of 0.64 for ∆HbO2 in the data sensitivity analysis, but
a normalised µ? of only 0.15 in the steady state analysis. Similarly, CMRgluc,n had the
second highest normalised µ? of 0.53 for lactate in the data analysis, but a normalised
µ? of only 0.06 in the steady state analysis. These differences may be caused by the
differences in the simulations. These parameters may be much more influential when
the oxygen supply is low.
Ideally, the robustness of the method would be checked by repeating the analyses and
using different numbers of simulations. However this was not possible due to the time
taken to carry out each sensitivity analysis. On the machine available (with an Intel
Core 2 Duo processor) one sensitivity analysis as described takes 20–30 h.
The Morris method was used here because it is less computationally intensive than other
methods. Other sensitivity analysis methods are based on decomposition of the variance
of the model output, and therefore provide more quantitative information [262]. How-
ever these methods require more simulations, and some methods such as the Sobol’
method cannot be used, as the model does not have a solution at all points in the param-
eter space as described in Section 3.4.
6.5.2 Parameter optimisation
Without parameter optimisation, the model was able to correctly predict the direction
of change for all the signals, however it did not correctly predict the magnitude of
these changes. Sensitivity analysis showed that different groups of parameters were the
most influential for different signals. This allowed simpler parameter optimisation by
treating the groups separately. Following optimisation, the simulations were improved,
but there were still significant differences between the modelled and measured signals.
In general, the haemoglobin signals were fitted well. However, the overshoot of ∆HbO2
following the insult seen in some of the piglets was not reproduced by the model. The
cause of this overshoot is not known but it may be a consequence of the carotid artery
occlusion itself, for example, blood may build up behind the occluders. The fact that
was seen only in piglets monitored with H-MRS suggests it is related to the details of
the experimental protocol.
The other signals were less well simulated, in particular the time course of the changes
were not matched well. The model changes occurred more quickly than those that were
measured, in particular in the recovery of the 31P-MRS and CCO signals. This may be
because there are physiological changes occurring, or processes taking place, which are
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not included in the model and this will require further investigation.
The optimisation may have been improved if different parameters or more parameters
were included. Although sensitivity analysis is helpful in identifying parameters that
influence the fit, this method did not distinguish parameters that improved the fit from
those that worsened it. A different metric could be used in the sensitivity analysis to
identify parameters that are able to improve the fit, and optimising these may result in
a more successful fit.
In most cases, there was good agreement between the parameter values found by the
two optimisation methods. However there were some differences, particularly when
the dead compartment was included, when more parameters were optimised simulta-
neously. The modified Powell method tended to find points closer to the starting pa-
rameter values, as would be expected. Although, in some cases, these points had a
slightly lower error than the points found by the global PSwarm method. It is possible
the performance of the PSwarm method would be improved if its settings were altered,
in particular, if the number of particles in the swarm was increased. This will require
further investigation.
Lactate
In all of the piglets where Lac/NAA ratio was measured except for one, the lactate
measured signal showed a delay before beginning to increase relative to the other signals
and relative to the model. Although a delay was also seen in the model, it was less than
that in the measured data.
The comparison of the modelled lactate with the experimental measurement is compli-
cated by two facts. Firstly, it is the lactate to NAA ratio that was measured rather than
absolute lactate concentration. NAA concentration is an important marker of cell death
and also of cell function, and it has been shown to decrease following HI [124]. How-
ever this is likely to occur on a longer time scale than changes in lactate concentration
and so here is assumed to remain constant throughout. It will be necessary to include
NAA in future versions of the model, if it is to be used for longer-term applications
such as investigating secondary energy failure and treatments of HI. This will require a
distinction between astrocytes and neurons which may also benefit the modelling of lac-
tate. The second difficulty in comparing lactate with measured Lac/NAA ratio comes
from the inability to determine the lactate concentration at baseline conditions. It is
not known at exactly what concentration the lactate can be detected. The choice to both
scale and offset the modelled lactate signal is based on these considerations. The scaling
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factor represents an unknown (but constant) concentration of NAA. The offset allows
for low concentrations of lactate not being measurable. An alternative to an offset is a
cutoff i.e. a concentration of lactate below which the lactate measured was considered
to be 0. This was attempted, but gave poor results. This is because a step would be seen
as the Lac/NAA concentration returned to baseline following the insult. This was not
seen in the experimental results: instead a gradual return to baseline was seen.
A difficulty in modelling cell lactate concentration is caused by the unknown concen-
tration of lactate in the blood. Lactate from the blood is metabolised mainly by the
liver. Modelling this is beyond the scope of the model, since it is a model of the brain.
Although blood lactate levels were measured during the experiment, this occurred in-
frequently. The blood lactate concentration was therefore assumed to remain constant
throughout the experiment. Further investigation into how large an effect this plays
upon the rate of recovery of lactate would be helpful. Alternative solutions to this prob-
lem, such as setting blood lactate concentration based on cell lactate concentration and
blood lactate measurements, could also be investigated.
6.5.3 Cell death
Modelling a fraction of the cells as dead was able to account for the incomplete re-
covery of NTP and ∆oxCCO following HI. However, it was not able to account for
the ∆HbO2 and ∆HHb measurements that were observed. The model predicted that
a reduced number of cells metabolising oxygen would lead to an overall reduction in
CMRO2 and therefore a drop in oxygen extraction fraction. This would mean that more
oxygen remained in the blood and so ∆HbO2 would rise and ∆HHb would fall. However
this was not seen in the measurements. In some of the piglets which did not recover,
the opposite was seen i.e. ∆HbO2 was significantly decreased relative to baseline and
∆HHb was increased. Assuming the hypothesis of dead cells is correct, the two possi-
ble explanations which appear most likely are: firstly, that blood is no longer flowing to
all parts of the brain. This would cause a decrease in CBF and therefore a decrease in
oxygen delivery, despite normal SaO2 levels. The second explanation is that CMRO2
in the functioning cells is greatly increased. This may occur as a result of uncoupling
in the mitochondria between the reduction of oxygen and the synthesis of ATP. Un-
coupling is known to occur after hypoxic or ischaemic injury [263]. It would generally
be expected to cause an oxidation of CCO; but if uncoupling occurred alongside cell
death, this oxidation may be masked by the larger reduction effect. Another possibility
is that oxygen consumption is taking place in the dead cells but by NADPH oxidase
rather than via CCO which can occur following phagocytosis [264].
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If the assumption of cell death is incorrect, it is more difficult to explain the relation-
ships between the ∆oxCCO and MRS measurements. Uncoupling in the mitochondria
could lead to a reduced NTP concentration. The model includes a simple way of rep-
resenting uncoupling (see Equation 2.47). Figure 6.16 shows the effects of increasing
the uncoupling parameter kunc from its default value of 1.0 to 5 after the nadir of the
insult. With the other parameters at their normal values, the model predicts an oxida-
tion of CuA. A small oxidation of CuA has also been observed experimentally after the
administration of an uncoupler (dinitrophenol) to newborn piglets [265]. However, the
effect of uncouplers on CuA redox state is not straightforward [266] and altering the
model parameter ck2 from 0.02 to −0.02 causes CuA to instead become more reduced.
This change has only a small effect on the NTP concentration and the CMRO2, which
the model predicts to be increased slightly from baseline. The parameter ck2 controls
how the rate of the second reaction, of the three that represent the electron transport
chain, depends on the protonmotive force. It is one of several parameters which could
change the way that the oxidation state of CuA responds to uncoupling, and this is an
area of the model which requires further investigation. However, the relationship seen
in the model between NTP and PCr concentrations does not match that seen in the mea-
surements. The model predicts that the typical buffering relationship between NTP and
PCr will still be present despite mitochondrial dysfunction, and therefore PCr concen-
tration is predicted to be low after HI. This is observed in secondary energy failure in
piglets subjected to HI i.e. the relationship between NTP and PCr/Pi is the same in the
primary insult and in the delayed secondary energy failure, suggesting mitochondrial
dysfunction [267]. However, these measurements show a similar drop in PCr and NTP
concentrations which is more consistent with cell death.
Other possible explanations for the results include an impairment in glycolysis or the
TCA cycle, but this would lead to an oxidation in CCO. A large decrease in oxygen de-
livery relative to baseline may also explain the results. This is unlikely since SaO2 levels
returned to normal, however measurements of CBF would give further confirmation of
this.
Several factors need to be kept in mind when analysing this data. Firstly, the NIRS
and MRS measurements do not come from exactly the same area of the brain and it is
known that HI damages different parts of the brain to different extents. Secondly, there
are other changes to the brain following HI. In particular, cerebral oedema is likely to
occur [268] which could have an effect on the measurements. Finally, the haemoglobin
measurements may also be influenced by changes in haematocrit that have taken place
during or after the insult.
In order to further investigate these changes, it will be helpful to simulate two or more
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cell populations which may have been damaged in different ways or to different extents.
This is currently not easy to do using the BRAINCIRC environment, but it is important
since brain metabolism is likely to become more heterogeneous after damage is incurred
during HI. It will also be necessary to look more closely at mitochondrial uncoupling
in the model. Although it is currently possible to simulate uncoupling, even severe
uncoupling does not lead to the large increase in CMRO2 that might be expected. Mea-
surements from a greater number of piglets and measurements of CBF will also allow
these effects to be investigated further.
6.6 Conclusions
The BrainPiglet model was applied to data from 14 piglets subjected to HI. The model
was found to reproduce the patterns seen in the data well, but there were differences,
particularly in the speed at which the changes occurred. Morris sensitivity analysis was
used to determine which parameters had a significant influence on the fit of the model
to the data. The parameters identified were optimised, leading to a significant improve-
ment in the fit of the model to the data, confirming that the Morris method is useful
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for screening parameters. However, parameter optimisation led to some physiologi-
cally unrealistic parameter values, suggesting the parameters could not all be uniquely
identified.
Introducing a dead compartment to the model improved the simulation of data from
piglets which did not recover. Simulation of mitochondrial uncoupling by the model
suggests that dead cells (possibly in combination with mitochondrial uncoupling) is
a more likely explanation for the non-recovery of the piglets than mitochondrial un-
coupling alone. More investigation will be required to understand why the measured
haemoglobin signals are not consistent with the predictions of the model when a dead
compartment is included.
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Chapter 7
Discussion
7.1 Summary
This thesis described the use and development of novel physiological models of cerebral
circulation and metabolism. The models were developed with the aim of simulating the
non-invasive measurements made by near-infrared spectroscopy (NIRS) and magnetic
resonance spectroscopy (MRS). As far as possible, the models aim to represent the un-
derlying physiological processes occurring, whilst also simplifying where possible to
reduce complexity. Where appropriate, parts of other relevant models have been mod-
ified and incorporated, and standard biological modelling techniques have been used.
The models were developed, and simulations were carried out using the BRAINCIRC
modelling environment.
Firstly, in Chapter 4, the BrainSignals model [12] was used to simulate cerebral re-
sponses to a hypercapnia challenge in healthy adult humans. The model correctly pre-
dicted that during hypercapnia, tissue oxygenation index (TOI) and velocity of blood
in the middle cerebral artery (Vmca) would both increase as a consequence of the well
known vasodilation effect of CO2. In order for the model to correctly reproduce the
magnitudes of the changes in TOI and Vmca, the parameter RC, representing the sen-
sitivity of blood flow to carbon dioxide levels, was optimised for each of the fourteen
subjects. For TOI, the haemoglobin concentration [Hbtot] was also optimised to al-
low matching of the baseline TOI value. After optimising these parameters using both
the modified Powell’s method and the PSwarm method to minimise the mean square
error between modelled and measured signals, the model was able to reproduce the
changes in TOI and Vmca when optimising to each signal individually. However, the
model was not able to reproduce both measured signals simultaneously. Matching the
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measured TOI signal required a smaller sensitivity to CO2 (i.e. a smaller value for RC)
than matching the measured Vmca.
Three possible reasons for this discrepancy were investigated using the model. Firstly,
that changes in venous volume (held fixed in the BrainSignals model) could be impor-
tant; secondly, that changes in oxygen metabolism caused by CO2 may not be accounted
for in the model and finally, that the TOI signal may not originate entirely from within
the brain. The model was used to show that the first two of these effects would have to
be large in order to account for the discrepancy, much larger than suggested by relevant
previously reported experiments in humans and animals. Therefore, the model suggests
that TOI measurements should be interpreted with caution, and may not accurately re-
flect the tissue oxygen saturation of the brain tissue. More information could be gained
by investigating other signals such as changes in the total haemoglobin concentration,
which is related to cerebral blood volume, or oxidation changes of CCO which can re-
flect changes in oxidative metabolism. The work from this chapter has been published
in Advances in Experimental Medicine and Biology [209].
Chapter 5 described the modification and extension of the BrainSignals model to create
the BrainPiglet model and apply this type of modelling to neonatal piglets for the first
time. Several of the model parameters were altered to values appropriate for newborn
piglets. The metabolic part of the model was expanded to allow simulation of metabolite
concentrations measurable by MRS. This included the addition of ATP production and
use to simulate the concentrations of ATP, phosphocreatine and inorganic phosphate
which can be measured by 31P-MRS. It also included the addition of lactate dynamics
for comparison of lactate concentration changes with measurements from H-MRS. The
circulation part of the model was also altered to include a varying venous volume, and
a supplying arterial compartment was added for simulating carotid artery occlusion.
The BrainPiglet model was first applied to data from a study in which newborn piglets
were subjected to brief periods of anoxia [247]. Blood pressure data, presented in
the paper, and oxygen saturation estimated from the protocol were used as inputs to
the model, and its outputs were compared with averaged data measured by NIRS and
31P-MRS. Initial comparisons between the simulations and measured data showed four
key differences which were improved by changing the values of particular model pa-
rameters. In order to simulate the hyperaemia observed following the resumption of
the oxygen supply, the autoregulation parameter was reduced from 1 to 0.5. This sup-
ports the hypothesis that autoregulation may be impaired or not fully developed in these
piglets. However, this would need further investigation to confirm, since the autoregula-
tion curve of piglets is not well known and may depend on a number of factors including
the anaesthesia used and the age of the piglets. It is also possible a temporary impair-
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ment in autoregulation may have occurred following the anoxia. The ratio between the
changes in PCr and Pi measured in the experiment required that, given the normal con-
centration of PCr assumed in the model, the normal ratio of PCr to Pi be increased to
2.7. The normal NAD to NADH ratio was decreased in order to reduce the rate of CCO
reduction, and the sensitivity of glycolysis rate to changes in ATP concentration was
increased to decrease the simulated drop in PCr.
With these parameters, the model was able to reproduce the measured data well. How-
ever, it is possible that changes to other parameter values could also produce these
results, particularly in the case of the last two parameters mentioned. It is therefore
important that physiological knowledge is combined with a systematic, mathematical
analysis of the effects of changing parameter values, which was consequently included
when using the model to simulate hypoxia ischaemia (HI) which was the subject of the
following chapter.
The final aspect of the results from the anoxia study investigated using the model was
two previously observed, but not well understood features of the ∆oxCCO signal. The
model was used to demonstrate that a low affinity of CCO for oxygen could explain
the delay in reduction of CCO, although the mechanism for this effect, and the reasons
why it is observed in piglets but not in adult humans remain unknown. The model also
demonstrated that this low affinity of CCO for oxygen is consistent with the hyperox-
idation of CCO seen following anoxia; and although the effect is reduced when the
affinity for oxygen is reduced in the model, it is still present. The hyperoxidation is not
seen in the model, however, when the dependence of metabolic rate on phosphoryla-
tion potential is removed. Therefore, the model supports the suggestion that increased
metabolism following anoxia is a likely cause of the observed hyperoxidation of CCO.
The work from this chapter has been published in the Journal of Royal Society Interface
[236].
The BrainPiglet model was then used to simulate data from individual piglets subjected
to HI and monitored by NIRS and MRS which was the subject of Chapter 6. Before ap-
plying the model to the data, a Morris sensitivity analysis was used to investigate which
of the parameters were most influential on the steady state of the model. Around one
third of the parameters were found to have very little, or no influence on the steady state
values of any of the model variables that are compared with measured data in this thesis.
For most of these variables, there were one or two parameters with a much greater influ-
ence than the others. In most cases, the parameters with the largest influence were those
that represent the normal concentration of the variable. The results of a Morris sensitiv-
ity analysis depend on the ranges that are used for the parameters. Here the range was
set to ±20 % for most parameters, and the analysis could be improved by considering
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the ranges more carefully and incorporating existing physiological knowledge into their
ranges.
The oxygen saturation, blood pressure measurements and occlusion times from fourteen
piglets in which HI had been induced by carotid artery occlusion and reduced oxygen
inspiration fraction were used as inputs to the model. Its outputs were compared with
NIRS measurements for all piglets and H-MRS measurements for some piglets and 31P-
MRS measurements for others. The model predicted the direction of change, but did not
replicate the magnitude and time course of the changes. For some piglets, the CCO and
31P-MRS measurements did not return to baseline following the insult. The model was
not able to replicate this. Further Morris sensitivity analysis was performed to assess
which parameters influenced the fit of the model to the data. The results identified
several parameters which were then optimised to the signals for each individual piglet.
In order to simplify the optimisations, the parameters were only optimised to the signals
for which they were found to be influential. After optimising these parameters, the fit
of the model to the data was improved, however not all of the parameter values were
well identified by the data.
In the piglets which did not recover following HI, the data showed a relationship be-
tween the extent of CCO, ATP and PCr recovery. To investigate this, a fraction of the
brain was modelled as dead following the insult. This was done in a simple way, by
assuming no oxygen consumption in the dead cells, with CCO fully reduced and all
exchangeable phosphate in the form of Pi. The fraction of cells considered as dead was
optimised, and the optimised values ranged from almost 0 to 0.8. This greatly improved
simulation of CCO and MRS signals in the piglets that did not recover. However, there
was a worsening of the fit of the simulated haemoglobin signals to the data following
HI. The reasons for this will require further investigation. Different mechanisms of cell
death will also need to be investigated. Mitochondrial uncoupling was also considered
as a cause of the non-recovery of the CCO and MRS signals. Although mitochondrial
uncoupling would generally be expected to cause an oxidation of CCO, the model sug-
gested it could also be associated with a reduction depending on the properties of the
electron transport chain. However, the model also demonstrated that the relationship
between the ATP and PCr signals was not consistent with mitochondrial uncoupling
being the sole cause of the failure of the 31P-MRS signals to fully recover. Part of the
work from this chapter has been published in Advances in Experimental Medicine and
Biology [255] and part of this work has also been submitted to PLOS Computational
Biology.
The BrainPiglet model has been shown to aid data interpretation from experiments on
newborn piglets, and help to generate and assess hypotheses relating to the underlying
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physiology. To our knowledge, this is the first time that this type of model has been
applied to HI in piglets. There are many ways in which the model and the modelling
process can be improved, both to widen the measurements and situations to which the
model can be applied, and to increase accuracy and confidence in its predictions. These
are discussed below.
7.2 Future work
This section discusses research which is beyond the scope of the work in this thesis.
Possible areas of future improvement and expansion are outlined. I have carried out
some preliminary work related to improvements in parameter estimation which is de-
scribed here. This, and other areas or research are currently being pursued by other
members of the group.
7.2.1 Mathematical and computational techniques
Sensitivity analysis
Improved methods of sensitivity analysis will allow a more rigorous and in-depth analy-
sis of the model. Morris sensitivity analysis could be improved by choosing the param-
eter distributions more carefully, choosing different functions as the output of interest,
and investigating the effect of using different numbers of repeats. Other methods of
sensitivity analysis could also be investigated, such as a variance based approach using
Monte Carlo methods [262].
Parameter estimation
Parameter estimation could be improved by using different frameworks, such as Bayes-
ian methods. This has already begun to carried out, and will therefore be described
briefly here.
For a set of model parameters θ and measured data D, Bayes theorem states that
P(θ|D) = P(D|θ)P(θ)
P(D)
(7.1)
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where P(θ) is the prior probability distribution of the parameters, P(θ|D) is the likeli-
hood of the measured data given the parameters and P(D) is known as the marginal like-
lihood. Bayesian inference aims to determine the posterior distribution P(θ|D). Usually,
the relative probabilities are compared and P(D) is not calculated.
For a deterministic model M and a set of measurements at different times D with inde-
pendent identically, normally distributed errors with precision τ = 1/σ2, the likelihood
at each time point is given by √
τ
2pi
−τ (M(t) − D(t))22
 (7.2)
and the log of the overall likelihood for N time points is
log P(θ|D) = −τ
2
N∑
t=1
(
M(t) − D(t))2 + N
2
log
τ
2pi
. (7.3)
Therefore, maximising the likelihood is equivalent to minimising the mean square error
between modelled and measured data, as is typical in traditional parameter optimisation.
Bayesian methods are superior to these methods in two ways: i) they incorporate prior
information about the distribution of the parameters and ii) instead of finding a single
point in the parameter space, they generate a posterior parameter distribution, usually
by the use of a Markov chain Monte Carlo (MCMC) sampling method. However, the
disadvantages of these methods are that they require many more model evaluations, and
the assumption of independent, identically distributed errors may not be appropriate, or
the precision of the errors may not be known. Bayesian methods have recently begun
to be used for parameter estimation in models of dynamic biological systems [269].
If a model is not deterministic, calculating the likelihood is usually not possible within
a reasonable time frame. Likelihood-free Bayesian inference methods provide an esti-
mate of the posterior distribution without requiring calculation of the likelihood. One
of these methods is approximate Bayesian computation (ABC). In its simplest form,
ABC can be implemented with a rejection sampler. A trial point is chosen by sampling
from the prior distribution. A distance between the simulated data at this trial point and
the measured data is then calculated. A typical choice for this distance is the sum of
the squared errors at each of the time points. If the distance is less than a chosen tol-
erance, the trial point is accepted, otherwise it is rejected. This is then continued until
the chosen number of points have been accepted, and these points make up the estimate
of the posterior distribution. This method can be very inefficient (i.e. have a very low
acceptance rate) and it is has therefore been combined with MCMC methods [270]. A
high tolerance value is used initially, which is then gradually reduced over a series of
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sample populations until a final small tolerance is reached. ABC methods have been
used in systems biology for both parameter estimation and model selection [270, 271].
ABC-SysBio [272] is a software package that performs parameter estimation and model
selection using ABC. It is now being used for parameter estimation with the Brain-
Signals model. This involved writing extensions to the package to enable the simula-
tions to be carried out using the BRAINCIRC environment. An example of applying
this method to hypercapnia data from one of the 14 subjects described in Chapter 4 is
described here. To take into account the uncertainty in the measurements used as in-
puts, normally distributed random errors with fixed variance were added to the input
data at each time point for each simulation. As in Chapter 4, the PaCO2, SaO2 and Pa
measurements were used as inputs, but this time with added random errors of standard
deviation 1 mmHg, 1 % and 0.5 mmHg respectively. An example is shown in Figure
7.1.
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Figure 7.1: Measured PaCO2, SaO2 and Pa during a hypercapnia challenge in one sub-
ject (black), and model inputs generated by adding normally distributed noise to the
measurements (red).
Two parameters were used (the same as those optimised in Chapter 4): [Hbtot] with a
normal prior of mean 9.1 mM and standard deviation of 5.0 mM and RC with a uniform
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prior from -1 to 10. The modelled and measured TOI and Vmca were compared. The
details of the ABC MCMC method can be found in Toni et al. [270].
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Figure 7.2: Example of ABC parameter estimation. Estimated posterior distribution for
model parameters [Hbtot] and RC generated by comparing measured and simulated TOI
and Vmca signals.
A population size of 500 was used, and an automated tolerance schedule was run, with
the final tolerance set to a small value which was not reached. The process was stopped
after 120 populations by which time the acceptance rate had fallen to 0.004 indicating
that the tolerance was very close to its minimum possible value. The resulting sample
of 500 points, which serve as an estimate of the posterior distribution, is shown in
Figure 7.2. There is a slight relationship between the two parameters, but both have
been identified to within a fairly narrow range. It is difficult to compare this with the
optimisation from Chapter 4 since the weightings used in that optimisation affect the
results.
This is ongoing work. In particular, the effect of using different distributions to represent
uncertainty in the input will be investigated. Also, different numbers and groups of
parameters will be used, since a major advantage of this method is that it can show
relationships between parameters and help to assess whether their values have been
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successfully identified.
Modelling language
Improvements can be made by extending and enhancing the BRAINCIRC modelling
environment. Improving the compatibility with SBML and CellML would make exper-
imentation with other models simpler, and could also enable inclusion of other models
in a modular way. It would also improve the ability to make use of SBML software tools
developed by other groups, of which there are many [187]. In particular, the Systems
Biology Workbench is an opensource project that provides a framework for different
simulation software to communicate in order to encourage code reuse and tool sharing
[273]. Making BRAINCIRC compatible with this framework would help to integrate
its use with other tools.
7.2.2 Representation of physiology
Future improvements to the model itself will include a more detailed analysis of sev-
eral of the simulated processes, including the TCA cycle and glycolysis, in order to
further validate the simplified equations that are used. In addition, the model would
benefit from separating the cellular compartments to differentiate between astrocytes
and neurons. This feature is present in many models, and other models have also been
altered in this way. For example, the model by Aubert and Costalat of brain metabolism
and haemodynamics [174] was later modified to distinguish between the two cell types
[147]. The metabolic differences between astrocytes and neurons include their glucose
and lactate transport properties, a consequence of the different type and distribution of
their transport proteins as discussed in Section 1.2.3. The aim of this modification for
our model would be to better simulate the changes in lactate concentration which are
an important feature of HI. It would also allow the simulation of NAA which is visible
on the H-MRS spectrum. NAA is found only in neurons, but it undergoes a metabolic
cycle in the brain involving astrocytes and oligodendrocytes [274]. NAA concentration
has been observed to decrease following HI [124], and H-MRS measurements are often
expressed as Lac/NAA ratios, so its simulation is important.
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7.2.3 Spatial resolution
The model could also be improved by adding spatial resolution. This is a significant
change which would make the model more complex and therefore increase the time
taken to solve it. At its simplest, this would involve creating multiple copies of the
model with different input parameters. For example, regional measurements of CBF
could be used as an input. CBF varies throughout the brain, and its pattern is likely to
be altered during ischaemia. This is particularly the case for piglets subjected to carotid
artery occlusion whose remaining cerebral circulation is provided via the vertebral ar-
teries and the circle of Willis [122]. Furthermore, it is known that different regions of
the brain are affected differently by HI, for example the cerebellum and hippocampus
are particularly vulnerable to HI [275]. Other than varying CBF, the possible causes of
this regional variation of HI damage include differing metabolic rates. By altering pa-
rameter values across the model to reflect regional differences, these hypotheses could
be investigated. It would also be interesting to add an extracellular space compartment
to the model so that the diffusion of metabolites including glucose and lactate could be
modelled. This approach has recently been used to investigate brain damage caused by
stroke [276].
Similar to, but simpler than adding spatial resolution to the model, would be simulating
distinct (but spatially unrelated) populations of cells, representing, for example, dam-
aged and healthy cells following HI. This is an extension to the simplified method of
modelling cell death used in Chapter 6. It will also be necessary to investigate and
simulate mechanisms of cell death, rather than using a switch parameter. Modelling of
uncoupling will also be investigated further, which may help improve the simulation of
the recovery period following HI.
7.2.4 Comparison with new measurements
The model has been developed to simulate measured signals, and its development will
continue to be driven by this aim. Additional available measurements will allow further
validation and testing of the model. Measurements of CBF from arterial spin labelling
should become available, and will help to improve and validate the modelling of carotid
artery occlusion and other aspects of blood flow. It is already possible to simulate
pH changes with the model, and its simulations are currently being compared with
measurements from 31P-MRS [277]. Further in the future, it is planned to collect EEG
measurements during the insult, and the model could be extended to simulate these.
More details on pH and EEG measurements are discussed below. Finally, simulation of
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cell death may be improved by information from histological analysis of brain samples
from the piglets which is currently in progress.
In this thesis, averaged datasets for HI in piglets were not used. This is because the
number of piglets included was fairly small, and differences in the experimental proto-
col and the timings of the insult between piglets make these difficult to create. Measure-
ments from a greater number of piglets will allow averaged datasets to be generated. In
particular, datasets from groups of piglets classified as having good and poor outcomes
could be compared. Modelling of averaged data will complement modelling of data
from individual piglets, which allows differences between piglets to be investigated. Si-
multaneous data from 1H-MRS and 31P-MRS may also become available, which would
help with understanding the relationships between the signals.
pH
Measurements of pH from 31P-MRS are currently being compared with simulated pH.
Acidosis is an important feature of HI, and a shift in brain pH is known to occur fol-
lowing HI [278]. Changes in pH can alter protein structure and consequently affect
cell function. It is therefore important that pH is properly taken into account in the
BrainPiglet model. Some measurements of pH calculated from the chemical shifts of
the Pi and phosphoethanolamine (PEt) peaks of the
31P-MRS spectra by the method
described by Cady et al. [279] are available. A preliminary comparison of this mea-
surement with simulated cytoplasmic pH for one piglet is shown in Figure 7.3. The
simulated mitochondrial pH is also shown. There is promising agreement between the
measured pH and simulated cytoplasmic pH. More work in this area has been published
by Hapuarachchi et al. [277].
One difficulty in interpreting these measurements is that they originate from different
compartments. The model shows an increase in mitochondrial pH during the insult
and a fall following it. It is very difficult to measure mitochondrial pH, so it will be
interesting to look further into the model’s predictions.
EEG
Another measurement that may become available is EEG. Mathematical modelling of
electrical activity in neurons has a long history. One of the most well-known math-
ematical models in biology is the Hodgkin-Huxley model which describes the action
potential of a neuron [280]. Neuronal activity in the brain has also been extensively
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Figure 7.3: Left: Modelled cytoplasmic pH (solid) and pH calculated from 31P-MRS
spectra (dashed) for piglet LWP180 Right: Modelled mitochondrial pH
studied and modelled using networks and graph theory [281]. Several models exist
which link neuronal activity throughout the brain to EEG signals [282, 283]. Sotero et
al. [284] have linked a model of this type to a simple model of metabolism and blood
flow which aims to explain the BOLD response seen in fMRI. The EEG part of the
model involves spatial interactions between voxels, whereas the metabolic and blood
flow part of the model is solved separately for each voxel i.e. no spatial interactions
between metabolites are considered. A similar integration with a model of electrical ac-
tivity and EEG measurements may be possible with the BrainPiglet model. Solving the
model equations for many different voxels would be more computationally expensive
than for a single voxel as is currently the case. However, since the NIRS and MRS mea-
surements collected during the HI experiments do not have spatial resolution, it may be
possible to reduce the resolution required for the model.
7.2.5 Adaptation to humans
Long-term, the aim is to use the model in a clinical setting to help inform and monitor
the treatment of birth-asphyxiated infants. Adaptation of the model to human infants
will require taking into account the physiological differences between human babies
and piglets. For example, the CBF in a newborn human is 10–20 ml 100 gbrain−1 min−1
which is approximately one third of the adult value [285]. In piglets, the CBF is higher
at around 50 ml 100 gbrain−1 min−1 [59] and much closer to the value in the adult pig
[286]. The CMRO2 in newborn humans is around 0.5–1.5 ml 100 gbrain−1 min−1 [287]
whereas the value in an adult is approximately 3 ml 100 gbrain−1 min−1 [288]. Again, the
pig has a higher CMRO2 at birth of 2.5 ml 100 gbrain−1 min−1 [238] but the adult value of
2.5–3.5 ml 100 gbrain−1 [286, 289] is not much greater.
The effects of anaesthesia must also be considered. In general, piglets are anaesthetised
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throughout experiments involving HI, whereas human infants will not usually be anaes-
thetised. Isoflurane anaesthesia, which has been used in the experiments analysed in this
thesis, is generally reported to either have no effect on CBF or to slightly increase it, but
to significantly decrease CMRO2 [290, 291, 292]. The values used in the BrainPiglet
model are appropriate to anaesthetised piglets. However, the fact that these values are
different from the ‘normal’ awake values has not been taken into account and this may
have consequences when adapting the animal model to the human.
7.2.6 Secondary energy failure and treatment
Before adapting the model to humans, the modelled period must be extended to include
secondary energy failure. This is essential, since data from the period of asphyxia
will not be available for human infants. To do this, it will be necessary to simulate
additional biochemical processes. This will include modelling additional metabolites
such as glutamate and nitric oxide (NO) so that the processes involved in secondary
energy failure as discussed in Section 1.2.4 can be simulated. Addition of NO to the
BrainPiglet model would be aided by previous work involving the addition of NO to
the BrainSignals model to investigate hypoxic vasodilation [293]. It is hoped the model
will help to suggest hypotheses and experiments that will improve understanding of
secondary energy failure. Modelling the mechanisms that lead to damage will also
allow the possibility of modelling therapies which target these mechanisms, for example
xenon, which is an antagonist of the NMDA glutamate receptor. Simulation of the
effects of hypothermia, one of the most commonly used treatments, will help to bring
the model closer to a tool which can be used in the clinic.
7.3 Summary
As part of this PhD a new physiological model (BrainPiglet) has been developed to
simulate circulation and metabolism in the brain of neonatal piglets. This model can in-
tegrate multimodal data and has been used to simulate NIRS and MRS measured signals
during both anoxia and HI in piglets. The piglet HI experiments are used to mimic birth
asphyxia in human infants, and it is of great clinical importance to be able to understand
the circulatory and metabolic changes that happen during and after these episodes. The
modelling approach developed as part of this PhD has demonstrated the potential of
the use of computational modelling to aid in the interpretation and integration of these
multimodal non-invasive measurements, with the aim of enhancing our understanding
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of HI. In particular, the use of the model suggested that autoregulation was impaired
in the piglets subjected to anoxia, and that the failure to recover following HI seen in
some piglets was caused by cell death. In addition, this thesis demonstrated and applied
mathematical techniques for sensitivity analysis and parameter optimisation to physi-
ological models. These techniques can enhance the interpretation of these models by
suggesting important physiological connections between measured data and model pa-
rameters. Further work is concentrated on extending the model to simulate the human
neonatal brain, and improving optimisation and parameter fitting methods such as the
Bayesian method described in this chapter.
191
Appendix A
Piglet data
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Figure A.1: Measured data for Piglet LWP158
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Figure A.2: Measured data for Piglet LWP164
193
0 50 100
0.4
0.6
0.8
1
SaO2
S a
O
2
(%
)
0
0.5
1
Occlusion
0 50 100
40
60
80
M
A
B
P
(m
m
H
g)
0 50 100
−20
0
20
∆HbO2 (µM)
∆HHb (µM)
0 50 100
−4
−2
0
time (min)
∆
ox
C
C
O
(µ
M
)
0 50 100
0
1
2
time (min)
L
ac
/N
aa
Figure A.3: Measured data for Piglet LWP167
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Figure A.4: Measured data for Piglet LWP168
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Figure A.5: Measured data for Piglet LWP169
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Figure A.6: Measured data for Piglet LWP170
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Figure A.7: Measured data for Piglet LWP173
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Figure A.8: Measured data for Piglet LWP175
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Figure A.9: Measured data for Piglet LWP179
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Figure A.10: Measured data for Piglet LWP180
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Figure A.11: Measured data for Piglet LWP183
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Figure A.12: Measured data for Piglet LWP185
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Figure A.13: Measured data for Piglet LWP186
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Figure A.14: Measured data for Piglet LWP188
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Appendix B
Error Calculations
The aim is to find the values of f1 and f2 which minimise the mean square error (MSE)
between a modelled signal X and a measured signal Y , where X has been scaled by a
factor f1 and offset by a factor f2. If there are N measurements then
MSE =
1
N
∑
i
(
f1Xi + f2 − Yi)2 . (B.1)
The partial derivatives are given by
∂MSE
∂ f1
=
1
N
∑
i
2Xi
(
f1Xi + f2 − Yi) = 2 ( f1(X2) + f2X − (XY)) (B.2)
∂MSE
∂ f2
=
1
N
∑
i
2
(
f1Xi + f2 − Yi) = 2 ( f1X + f2 − Y) (B.3)
using the notation A =
∑
i Ai/N. When there is only scaling and no offset ( f2 = 0) then
B.2 must be zero, and so
f1 =
(XY)
(X2)
. (B.4)
When there is only offset and no scaling ( f1 = 1) then B.3 must be zero, and so
f2 = Y − X. (B.5)
When there is both scaling and offset, both B.2 and B.3 must be zero, and so
f2 = Y − f1X (B.6)
f1 =
(XY) − Y · X
(X2) − X2
. (B.7)
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Therefore for the four cases
1. No scale or offset (unmodified)
2. Only offset
3. Only scale
4. Both scale and offset
the minimum MSEs between the measured signal and the modified modelled signals
are
MSEu =
1
N
∑
i
(Xi − Yi)2 (B.8)
MSEo =
1
N
∑
i
(
Xi −
(
X + Y
)
− Yi
)2
(B.9)
MSEs =
1
N
∑
i
 (XY)(X2) Xi − Yi

2
(B.10)
MSEso =
1
N
∑
i
(
aXi −
(
aX − Y
)
− Yi
)
a =
(XY) − Y · X
(X2) − X2
. (B.11)
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Appendix C
BrainSignals model equations,
variables and parameters
C.1 Differential Equations
(C.1)
dCuA,o
dt
= 4Taox − 4Tared
(C.2)
dcyt a3,r
dt
= 4Taox − 4Tbox
(C.3)
d∆Ψ
dt
=
p2 f2 + p1 f1 + p3 f3 − L
Cim
(C.4)
d[H+m]
dt
=
−p2Taox
RHi
− p1Tared
RHi
− p3Tbox
RHi
+
Tpsiout
RHi
(C.5)
d[O2]
dt
= −Tbox + TO2inVmit
(C.6)
dνCO2
dt
=
1
τCO2
(
PaCO2 − νCO2
)
(C.7)
dνO2
dt
=
1
τO2
(
[O2,c] − νO2
)
(C.8)
dνPa
dt
=
1
τPa
(
Pa − νPa
)
(C.9)
dνu
dt
=
1
τu
(u − νu)
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C.2 Algebraic Equations
(C.10)φ
(
ScO2
1 − ScO2
)1/nh
− [O2,c] = 0
(C.11)Te + Tm − (P1 − Pic) r = 0
(C.12)CBF
(
[HbO2,a] − [HbO2,v]
)
− JO2 = 0
C.3 Chemical Reactions
Reactions are represented as terms in differential equations (see section C.1).
(C.13)aox : p2 H+m → 4 CuA,o + 4 cyt a3,r
the reaction in which cyt a3,o oxidises CuA,r and p2 protons are pumped
out of the matrix (Rate Taox)
(C.14)ared : 4 CuA,o + p1 H+m →
the reaction in which CuA,o is reduced and p1 protons are pumped out
of the matrix (Rate Tared)
(C.15)box : p3 H+m + 4 cyt a3,r + O2 →
the reaction in which O2 oxidises cyt a3,r and p3 protons are pumped out
of the matrix (Rate Tbox)
(C.16)O2in :→ O2
the reaction in which oxygen is supplied to the mitochondria (Rate
TO2in)
(C.17)psiout :→ H+m
the reaction in which protons re-enter the matrix (via leak and Complex
V) (Rate Tpsiout)
C.4 Variables
CuA,o (mM) Inital Value = CuA,o,init = 0.06567 mM
the concentration of oxidised cytochrome-c-oxidase
cyt a3,r (mM) Inital Value = cyt a3,r,init = 0.001408 mM
concentration of reduced cytochrome a3 in mitochondria
∆Ψ (mV) Inital Value = ∆Ψinit = 145 mV
mitochondrial inner membrane potential
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[H+m] (mM) Inital Value = H
+
m,init = 3.981e − 05 mM
concentration of hydrogen ions in mitochondria
[O2] (mM) Inital Value = [O2]init = 0.024 mM
the concentration of oxygen in the mitochondria
[O2,c] (mM) Inital Value = [O2,c]init = 0.06061 mM
the concentration of oxygen in the capillary
r (cm) Inital Value = rinit = 0.0187 cm
typical radius of cerebral vessels
νCO2 (mmHg) Inital Value = νCO2,n = 40 mmHg
PaCO2 passed through a first order filter
νO2 (mM) Inital Value = νO2,n = 0.06061 mM
[O2,c] passed through a first order filter
νPa (mmHg) Inital Value = νPa,n = 100 mmHg
ABP passed through a first order filter
νu (dimensionless) Inital Value = νu,n = 1 (dimensionless)
the demand parameter u passed through a first order filter
[HbO2,v] (mM) Inital Value = [HbO2,v]init = 5.573 mM
the concentration of bound oxygen in the veins
C.5 Temporary Variables
(C.18)CuA,r = [CCO]mit − CuA,o, (mM)
the concentration of reduced cytochrome-c-oxidase in the mitochondria
(C.19)AVR =
Va
Vv
, (dimensionless)
arterio-venous volume ratio
(C.20)cyt a3,o = [CCO]mit − cyt a3,r, (mM)
concentration of oxidised cytochrome a3 in mitochondria
(C.21)C0i =
10−pHm − 10−pHm−dpH
dpH
, (dimensionless)
natural buffering capacity for protons in mitochondria
(C.22)CBF = G (Pa − Pv) , (mlblood mlbrain−1 s−1)
cerebral blood flow
(C.23)∆oxCCO = ∆oxCCOoffset + 1000Vmit
(
CuA,o − CuA,o,n
)
, (µM)
the expected CCO signal (as measured by NIRS)
(C.24)CMRO2 = f3Vmit, (mM s−1)
cerebral metabolic rate of oxygen consumption
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(C.25)CNADH =
Z
2
log
(
1
[NAD]/[NADH]
)
, (mV)
redox potential minus standard redox potential for NADH at normal
demand
(C.26)∆G1 = −4
E1 + Z log (CuA,oCuA,r
) + p1∆p, (mV)
free energy associated with reaction ared
(C.27)∆G2 = −4
E2 + Z log (CuA,rCuA,o
)
− log
(
cyt a3,r
cyt a3,o
) + p2∆p, (mV)
free energy associated with reaction aox
(C.28)∆Hbdiff = ∆Hbdiffoffset + ∆HbO2 − ∆HHb, (µM)
change in (HbO2 − HHb) (NIRS)
(C.29)∆HbO2 = ∆HbO2,offset + HbO2 − HbO2,n, (µM)
change in total oxygenated haemoglobin (NIRS)
(C.30)∆Hbt = ∆HbToffset + Hbt − Hbtn, (µM)
change in total haemoglobin (NIRS)
(C.31)∆HHb = ∆HHboffset + HHb − HHbn, (µM)
change in total deoxygenated haemoglobin (NIRS)
(C.32)∆p = ∆Ψ + Z
(
pHm − pHo) , (mV)
the proton motive force across the mitochondrial inner membrane
η = RP
(
νPa
νPa,n
− 1
)
+ RO
(
νO2
νO2,n
− 1
)
+ Ru
(
1 − νu
νu,n
)
+ RC
(
1 − νCO2
νCO2,n
)
, (dimensionless)
(C.33)
total autoregulatory stimuli
(C.34)f1 = k1CuA,o − k−1CuA,r, (mM s−1)
the rate at which CuA,o is reduced
(C.35)f2 = k2CuA,rcyt a3,o − k−2CuA,ocyt a3,r, (mM s−1)
the rate at which CuA,r is oxidised and cyt a3,o reduced
(C.36)f3 =
k3[O2]cyt a3,r exp
(
−c3
(
∆p − ∆p30
))
1 + exp
(
−c3
(
∆p − ∆p30
)) , (mM s−1)
the rate at which cyt a3,r is oxidised
(C.37)G = KGr4, (mlblood mlbrain−1 mmHg−1 s−1)
resistance of cerebral circulation
(C.38)h = −r +
√
r2 + 2r0h0 + h02, (cm)
wall thickness of cerebral vessels
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(C.39)HbO2 = 1000
Va[HbO2,a] + Vv[HbO2,v]
4
Vblood,n, (µM)
total oxygenated haemoglobin (NIRS)
(C.40)Hbt = 1000
(Va + Vv) [Hbtot]
4
Vblood,n, (µM)
total haemoglobin (NIRS)
(C.41)HHb = 1000
Va[HHba] + Vv[HHbv]
4
Vblood,n, (µM)
total deoxygenated haemoglobin (NIRS)
(C.42)JO2,min = min
(
DO2
(
[O2,c] − [O2]
)
CBF[HbO2,a]
)
, (mM s−1)
rate at which oxygen is supplied to the mitochondria, minimum of dif-
fusion rate and delivery rate
(C.43)JO2 = JO2,min, (mM s−1)
the rate at which oxygen is supplied to the mitochondria
(C.44)k1 = k1,0 exp
(
−ck1 (∆p − ∆pn)) , (s−1)
forward rate constant for reaction ared
(C.45)k2 = k2,n exp
(
−ck2 (∆p − ∆pn)) , (mM−1 s−1)
forward rate constant for reaction aox
(C.46)Keq1 = 10(−1/Z)(p1∆p/4−E1), (dimensionless)
equilibrium constant for reaction ared
(C.47)Keq2 = 10(−1/Z)(p2∆p/4−E2), (dimensionless)
equilibrium constant for reaction aox
(C.48)k−1 =
k1
Keq1
, (s−1)
backward rate constant for reaction ared
(C.49)k−2 =
k2
Keq2
, (mM−1 s−1)
backward rate constant for reaction aox
(C.50)L = LCV + Llk, (mM s−1)
the rate at which protons reenter the mitochondrial matrix
(C.51)LCV =
CVinhLCV,max
(
1 − e−θ
)
1 + rCVe−θ
, (mM s−1)
the rate at which protons reenter the mitochondrial matrix associated
with ADP phosphorylation
(C.52)Llk = kuncLlk0
(
exp
(
∆pklk2
) − 1) , (mM s−1)
the rate at which protons reenter the mitochondrial matrix through leak
channels
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(C.53)µ =
µmin + µmaxeη
1 + eη
, (dimensionless)
total autoregulatory stimuli filtered through sigmoidal function
(C.54)pHm = − log
(
[H+m]
1000
)
, (dimensionless)
mitochondrial pH
(C.55)rbuffi =
Cbuffi
C0i
, (dimensionless)
buffering capacity for protons in mitochondria
(C.56)RHi = rbuffi, (dimensionless)
relative mitochondrial volume for protons
(C.57)ScO2 =
SaO2 + SvO2
2
, (dimensionless)
capillary oxygen saturation
(C.58)σe = σe0
exp (Kσ (r − r0)r0
)
− 1
 − σcoll, (mmHg)
elastic stress in vessel walls
(C.59)SvO2 =
[HbO2,v]
[Hbtot]
, (dimensionless)
venous oxygen saturation
(C.60)Taox = f2, (mM s−1)
Rate of reaction aox
(C.61)Tared = f1, (mM s−1)
Rate of reaction ared
(C.62)Tbox = f3, (mM s−1)
Rate of reaction box
(C.63)Te = σeh, (mmHg cm)
elastic tension in vessel walls
(C.64)θ = kCV
(
∆p + Z log (u) − ∆pCV0) , (dimensionless)
driving force for Complex V
(C.65)Tm = Tmax exp
− ∣∣∣∣∣∣ r − rmrt − rm
∣∣∣∣∣∣
nm , (mmHg cm)
muscular tension in vessel walls
(C.66)Tmax = Tmax0
(
1 + kautµ
)
, (mmHg cm)
maximum muscular tension developed by circulation
(C.67)TO2in = JO2, (mM s
−1)
Rate of reaction O2in
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(C.68)TOS =
100
[Hbtot]

(
r
rn
)2
[HbO2,a](
r
rn
)2
+ VAratn
+
VAratn[HbO2,v](
r
rn
)2
+ VAratn
 , (dimensionless)
tissue oxygenation index
(C.69)Tpsiout = L, (mM s−1)
Rate of reaction psiout
(C.70)Vmca = CBFCBFscale, (cm s−1)
the velocity of blood in the middle cerebral artery
(C.71)Va = Va,n
(
r
rn
)2
, (dimensionless)
arterial blood volume as a fraction of normal total blood volume
(C.72)Vt = Va + Vv, (dimensionless)
normalised total blood volume
(C.73)[HHbv] = [Hbtot] − [HbO2,v], (mM)
concentration of haemoglobin O2 binding sites not occupied by O2 (four
times deoxyhaemoglobin concentration) in the veins
C.6 Parameters
CuA,frac,n = 0.8 (dimensionless)
normal oxidised fraction of CuA
Vblood,n = 0.04 (dimensionless)
normal blood volume as a fraction of brain tissue volume
c3 = 0.11 mV−1
parameter controlling the sensitivity of reaction box to ∆p
CBFn = 0.01075 mlblood mlbrain−1 s−1
normal cerebral blood flow
CBFscale = 5000 cm
ratio between Vmca and CBF
Cbuffi = 0.022 (dimensionless)
buffering capacity for protons in mitochondria
∆oxCCOoffset = 0 µM
an arbitrary baseline offset to the ∆oxCCO signal (NIRS)
Cim = 0.00675 mM mV−1
capacitance of mitochondrial inner membrane
ck1 = 0.01 mV−1
parameter constrolling sensitivity of k1 to ∆p
ck2 = 0.02 mV−1
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parameter constrolling sensitivity of k2 to ∆p
CMRO2,n = 0.034 mM s−1
The resting CMRO2
CVinh = 1 (dimensionless)
a control parameter representing the action of Complex V inhibitors
[CCO]tis = 0.0055 mM
concentration of cytochrome c oxidase in tissue
∆Hbdiffoffset = 0 µM
an arbitrary baseline offset to the ∆Hbdiff signal (NIRS)
∆HbO2,offset = 0 µM
an arbitrary baseline offset to the ∆HbO2 signal (NIRS)
∆HbToffset = 0 µM
an arbitrary baseline offset to the ∆Hbt signal (NIRS)
∆HHboffset = 0 µM
an arbitrary baseline offset to the ∆HHb signal (NIRS)
DNADH = 0.01 (dimensionless)
DNADH×Z is the change in NADH redox potential for a ten-fold increase
in u
∆p3,corr = −25 mV
∆p30 minus normal ∆p
∆pCV0 = 90 mV
a constant in the rate of Complex V
dpH = 0.001 (dimensionless)
a constant in the buffering relationship
∆Ψn = 145 mV
normal mitochondrial inner membrane potential
E0(cyt a3) = 350 mV
cytochrome a3 standard redox potential
E0(CuA) = 247 mV
CuA standard redox potential
E0(NADH) = −320 mV
NADH standard redox potential
h0 = 0.003 cm
vascular wall thickness when radius is r0
kH,O2 = 0.0014 mM mmHg
−1
constant setting relationship between oxygen saturation and oxygen
concentration in artery
k3,0 = 2.5e + 05 mM−1 s−1
an apparent second-order rate constant for reaction box at zero ∆p
kaut = 1 (dimensionless)
control parameter allowing destruction of autoregulation
klk2 = 0.038 mV−1
second constant controlling rate of Llk of ∆p
Kσ = 10 (dimensionless)
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parameter controlling sensitivity of σe to radius
kunc = 1 (dimensionless)
a parameter representing the action of uncouplers
LCV,0 = 0.4 (dimensionless)
normal Complex V flux as a fraction of maximum possible flux
Llk,frac = 0.25 (dimensionless)
normal fraction of proton entry into mitochondria which is via leak
channels
µmax = 1 (dimensionless)
maximum value of µ
µmin = −1 (dimensionless)
minimum value of µ
µn = 0 (dimensionless)
normal value of µ
[NAD]n/[NADH]n = 9 (dimensionless)
normal NAD/NADH ratio
Nt = 3 mM
total mitochondrial NAD and NADH concentration
nh = 2.5 (dimensionless)
Hill coefficient for haemoglobin saturation
nm = 1.83 (dimensionless)
exponent in the muscular tension relationship
[O2]n = 0.024 mM
normal oxygen concentration in mitochondria
Pa = 100 mmHg
arterial blood pressure
PaCO2 = 40 mmHg
arterial partial pressure of CO2
PaCO2,n = 40 mmHg
normal arterial partial pressure of CO2
Pa,n = 100 mmHg
normal value of ABP
φ = 0.036 mM
value of O2 concentration at half maximal saturation
pHm,n = 7.4 (dimensionless)
normal mitochondrial pH
pHo = 7 (dimensionless)
extra-mitochondrial pH
pHo,n = 7 (dimensionless)
normal extra-mitochondrial pH
Pic = 9.5 mmHg
intracranial blood pressure
Pic,n = 9.5 mmHg
normal intracranial blood pressure
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ptot = 20 (dimensionless)
total protons pumped by reactions ared, aox and box
Pv = 4 mmHg
venous blood pressure
Pv,n = 4 mmHg
normal venous blood pressure
r0 = 0.0126 cm
a special radius in the elastic tension relationship
RC = 2.2 (dimensionless)
parameter controlling sensitivity of η to PaCO2
RO = 1.5 (dimensionless)
parameter controlling sensitivity of η to [O2,c]
RP = 4 (dimensionless)
parameter controlling sensitivity of η to Pa
Ru = 0.5 (dimensionless)
parameter controlling sensitivity of η to u
rCV = 5 (dimensionless)
a parameter controlling the ratio of maximal to minimal rates of oxida-
tive phosphorylation
rm = 0.027 cm
value of vessel radius giving maximum muscular tension
rn = 0.0187 cm
normal radius of blood vessels
rt = 0.018 cm
parameter in the muscular tension relationship
SaO2,n = 0.96 (dimensionless)
normal saturation of the arterial haemoglobin
SaO2 = 0.96 (dimensionless)
saturation of the arterial haemoglobin
σcoll = 62.79 mmHg
value of pressure at which vessels collapse
σe0 = 0.1425 mmHg
parameter in relationship determining σe
τCO2 = 5 s
the time constant associated with νCO2
τO2 = 20 s
the time constant associated with νO2
τPa = 5 s
the time constant associated with νPa
τu = 0.5 s
the time constant associated with νu
u = 1 (dimensionless)
the representation of “demand” in the model
un = 1 (dimensionless)
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resting “demand”
VAratn = 3 (dimensionless)
the normal ratio of the volume of the veins to the volume of the arteries
Vmit = 0.067 (dimensionless)
fraction of brain water which is mitochondria
Vt,n = 1 (dimensionless)
normal total blood volume
[Hbtot] = 9.1 mM
total concentration of haemoglobin O2 binding sites in the arteries and
veins (four times haemoglobin concentration)
[Hbtot]n = 9.1 mM
normal total concentration of haemoglobin O2 binding sites in the ar-
teries and veins (four times haemoglobin concentration)
Z = 59.03 mV
2.303× RT/F where R is the ideal gas constant (8300 mJ K−1 mol−1),
T is the temperature (298 K), F is the Faraday constant (9.65 × 104
C mol−1) and 2.303 arises from 1/log10 e.
C.7 Derived Parameters
(C.74)CuA,o,init = CuA,o,n = 0.06567 mM
initial oxidized CuA
(C.75)CuA,o,n = [CCO]mitCuA,frac,n = 0.06567 mM
normal oxidized CuA
(C.76)CuA,r,n = [CCO]mit − CuA,o,n = 0.01642 mM
the resting amount of reduced cytochrome-c-oxidase
(C.77)a3frac,n = 1 − cyt a3,r,n[CCO]mit = 0.9829 (dimensionless)
normal oxidised fraction of cytochrome a3
(C.78)cyt a3,o,n = [CCO]mit − cyt a3,r,n = 0.08068 mM
normal oxidised cytochrome a3
(C.79)cyt a3,r,init = cyt a3,r,n = 0.001408 mM
initial reduced cytochrome a3
(C.80)cyt a3,r,n =
fn
(
1 + exp
(
−c3
(
∆pn − ∆p30
)))
k3[O2]n exp
(
−c3
(
∆pn − ∆p30
)) = 0.001408 mM
normal reduced cytochrome a3
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(C.81)CNADH,n =
Z
2
log
(
1
[NAD]n/[NADH]n
)
= −28.16 mV
normal value of CNADH
(C.82)[CCO]mit =
[CCO]tis
Vmit
= 0.08209 mM
concentration of cytochrome c oxidase in mitochondria
(C.83)∆G1,n = −4
E1,n + Z log (CuA,o,nCuA,r,n
) + p1∆pn = −274.2 mV
normal free energy associated with reaction ared
(C.84)∆G2,n = −4
E2 + Z log (CuA,r,nCuA,o,n
)
− log
(
cyt a3,r,n
cyt a3,o,n
) + p2∆pn = −10.56 mV
normal free energy associated with reaction aox
(C.85)DO2 =
JO2,n
[O2,c]n − [O2]n = 0.9287 s
−1
diffusion rate between capillaries and mitochondria
(C.86)∆p30 = ∆pn + ∆p3,corr = 143.6 mV
value of PMF at which reaction box is maximally sensitive to ∆p
(C.87)∆pHn = pHm,n − pHo,n = 0.4 (dimensionless)
the resting value of pH difference across mitochondrial inner membrane
(C.88)∆pn = ∆Ψn + Z∆pHn = 168.6 mV
the resting value of the proton motive force
(C.89)∆Ψinit = ∆Ψn = 145 mV
initial value of mitochondrial inner membrane potential
(C.90)E1 = E1,NADH = 538.8 mV
the energy provided by electron transfer to CuA,o
(C.91)E1,n = E1,NADH,n = 538.8 mV
the normal value of E1
(C.92)E1,NADH = E0(CuA) − E0(NADH) + CNADH = 538.8 mV
E1 when the reducing substrate is NADH
(C.93)E1,NADH,n = E0(CuA) − E0(NADH) + CNADH,n = 538.8 mV
normal value of E1,NADH
(C.94)E2 = E0(cyt a3) − E0(CuA) = 103 mV
the energy provided by transfer of four electrons from CuA,r to to cyt a3,o
(C.95)fn =
CMRO2,n
Vmit
= 0.5075 mM s−1
normal resting rate of f1 and f2
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(C.96)Gn =
CBFn
Pa,n − Pv,n = 0.000112 mlblood mlbrain
−1 mmHg−1 s−1
normal resistance of cerebral circulation
(C.97)HbO2,n = 1000
Va,n[HbO2,a]n + Vv[HbO2,v]n
4
Vblood,n = 63.64 µM
normal total oxygenated haemoglobin (NIRS)
(C.98)Hbtn = 1000
(
Va,n + Vv
)
[Hbtot]n
4
Vblood,n = 91 µM
normal total haemoglobin (NIRS)
(C.99)HHbn = 1000
Va,n[HHba]n + Vv[HHbv]n
4
Vblood,n = 27.36 µM
normal total deoxygenated haemoglobin (NIRS)
(C.100)H+m,init = H
+
m,n = 3.981e − 05 mM
initial hydrogen ion concentration in mitochondria
(C.101)H+m,n = 10
3−pHm,n = 3.981e − 05 mM
normal hydrogen ion concentration in mitochondria
(C.102)hn = −rn +
√
rn2 + 2r0h0 + h0h0 = 0.00214 cm
normal wall thickness of cerebral vessels
(C.103)JO2,n = CMRO2,n = 0.034 mM s−1
the resting rate of supply of oxygen to the mitochondria
(C.104)k1,0 =
k1,nNADH
NADHn
= 8.3 s−1
forward rate constant for reaction ared at normal ∆p
(C.105)k1,n =
fn
CuA,o,n − 1Keq1,n CuA,r,n
= 8.3 s−1
the value of k1 at normal ∆p and NADH
(C.106)k2,n =
fn
CuA,r,ncyt a3,o,n − 1Keq2,n CuA,o,ncyt a3,r,n
= 3916 mM−1 s−1
normal forward rate constant for reaction aox
(C.107)k3 =
k3,0
(
1 + exp
(
−c3
(
0 − ∆p30
)))
exp
(
−c3
(
0 − ∆p30
)) = 2.5e + 05 mM−1 s−1
rate constant for reaction box
(C.108)kCV =
−1
∆pn − ∆pCV0 ln
(
1 − LCV,0
1 + rCV LCV,0
)
= 0.02047 mV−1
a parameter controlling the sensitivity of Complex V flux to driving
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force
(C.109)Keq1,n = 10(−1/Z)(p1∆pn/4−E1,n) = 3.623 (dimensionless)
normal equilibrium constant for reaction ared
(C.110)Keq2,n = 10(−1/Z)(p2∆pn/4−E2) = 0.07735 (dimensionless)
normal equilibrium constant for reaction aox
(C.111)KG =
Gn
rn4
= 915.7 mlblood mlbrain−1 mmHg−1 s−1 cm−4
constant of proportionality relating pressure drop to flow
(C.112)LCV,frac = 1 − Llk,frac = 0.75 (dimensionless)
normal fraction of proton entry into mitochondria associated with ADP
phosphorylation
(C.113)LCV,max =
LCV,n
LCV,0
= 19.03 mM s−1
the maximum rate of proton flow through Complex V
(C.114)LCV,n = LnLCV,frac = 7.612 mM s−1
the resting flow of protons into the matrix through Complex V
(C.115)Llk0 =
Llk,n
exp
(
∆pnklk2
) − 1 = 0.004193 mM s−1
first constant controlling rate of Llk of ∆p
(C.116)Llk,n = LnLlk,frac = 2.537 mM s−1
the resting flow of protons into the matrix via leak channels
(C.117)Ln = ptot fn = 10.15 mM s−1
the total flow of protons back into mitochondria
(C.118)NADH =
Nt
1 + [NAD]/[NADH]
= 0.3 mM
concentration of NADH in the mitochondria
(C.119)NADHn =
Nt
1 + [NAD]n/[NADH]n
= 0.3 mM
normal concentration of NADH in the mitochondria
(C.120)[NAD]/[NADH] =
[NAD]n/[NADH]n
u2DNADH
= 9 (dimensionless)
NAD/NADH ratio
(C.121)[O2,a] = φ
(
SaO2
1 − SaO2
)1/nh
= 0.1283 mM
arterial dissolved oxygen concentration
(C.122)[O2,c]init = [O2,c]n = 0.06061 mM
initial concentration of dissolved oxygen in the capillary
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(C.123)[O2,c]n = φ
(
ScO2,n
1 − ScO2,n
)1/nh
= 0.06061 mM
normal concentration of dissolved oxygen in the capillary
(C.124)[O2]init = [O2]n = 0.024 mM
initial oxygen concentration in mitochondria
(C.125)P1 =
Pa + Pv
2
= 52 mmHg
average blood pressure in vessels
(C.126)p1 = ptot − p23 = 12 (dimensionless)
the number of protons pumped by reaction ared
(C.127)P1,n =
Pa,n + Pv,n
2
= 52 mmHg
normal average blood pressure in vessels
(C.128)p2 = 4 × 1 = 4 (dimensionless)
total protons pumped by reaction aox
(C.129)p23 = 4 × 2 = 8 (dimensionless)
total protons pumped by reactions aox and box
(C.130)p3 = p23 − p2 = 4 (dimensionless)
total protons pumped by reaction box
(C.131)PaO2 =
[O2,a]
kH,O2
= 91.68 mmHg
partial pressure of oxygen in the arteries
(C.132)rinit = rn = 0.0187 cm
initial radius of blood vessels
(C.133)ScO2,n =
SaO2,n + SvO2n
2
= 0.7862 (dimensionless)
normal capillary oxygen saturation
(C.134)σe,n = σe0
exp (Kσ (rn − r0)r0
)
− 1
 − σcoll = −44.89 mmHg
normal elastic stress in vessel walls
(C.135)SvO2n =
[HbO2,v]n
[Hbtot]n
= 0.6124 (dimensionless)
normal venous oxygen saturation
(C.136)Te,n = σe,nhn = −0.09604 mmHg cm
normal elastic tension in vessel walls
(C.137)Tmax0 =
Tmax,n
1 + kautµn
= 2.11 mmHg cm
Tmax at normal µ
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(C.138)Tmax,n =
Tm,n
exp
− ∣∣∣∣∣∣rn − rmrt − rm
∣∣∣∣∣∣
nm = 2.11 mmHg cm
normal maximum muscular tension developed by circulation
(C.139)Tm,n =
(
P1,n − Pic,n
)
rn − Te,n = 0.8908 mmHg cm
normal muscular tension in vessel walls
(C.140)νCO2,n = PaCO2,n = 40 mmHg
normal value of νCO2 (PaCO2 passed through a first order filter)
(C.141)Va,n =
Vt,n
1 + VAratn
= 0.25 (dimensionless)
normal arterial blood volume as a fraction of total blood volume
(C.142)Vv = Vt,n
VAratn
1 + VAratn
= 0.75 (dimensionless)
venous blood volume as a fraction of total blood volume
(C.143)νO2,n = [O2,c]n = 0.06061 mM
normal value of νO2 ([O2,c] passed through a first order filter)
(C.144)νPa,n = Pa,n = 100 mmHg
normal value of νPa (Pa passed through a first order filter)
(C.145)νu,n = un = 1 (dimensionless)
normal value of νu (u passed through a first order filter)
(C.146)[HHba] = [Hbtot] (1 − SaO2) = 0.364 mM
concentration of haemoglobin O2 binding sites not occupied by O2 (four
times deoxyhaemoglobin concentration) in the arteries
(C.147)[HHba]n = [Hbtot]n
(
1 − SaO2,n
)
= 0.364 mM
normal concentration of haemoglobin O2 binding sites not occupied by
O2 (four times deoxyhaemoglobin concentration) in the arteries
(C.148)[HbO2,a] = [Hbtot]SaO2 = 8.736 mM
concentration of O2 bound to arterial haemoglobin (four times oxy-
haemoglobin concentration)
(C.149)[HbO2,a]n = [Hbtot]nSaO2,n = 8.736 mM
normal concentration of O2 bound to arterial haemoglobin (four times
oxyhaemoglobin concentration)
(C.150)[HbO2,v]init = [HbO2,v]n = 5.573 mM
initial concentration of O2 bound to venous haemoglobin (four times
oxyhaemoglobin concentration)
(C.151)[HbO2,v]n =
CBFn[HbO2,a]n − JO2,n
CBFn
= 5.573 mM
normal concentration of O2 bound to venous haemoglobin (four times
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oxyhaemoglobin concentration)
(C.152)[HHbv]n = [Hbtot]n − [HbO2,v]n = 3.527 mM
normal concentration of haemoglobin O2 binding sites not occupied by
O2 (four times deoxyhaemoglobin concentration) in the veins
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Appendix D
BrainPiglet model equations, variables
and parameters
D.1 Differential Equations
(D.1)
dCuA,o
dt
= 4Taox − 4Tared
(D.2)
d[ADP]
dt
= −TCK − TADPtoATP + TATPtoADP − 2TAK − 2TGlycolysis
(D.3)
d[AMP]
dt
= TAK
(D.4)
d[ATP]
dt
= TCK + TADPtoATP − TATPtoADP + TAK + 2TGlycolysis
(D.5)
dcyt a3,r
dt
= 4Taox − 4Tbox
(D.6)
d[Cr]
dt
= TCK
(D.7)
d∆Ψ
dt
=
p2 f2 + p1 f1 + p3 f3 − L
Cim
(D.8)
d[gluc]
dt
= −TGlycolysis + TGlucin − TGlucout
(D.9)
d[H+m]
dt
=
−p2Taox
RHi
−
(
p1 +
10
6
)
Tared
RHi
− p3Tbox
RHi
+
Tpsiout
RHi
+
4TTCA
RHi
+
TMAshuttle
RHiVmit
224
(D.10)
d[H+cyt]
dt
=
p2TaoxVmit
RHi,c
+
(
p1 + 4
)
TaredVmit
RHi,c
− TpsioutVmit
RHi,c
− TCK
RHi,c
+
4TGlycolysis
RHi,c
− TPytoLac
RHi,c
− TTCAVmit
RHi,c
+
TLacin
RHi,c
− TLacout
RHi,c
− TMAshuttle
RHi,c
(D.11)
d[lac]
dt
= TPytoLac + TLacin − TLacout
(D.12)
d[NAD]
dt
= 2Tared − 5TTCA − TMAshuttleVmit
(D.13)
d[NADcyt]
dt
= −2TGlycolysis + TPytoLac + TMAshuttle
(D.14)
d[O2]
dt
= −Tbox + TO2in
Vmit
(
1 − d f
)
(D.15)
d[Pi]
dt
= −TADPtoATP + TATPtoADP − 2TGlycolysis
(D.16)
d[PCr]
dt
= −TCK
(D.17)
d[Py]
dt
= 2TGlycolysis − TPytoLac − TTCAVmit1
(D.18)
dνCO2
dt
=
1
τCO2
(
PaCO2 − νCO2
)
(D.19)
dνO2
dt
=
1
τO2
(
[O2,c] − νO2
)
(D.20)
dνPa
dt
=
1
τPa
(
Pa2 − νPa
)
(D.21)
dνu
dt
=
1
τu
(u − νu)
D.2 Algebraic Equations
(D.22)φ
(
ScO2
1 − ScO2
)1/nh
− [O2,c] = 0
(D.23)Te + Tm − (P1 − Pic) r = 0
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(D.24)CBF
(
[HbO2,a] − [HbO2,v]
)
− JO2 = 0
D.3 Chemical Reactions
Reactions are represented as terms in differential equations (see section D.1).
(D.25)AK : 2 ADP ⇀↽ ATP + AMP
a two way reaction in which two molecules of ADP are converted into
one of ATP and one of AMP catalysed by adenylate kinase (Rate TAK)
(D.26)ADPtoATP : ADP + Pi → ATP
phosphorylation of ADP by Complex V (Rate TADPtoATP)
(D.27)aox : p2 H+m → 4 CuA,o + 4 cyt a3,r + p2 H+cyt
the reaction in which cyt a3,o oxidises CuA,r and p2 protons are pumped
out of the matrix (Rate Taox)
(D.28)ared : 4 CuA,o + (p1 +
10
6
) H+m → (p1 + 4) H+cyt + 2 NAD
the reaction in which CuA,o is reduced and p1 protons are pumped out
of the matrix (Rate Tared)
(D.29)ATPtoADP : ATP→ ADP + Pi
hydrolysis of ATP (Rate TATPtoADP)
(D.30)box : p3 H+m + 4 cyt a3,r + O2 →
the reaction in which O2 oxidises cyt a3,r and p3 protons are pumped out
of the matrix (Rate Tbox)
(D.31)Glucin :→ gluc
transport of glucose from the blood to the cytoplasm (fixed rate) (Rate
TGlucin)
(D.32)Glucout : gluc→
transport of glucose from the cytoplasm to the blood (Rate TGlucout)
(D.33)Glycolysis : gluc + 2 ADP + 2 NADcyt + 2 Pi → 2 ATP + 4 H+cyt + 2 Py
a one way Michaelis Menten reaction which is assumed to capture the
process of glycolysis (Rate TGlycolysis)
(D.34)Lacin :→ lac + H+cyt
transport of lactate from the blood to the cytoplasm (fixed rate) (Rate
TLacin)
(D.35)Lacout : lac + H+cyt →
transport of lactate from the cytoplasm to the blood (Rate TLacout)
(D.36)MAshuttle : H+cyt + NAD ⇀↽ H
+
m + NADcyt
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malate aspartate shuttle: transfer between NAD/NADH in the cyto-
plasm and the mitochondria (Rate TMAshuttle)
(D.37)O2in :→ O2
the reaction in which oxygen is supplied to the mitochondria (Rate
TO2in)
(D.38)CK : PCr + ADP + H+cyt ⇀↽ Cr + ATP
a two way mass action reaction representing the interconversion of PCr
and ADP to Cr and ATP (Rate TCK)
(D.39)psiout : H+cyt → H+m
the reaction in which protons re-enter the matrix (via leak and Complex
V) (Rate Tpsiout)
(D.40)PytoLac : H+cyt + Py ⇀↽ lac + NADcyt
interconversion between pyruvate and lactate (Rate TPytoLac)
(D.41)TCA : 5 NAD + Py + H+cyt → 4 H+m
one step simple representation of pyruvate dehyrogenase and the TCA
cycle (Rate TTCA)
D.4 Variables
CuA,o (mM) Inital Value = CuA,o,init = 0.022 mM
the concentration of oxidised cytochrome-c-oxidase
[ADP] (mM) Inital Value = [ADP]n = 0.012 mM
ADP concentration in cytoplasm
[AMP] (mM) Inital Value = [AMP]n = 0.000334 mM
AMP concentration in cytoplasm
[ATP] (mM) Inital Value = [ATP]n = 1.2 mM
ATP concentration in cytoplasm
cyt a3,r (mM) Inital Value = cyt a3,r,init = 0.000828 mM
concentration of reduced cytochrome a3 in mitochondria
[Cr] (mM) Inital Value = [Cr]n = 4.316 mM
creatine concentration in cytoplasm
∆Ψ (mV) Inital Value = ∆Ψinit = 145 mV
mitochondrial inner membrane potential
[gluc] (mM) Inital Value = [gluc]n = 1.2 mM
concentration of glucose in the cytoplasm
[H+m] (mM) Inital Value = H
+
m,init = 3.981e − 05 mM
concentration of hydrogen ions in mitochondria
[H+cyt] (mM) Inital Value = [H
+]n = 0.0001 mM
concentration of hydrogen ions in the cytoplasm
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[lac] (mM) Inital Value = [lac]n = 3 mM
concentration of lactate in the cytoplasm
[NAD] (mM) Inital Value = [NAD]n = 2.7 mM
concentration of NAD in the mitochondria
[NADcyt] (mM) Inital Value = [NADcyt]n = 359 mM
concentration of NAD in the cytoplasm
[O2] (mM) Inital Value = [O2]init = 0.024 mM
the concentration of oxygen in the mitochondria
[O2,c] (mM) Inital Value = [O2,c]init = 0.05343 mM
the concentration of oxygen in the capillary
[Pi] (mM) Inital Value = [P]n = 0.9524 mM
inorganic phosphate concentration in cytoplasm
[PCr] (mM) Inital Value = [PCr]n = 2.6 mM
phosphocreatine concentration in cytoplasm
[Py] (mM) Inital Value = [Py]n = 0.1 mM
concentration of pyruvate in the cytoplasm
r (cm) Inital Value = rn = 0.0187 cm
typical radius of cerebral vessels
νCO2 (mmHg) Inital Value = νCO2,n = 40 mmHg
PaCO2 passed through a first order filter
νO2 (mM) Inital Value = νO2,n = 0.05343 mM
[O2,c] passed through a first order filter
νPa (mmHg) Inital Value = νPa,n = 43.31 mmHg
ABP passed through a first order filter
νu (dimensionless) Inital Value = νu,n = 1 (dimensionless)
the demand parameter u passed through a first order filter
[HbO2,v] (mM) Inital Value = [HbO2,v]init = 2.684 mM
the concentration of bound oxygen in the veins
D.5 Temporary Variables
(D.42)CuA,r = [CCO]mit − CuA,o, (mM)
the concentration of reduced cytochrome-c-oxidase in the mitochondria
(D.43)AVR =
Va
Vv
, (dimensionless)
arterio-venous volume ratio
(D.44)cyt a3,o = [CCO]mit − cyt a3,r, (mM)
concentration of oxidised cytochrome a3 in mitochondria
(D.45)C0i,m =
10−pHm − 10−pHm−dpH
dpH
, (dimensionless)
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natural buffering capacity for protons in mitochondria
(D.46)C0i,c =
10−pHo − 10−pHo−dpH
dpH
, (dimensionless)
natural buffering capacity for protons in the cytoplasm
(D.47)CBF = G (Pa2 − Pv) , (mlblood mlbrain−1 s−1)
cerebral blood flow
(D.48)∆oxCCO = ∆oxCCOoffset + 1000Vmit
((
1 − d f
)
CuA,o − CuA,o,n
)
, (µM)
the expected CCO signal (as measured by NIRS)
(D.49)CMRgluc = TGlucin − TGlucout , (mM s−1)
rate of glucose metabolism
(D.50)CMRlac = TLacin − TLacout , (mM s−1)
rate of lactate metabolism
(D.51)CMRO2 =
(
1 − d f
)
f3Vmit, (mM s−1)
cerebral metabolic rate of oxygen consumption
(D.52)CNADH =
Z
2
log
(
1
[NAD]/[NADH]
)
, (mV)
redox potential minus standard redox potential for NADH at normal
demand
(D.53)∆G1 = −4
E1 + Z log (CuA,oCuA,r
) + p1∆p, (mV)
free energy associated with reaction ared
(D.54)∆G2 = −4
E2 + Z log (CuA,rCuA,o
)
− log
(
cyt a3,r
cyt a3,o
) + p2∆p, (mV)
free energy associated with reaction aox
(D.55)∆G = ∆G◦ + ZF log
(
gp
)
, (J mol−1)
Gibbs free energy of ATP hydrolysis
(D.56)∆Hbdiff = ∆Hbdiffoffset + ∆HbO2 − ∆HHb, (µM)
change in (HbO2 − HHb) (NIRS)
(D.57)∆HbO2 = ∆HbO2,offset + HbO2 − HbO2,n, (µM)
change in total oxygenated haemoglobin (NIRS)
(D.58)∆Hbt = ∆HbToffset + Hbt − Hbtn, (µM)
change in total haemoglobin (NIRS)
(D.59)∆HHb = ∆HHboffset + HHb − HHbn, (µM)
change in total deoxygenated haemoglobin (NIRS)
(D.60)∆p = ∆Ψ + Z∆pH, (mV)
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the proton motive force across the mitochondrial inner membrane
(D.61)∆pH = pHm − pHo, (dimensionless)
the pH difference across mitochondrial inner membrane
(D.62)E1 = E1,NADH, (mV)
the energy provided by electron transfer to CuA,o
(D.63)E1,NADH = E0(CuA) − E0(NADH) + CNADH, (mV)
E1 when the reducing substrate is NADH
η = RP
(
νPa
νPa,n
− 1
)
+ RO
(
νO2
νO2,n
− 1
)
+ Ru
(
1 − νu
νu,n
)
+ RC
(
1 − νCO2
νCO2,n
)
, (dimensionless)
(D.64)
total autoregulatory stimuli
(D.65)f1 = k1CuA,o − k−1CuA,r, (mM s−1)
the rate at which CuA,o is reduced
(D.66)f2 = k2CuA,rcyt a3,o − k−2CuA,ocyt a3,r, (mM s−1)
the rate at which CuA,r is oxidised and cyt a3,o reduced
(D.67)f3 =
k3[O2]cyt a3,r exp
(
−c3
(
∆p − ∆p30
))
1 + exp
(
−c3
(
∆p − ∆p30
)) , (mM s−1)
the rate at which cyt a3,r is oxidised
(D.68)G = KGr4, (mlblood mlbrain−1 mmHg−1 s−1)
resistance of cerebral circulation
(D.69)gp =
[ADP][Pi]
1000[ATP]
, (dimensionless)
(normalised) phophorylation potential (or ADP/ATP ratio)
(D.70)Gt =
GG0Gv
GG0 + GGv + GvG0
, (mlblood mlbrain−1 mmHg−1 s−1)
the total conductance of the cerebral blood vessels
(D.71)h = −r +
√
r2 + 2r0h0 + h02, (cm)
wall thickness of cerebral vessels
(D.72)HbO2 = 1000
Va[HbO2,a] + Vv[HbO2,v]
4
Vblood,n, (µM)
total oxygenated haemoglobin (NIRS)
(D.73)Hbt = 1000
(Va + Vv) [Hbtot]
4
Vblood,n, (µM)
total haemoglobin (NIRS)
(D.74)HHb = 1000
Va[HHba] + Vv[HHbv]
4
Vblood,n, (µM)
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total deoxygenated haemoglobin (NIRS)
(D.75)JO2,min = min
(
DO2
(
[O2,c] − [O2]
)
CBF[HbO2,a]
)
, (mM s−1)
rate at which oxygen is supplied to the mitochondria, minimum of dif-
fusion rate and delivery rate
(D.76)JO2 = JO2,min, (mM s−1)
the rate at which oxygen is supplied to the mitochondria
(D.77)k1 = k1,0 exp
(
−ck1 (∆p − ∆pn)) , (s−1)
forward rate constant for reaction ared
(D.78)k1,0 =
k1,n
Nt
1 + [NAD]/[NADH]
NADHn
, (s−1)
forward rate constant for reaction ared at normal ∆p
(D.79)k2 = k2,n exp
(
−ck2 (∆p − ∆pn)) , (mM−1 s−1)
forward rate constant for reaction aox
(D.80)kATP,CV =
LCVVmit
na
, (mM s−1)
rate of ATP synthesis by Complex V
(D.81)Keq1 = 10(−1/Z)(p1∆p/4−E1), (dimensionless)
equilibrium constant for reaction ared
(D.82)Keq2 = 10(−1/Z)(p2∆p/4−E2), (dimensionless)
equilibrium constant for reaction aox
kMAshut =
CMRO2,n[NADHcyt]
3
(
[NADHcyt]n[NAD]n[H+]n − 1KeqMAshut [NADcyt]nNADHnH
+
m,n
) , (mM−1 s−1)
(D.83)
rate of forward reaction in the malate-aspartate shuttle
(D.84)k−1 =
k1
Keq1
, (s−1)
backward rate constant for reaction ared
(D.85)k−2 =
k2
Keq2
, (mM−1 s−1)
backward rate constant for reaction aox
(D.86)k−MAshut =
kMAshut[NADH]
[NADHcyt]KeqMAshut
, (mM−1 s−1)
rate of backward reaction in the malate-aspartate shuttle
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(D.87)kpl =
2CMRgluc,n − CMRO2,n3 + k
−
pl[lac]n[NADcyt]n
[Py]n[H+]n
[NADHcyt]
[NADHcyt]n
, (mM−1 s−1)
rate of forward reaction in the pyruvate lactate equilibrium
(D.88)kTCA =
vTCA[Py][NAD](
km,tcaN + [NAD]
) (
km,tcaP + [Py]
) , (mM s−1)
rate of the TCA cycle
(D.89)L = LCV + Llk, (mM s−1)
the rate at which protons reenter the mitochondrial matrix
(D.90)LCV =
CVinhLCV,max
(
1 − e−θ
)
1 + rCVe−θ
, (mM s−1)
the rate at which protons reenter the mitochondrial matrix associated
with ADP phosphorylation
(D.91)Llk = kuncLlk0
(
exp
(
∆pklk2
) − 1) , (mM s−1)
the rate at which protons reenter the mitochondrial matrix through leak
channels
(D.92)µ =
µmin + µmaxeη
1 + eη
, (dimensionless)
total autoregulatory stimuli filtered through sigmoidal function
(D.93)[NADH] = Nt − [NAD], (mM)
concentration of NADH in the mitochondria
(D.94)[NADHcyt] = [NADcyt]n + [NADHcyt]n − [NADcyt], (mM)
concentration of NADH in the cytoplasm
(D.95)[NAD]/[NADH] =
[NAD]
[NADH]
, (dimensionless)
NAD/NADH ratio
(D.96)NTP/EPP =
(
1 − d f
)
[ATP]
EPP
, (dimensionless)
the ratio [ATP]/EPP
(D.97)P1 =
Pa2 + Pv
2
, (mmHg)
average blood pressure in vessels
(D.98)Pa2 =
G0Pa + GPv
G + G0
, (mmHg)
the pressure at the start of the cerebral artery compartment
(D.99)PCr/EPP =
(
1 − d f
)
[PCr]
EPP
, (dimensionless)
the ratio [PCr]/EPP
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(D.100)pHm = − log
(
[H+m]
1000
)
, (dimensionless)
mitochondrial pH
(D.101)pHo = − log
 [H+cyt]1000
 , (dimensionless)
extra-mitochondrial pH
(D.102)Pi/EPP =
(
1 − d f
)
[Pi]
EPP
+ d f , (dimensionless)
the ratio [Pi]/EPP
(D.103)Pv =
Gt
Gv
(Pa − Pvs) + Pvs, (mmHg)
venous blood pressure
(D.104)RATPtoADP =
[ATP]
km + [ATP]
, (dimensionless)
Relative rate of reaction ATPtoADP
(D.105)rbuffi,m =
Cbuffi,m
C0i,m
, (dimensionless)
buffering capacity for protons in mitochondria
(D.106)rbuffi,c =
Cbuffi,c
C0i,c
, (dimensionless)
buffering capacity for protons in the cytoplasm
(D.107)RGlucin = Vglucosein, (dimensionless)
Relative rate of reaction Glucin
(D.108)RGlucout =
[gluc]
kglut + [gluc]
, (dimensionless)
Relative rate of reaction Glucout
RGlycolysis
=
[ADP]2[Pi]2[gluc][NADcyt]2(
km,glycA2 + [ADP]2
) (
km,glycP2 + [Pi]2
) (
km,glycG + [gluc]
) (
km,glycN2 + [NADcyt]2
) ,
(dimensionless)
(D.109)
Relative rate of reaction Glycolysis
(D.110)RHi = rbuffi,m, (dimensionless)
relative mitochondrial volume for protons
(D.111)RHi,c = rbuffi,c, (dimensionless)
relative cytoplasmic volume for protons
(D.112)RLacin = Vlacin, (dimensionless)
Relative rate of reaction Lacin
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(D.113)RLacout =
[lac][H+cyt](
kMCT + [lac]
) (
kMCT,H+ + [H+cyt]
) , (dimensionless)
Relative rate of reaction Lacout
(D.114)ScO2 =
SaO2 + SvO2
2
, (dimensionless)
capillary oxygen saturation
(D.115)σe = σe0
exp (Kσ (r − r0)r0
)
− 1
 − σcoll, (mmHg)
elastic stress in vessel walls
(D.116)SvO2 =
[HbO2,v]
[Hbtot]
, (dimensionless)
venous oxygen saturation
(D.117)TAK = kAK[ADP]2 − k−AK[ATP][AMP], (mM s−1)
Rate of reaction AK
(D.118)TADPtoATP = kATP,CV , (mM s
−1)
Rate of reaction ADPtoATP
(D.119)Taox = f2, (mM s−1)
Rate of reaction aox
(D.120)Tared = f1, (mM s−1)
Rate of reaction ared
(D.121)TATPtoADP =
Vmax,ATP[ATP]
km + [ATP]
, (mM s−1)
Rate of reaction ATPtoADP
(D.122)Tbox = f3, (mM s−1)
Rate of reaction box
(D.123)Te = σeh, (mmHg cm)
elastic tension in vessel walls
(D.124)TGlucin = vglutVglucosein, (mM s
−1)
Rate of reaction Glucin
(D.125)TGlucout =
vglut[gluc]
kglut + [gluc]
, (mM s−1)
Rate of reaction Glucout
TGlycolysis
=
vglyc[ADP]2[Pi]2[gluc][NADcyt]2(
km,glycA2 + [ADP]2
) (
km,glycP2 + [Pi]2
) (
km,glycG + [gluc]
) (
km,glycN2 + [NADcyt]2
) ,
(mM s−1)
(D.126)
Rate of reaction Glycolysis
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(D.127)θ = kCV
∆p + Zna log
 gpgp,n
 − ∆pCV0 , (dimensionless)
driving force for Complex V
(D.128)TLacin = vMCTVlacin, (mM s
−1)
Rate of reaction Lacin
(D.129)TLacout =
vMCT[lac][H+cyt](
kMCT + [lac]
) (
kMCT,H+ + [H+cyt]
) , (mM s−1)
Rate of reaction Lacout
(D.130)Tm = Tmax exp
− ∣∣∣∣∣∣ r − rmrt − rm
∣∣∣∣∣∣
nm , (mmHg cm)
muscular tension in vessel walls
(D.131)TMAshuttle = kMAshut[H+cyt][NAD] − k−MAshut[NADcyt][H+m], (mM s−1)
Rate of reaction MAshuttle
(D.132)Tmax = Tmax0
(
1 + kautµ
)
, (mmHg cm)
maximum muscular tension developed by circulation
(D.133)TO2in = JO2, (mM s
−1)
Rate of reaction O2in
(D.134)TOS =
100
[Hbtot]

(
r
rn
)2
[HbO2,a](
r
rn
)2
+
Vv
Va,n
+
Vv
Va,n
[HbO2,v](
r
rn
)2
+
Vv
Va,n
 , (dimensionless)
tissue oxygenation index
(D.135)TCK = kPCr[PCr][ADP][H+cyt] − k−PCr[ATP][Cr], (mM s−1)
Rate of reaction CK
(D.136)Tpsiout = L, (mM s−1)
Rate of reaction psiout
(D.137)TPytoLac = kpl[Py][H+cyt] − k−pl[lac][NADcyt], (mM s−1)
Rate of reaction PytoLac
(D.138)TTCA = kTCA, (mM s−1)
Rate of reaction TCA
(D.139)Vmax,ATP =
(
LCV,nVmit
na
+ 2CMRgluc,n
) (
1 + km,ATP
)
u, (mM s−1)
Vmax of ATP use
(D.140)vglyc =
vglyc,n (I + 1)
1 + I
[ATP]
[ATP]n
[AMP]n
[AMP]
, (mM s−1)
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Vmax for glycolysis
(D.141)Vmca = CBFCBFscale, (cm s−1)
the velocity of blood in the middle cerebral artery
(D.142)Va = Va,n
(
r
rn
)2
, (dimensionless)
arterial blood volume as a fraction of normal total blood volume
(D.143)Vt = Va + Vv, (dimensionless)
normalised total blood volume
(D.144)Vv = Vv,n + Cv
(
Pv − Pv,n
)
, (dimensionless)
venous blood volume as a fraction of total blood volume
(D.145)[HHbv] = [Hbtot] − [HbO2,v], (mM)
concentration of haemoglobin O2 binding sites not occupied by O2 (four
times deoxyhaemoglobin concentration) in the veins
D.6 Parameters
[ADP]n = 0.0120 mM Range: 0.0096 to 0.0144
the normal concentration of ADP in the cytoplasm [294]
CuA,frac,n = 0.67 (dimensionless) Range: 0.00 to 1.00
normal oxidised fraction of CuA
[ATP]n = 1.2 mM Range: 0.1 to 10.0
the normal concentration of ATP in the cytoplasm [295]
Vblood,n = 0.0325 (dimensionless) Range: 0.0260 to 0.0390
normal blood volume as a fraction of brain tissue volume
c3 = 0.110 mV−1 Range: 0.088 to 0.120
parameter controlling the sensitivity of reaction box to ∆p
CBFn = 0.0080 mlblood mlbrain−1 s−1 Range: 0.0064 to 0.0096
normal cerebral blood flow
CBFscale = 5000 cm Not included in sensitivity analysis
ratio between Vmca and CBF
Cbuffi,m = 0.0220 (dimensionless) Range: 0.0176 to 0.0264
buffering capacity for protons in mitochondria
Cbuffi,c = 0.025 (dimensionless) Range: 0.020 to 0.030
buffering capacity for protons in the cytoplasm
∆oxCCOoffset = 0 µM Not included in sensitivity analysis
an arbitrary baseline offset to the ∆oxCCO signal (NIRS)
occfrac = 0.80 (dimensionless) Range: 0.64 to 0.96
fraction of arterial blood which flows through the carotid arteries under
normal conditions
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Cim = 0.00675 mM mV−1 Range: 0.00540 to 0.00810
capacitance of mitochondrial inner membrane
ck1 = 0.010 mV−1 Range: 0.008 to 0.012
parameter constrolling sensitivity of k1 to ∆p
ck2 = 0.020 mV−1 Range: 0.016 to 0.024
parameter constrolling sensitivity of k2 to ∆p
CMRgluc,n = 0.00440 mM s−1 Range: 0.00352 to 0.00528
normal rate of glucose metabolism for the brain [296]
CMRO2,n = 0.020 mM s−1 Range: 0.016 to 0.024
The resting CMRO2
Cv = 0.0470 mmHg−1 Range: 0.0376 to 0.0564
compliance of the veins (normalised)
CVinh = 1.0 (dimensionless) Range: 0.8 to 1.2
a control parameter representing the action of Complex V inhibitors
[CCO]tis = 0.0022 mM Range: 0.0010 to 0.0070
concentration of cytochrome c oxidase in tissue
d = 0 (dimensionless) Not included in sensitivity analysis
a parameter controlling the fraction of cells considered as dead
∆Hbdiffoffset = 0 µM Not included in sensitivity analysis
an arbitrary baseline offset to the ∆Hbdiff signal (NIRS)
∆HbO2,offset = 0 µM Not included in sensitivity analysis
an arbitrary baseline offset to the ∆HbO2 signal (NIRS)
∆HbToffset = 0 µM Not included in sensitivity analysis
an arbitrary baseline offset to the ∆Hbt signal (NIRS)
∆HHboffset = 0 µM Not included in sensitivity analysis
an arbitrary baseline offset to the ∆HHb signal (NIRS)
∆p3,corr = −25 mV Range: -28 to -20
∆p30 minus normal ∆p
dpH = 0.0010 (dimensionless) Range: 0.0008 to 0.0012
a constant in the buffering relationship
∆Ψn = 145 mV Range: 125 to 150
normal mitochondrial inner membrane potential
E0(cyt a3) = 350 mV Range: 280 to 420
cytochrome a3 standard redox potential
E0(CuA) = 247.0 mV Range: 197.6 to 250.0
CuA standard redox potential
E0(NADH) = −320 mV Range: -384 to -256
NADH standard redox potential
F = 96.48 C mmol−1 Not included in sensitivity analysis
Faraday constant
G0,frac = 5 (dimensionless) Range: 4 to 6
ratio between the conductance of the cerebral arteries and the supplying
artery compartment
[glucc] = 5.30 mM Range: 4.24 to 6.36
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concentration of glucose in the blood [237]
[gluc]n = 1.20 mM Range: 0.96 to 1.44
normal cellular concentration of glucose [143]
∆G◦ = −3.05e + 04 J mol−1 Range: -3.07e+04 to -3.03e+04
standard Gibbs free energy of ATP hydrolysis
GVArat,n = 4.0 (dimensionless) Range: 3.2 to 4.8
normal ratio of conductances between arteries and veins Gv/Gn (deter-
mines venous pressure) [142]
h0 = 0.0030 cm Range: 0.0024 to 0.0036
vascular wall thickness when radius is r0
kH,O2 = 0.0014 mM mmHg
−1 Not included in sensitivity analysis
constant setting relationship between oxygen saturation and oxygen
concentration in artery
I = 3 (dimensionless) Range: 0 to 20
the parameter which describes how strongly the AMP/ATP ratio in-
hibits the conversion of glucose to pyruvate
k3,0 = 2.5e + 05 mM−1 s−1 Range: 2.0e+05 to 3.0e+05
an apparent second-order rate constant for reaction box at zero ∆p
kAK = 1055 mM−1 s−1 Range: 844 to 1266
the forward rate constant for the conversion of two molecules of ADP
to one of ATP and one of AMP [144, 180].
kaut = 1 (dimensionless) Range: 0 to 1
control parameter allowing destruction of autoregulation
KeqMAshut = 10 (dimensionless) Range: 8 to 12
equilibrium constant for the malate-aspartate shuttle
kglut = 6.20 mM Range: 4.96 to 7.44
km for the transport of glucose in and out of the cell [241]
kMCT,H+ = 0.0000 mM Range: 0.0000 to 0.0002
km for the transport of a proton coupled with lactate in and out of the
cell
kMCT = 2.0 mM Range: 1.6 to 2.4
km for the transport of lactate in and out of the cell
klk2 = 0.0380 mV−1 Range: 0.0304 to 0.0456
second constant controlling rate of Llk of ∆p
km,ATP = 0.025 (dimensionless) Range: 0.020 to 0.030
km for ATP use as a fraction of normal ATP concentration [144]
km,glycA,f = 0.20 (dimensionless) Range: 0.16 to 0.24
km for ADP in glycolysis as a fration of normal ADP concentration
[180]
km,glycG = 0.05 mM Range: 0.04 to 0.06
km for glucose in the caricature of glycolysis [13]
km,glycN = 0.00 mM Range: 0.18 to 1.00
km for NAD in the caricature of glycolysis
km,glycP,f = 0.20 (dimensionless) Range: 0.16 to 0.24
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km for inorganic phosphate in glycolysis as a fraction of normal phos-
phate concentration [180]
km,tcaN,f = 0.6 (dimensionless) Range: 0.0 to 10.0
km for NAD in the TCA cycle as a fraction of normal NAD concentra-
tion
km,tcaP,f = 0.005 (dimensionless) Range: 0.000 to 10.000
km for pyruvate in the TCA cycle as a fraction of normal pyruvate con-
centration
k−AK = 379.0 mM
−1 s−1 Range: 303.2 to 454.8
the backward rate constant for the conversion of two molecules of ADP
to one of ATP and one of AMP [144, 180].
K∗eq,PCr = 166.0 (dimensionless) Range: 132.8 to 199.2
effective equilibrium constant for the reaction in which phosphocreatine
combines with ADP to give creatine and ATP [297]
t1/2,PCr = 2.0e − 05 s Range: 1.6e-05 to 2.4e-05
halftime for the reaction in which phosphocreatine combines with ADP
to give creatine and ATP
t1/2,pl = 10 mM−1 s−1 Range: 8 to 12
time constant for pyruvate to lactate interconvertion
Kσ = 10 (dimensionless) Range: 8 to 12
parameter controlling sensitivity of σe to radius
kunc = 1.0 (dimensionless) Range: 0.8 to 1.2
a parameter representing the action of uncouplers
[lac]n = 3.0 mM Range: 0.1 to 5.0
normal concentration of lactate in the cytoplasm [298]
[lacc] = 1.0 mM Range: 0.8 to 1.2
capillary lactate concentration [237]
LCV,0 = 0.40 (dimensionless) Range: 0.32 to 0.48
normal Complex V flux as a fraction of maximum possible flux
Llk,frac = 0.25 (dimensionless) Range: 0.20 to 0.30
normal fraction of proton entry into mitochondria which is via leak
channels
µmax = 1 (dimensionless) Not included in sensitivity analysis
maximum value of µ
µmin = −1 (dimensionless) Not included in sensitivity analysis
minimum value of µ
µn = 0 (dimensionless) Not included in sensitivity analysis
normal value of µ
na = 4.33 (dimensionless) Range: 3.80 to 5.00
number of protons passing through Complex V for each ATP synthe-
sised [299]
[NADcyt]n = 359 mM Range: 318 to 400
normal concentration of NAD in the cytoplasm
[NADHcyt]n = 50 mM Range: 32 to 68
239
normal concentration of NADH in the cytoplasm
∆nadir = 0 (dimensionless) Not included in sensitivity analysis
a switch parameter introduced to allow parameter changes at the nadir
of hypoxia-ischaemia
[NAD]n/[NADH]n = 9.0 (dimensionless) Range: 0.1 to 20.0
normal NAD/NADH ratio
Nt = 3.0 mM Range: 2.4 to 3.6
total mitochondrial NAD and NADH concentration
nh = 2.5 (dimensionless) Range: 2.0 to 3.0
Hill coefficient for haemoglobin saturation
nm = 1.830 (dimensionless) Range: 1.464 to 2.196
exponent in the muscular tension relationship
[O2]n = 0.0240 mM Range: 0.0192 to 0.0288
normal oxygen concentration in mitochondria
Pa = 50 mmHg Range: 30 to 80
arterial blood pressure
PaCO2 = 40 mmHg Range: 20 to 60
arterial partial pressure of CO2
PaCO2,n = 40 mmHg Range: 32 to 48
normal arterial partial pressure of CO2
Pa,n = 50 mmHg Range: 45 to 60
normal value of ABP
[PCr]n = 2.6 mM Range: 0.1 to 10.0
normal concentration of phosphocreatine in cell cytoplasm [295]
[PCr]n/[Pi]n = 2.73 (dimensionless) Range: 0.10 to 10.00
normal PCr/Pi concentration in the cytoplasm
φ = 0.0360 mM Range: 0.0288 to 0.0432
value of O2 concentration at half maximal saturation
pHm,n = 7.4 (dimensionless) Range: 7.2 to 7.6
normal mitochondrial pH
pHo,n = 7.0 (dimensionless) Range: 6.8 to 7.2
normal extra-mitochondrial pH
Pic = 4.5 mmHg Range: 3.6 to 5.4
intracranial blood pressure
Pic,n = 4.5 mmHg Range: 3.6 to 5.4
normal intracranial blood pressure
ptot = 18.4 (dimensionless) Range: 18.0 to 20.0
total protons pumped by reactions ared, aox and box
Pvs = 1.5 mmHg Range: 1.2 to 1.8
pressure in the venous sinuses [300]
[Py]n = 0.10 mM Range: 0.08 to 0.12
normal concentration of pyruvate ions in the cytoplasm [301]
r0 = 0.01260 cm Range: 0.01008 to 0.01512
a special radius in the elastic tension relationship
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RC = 2.2 (dimensionless) Range: 0.0 to 10.0
parameter controlling sensitivity of η to PaCO2
RO = 1.5 (dimensionless) Range: 0.0 to 10.0
parameter controlling sensitivity of η to [O2,c]
RP = 4 (dimensionless) Range: 0 to 10
parameter controlling sensitivity of η to Pa
Ru = 0 (dimensionless) Not included in sensitivity analysis
parameter controlling sensitivity of η to u
rCV = 5 (dimensionless) Range: 4 to 6
a parameter controlling the ratio of maximal to minimal rates of oxida-
tive phosphorylation
rm = 0.0270 cm Range: 0.0216 to 0.0324
value of vessel radius giving maximum muscular tension
rn = 0.01870 cm Range: 0.01496 to 0.02244
normal radius of blood vessels
rocc = 0 (dimensionless) Range: 0 to 1
fraction by which the radius of the carotid arteries has been reduced
rt = 0.0180 cm Range: 0.0144 to 0.0216
parameter in the muscular tension relationship
SaO2,n = 0.96 (dimensionless) Range: 0.90 to 1.00
normal saturation of the arterial haemoglobin
SaO2 = 0.96 (dimensionless) Range: 0.50 to 1.00
saturation of the arterial haemoglobin
σcoll = 62.79 mmHg Range: 50.23 to 75.35
value of pressure at which vessels collapse
σe0 = 0.1425 mmHg Range: 0.1140 to 0.1710
parameter in relationship determining σe
τCO2 = 5 s Range: 4 to 6
the time constant associated with νCO2
τO2 = 20 s Range: 16 to 24
the time constant associated with νO2
τPa = 5 s Range: 4 to 6
the time constant associated with νPa
τu = 0.5 s Range: 0.4 to 0.6
the time constant associated with νu
un = 1 (dimensionless) Not included in sensitivity analysis
resting “demand”
VAratn = 3.0 (dimensionless) Range: 2.4 to 3.6
the normal ratio of the volume of the veins to the volume of the arteries
Vmit = 0.0670 (dimensionless) Range: 0.0536 to 0.0804
fraction of brain water which is mitochondria
Vt,n = 1.0 (dimensionless) Range: 0.8 to 1.2
normal total blood volume
[Hbtot]n = 5.4 mM Range: 3.5 to 8.0
241
normal total concentration of haemoglobin O2 binding sites in the ar-
teries and veins (four times haemoglobin concentration)
Z = 59.03 mV Not included in sensitivity analysis
2.303× RT/F where R is the ideal gas constant (8300 mJ K−1 mol−1),
T is the temperature (298 K), F is the Faraday constant (9.65 × 104
C mol−1) and 2.303 arises from 1/log10 e.
D.7 Derived Parameters
(D.146)CuA,o,init = CuA,o,n = 0.022 mM
initial oxidized CuA
(D.147)[AMP]n =
KeqADPATP[ADP]n2
[ATP]n
= 0.000334 mM
normal AMP concentration in cytoplasm
(D.148)CuA,o,n = [CCO]mitCuA,frac,n = 0.022 mM
normal oxidized CuA
(D.149)CuA,r,n = [CCO]mit − CuA,o,n = 0.01084 mM
the resting amount of reduced cytochrome-c-oxidase
(D.150)a3frac,n = 1 − cyt a3,r,n[CCO]mit = 0.9748 (dimensionless)
normal oxidised fraction of cytochrome a3
(D.151)cyt a3,o,n = [CCO]mit − cyt a3,r,n = 0.03201 mM
normal oxidised cytochrome a3
(D.152)cyt a3,r,init = cyt a3,r,n = 0.000828 mM
initial reduced cytochrome a3
(D.153)cyt a3,r,n =
fn
(
1 + exp
(
−c3
(
∆pn − ∆p30
)))
k3[O2]n exp
(
−c3
(
∆pn − ∆p30
)) = 0.000828 mM
normal reduced cytochrome a3
(D.154)CNADH,n =
Z
2
log
(
1
[NAD]n/[NADH]n
)
= −28.16 mV
normal value of CNADH
(D.155)[Cr]n =
K∗eq,PCr[ADP]n[PCr]n
[ATP]n
= 4.316 mM
normal concentration of creatine in cytoplasm
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(D.156)[CCO]mit =
[CCO]tis
Vmit
= 0.03284 mM
concentration of cytochrome c oxidase in mitochondria
(D.157)d f = d∆nadir = 0 (dimensionless)
the fraction of cells which are considered as dead
(D.158)∆G1,n = −4
E1,n + Z log (CuA,o,nCuA,r,n
) + p1∆pn = −474.4 mV
normal free energy associated with reaction ared
(D.159)∆G2,n = −4
E2 + Z log (CuA,r,nCuA,o,n
)
− log
(
cyt a3,r,n
cyt a3,o,n
) + p2∆pn = −39.7 mV
normal free energy associated with reaction aox
(D.160)∆Gn = ∆G◦ + ZF log
(
gp,n
)
= −5.91e + 04 J mol−1
normal Gibbs free energy of ATP hydrolysis
(D.161)DO2 =
JO2,n
[O2,c]n − [O2]n = 0.6796 s
−1
diffusion rate between capillaries and mitochondria
(D.162)∆p30 = ∆pn + ∆p3,corr = 143.6 mV
value of PMF at which reaction box is maximally sensitive to ∆p
(D.163)∆pCV0 =
−∆Gn
naF
= 141.5 mV
a constant in the rate of Complex V
(D.164)∆pHn = pHm,n − pHo,n = 0.4 (dimensionless)
the resting value of pH difference across mitochondrial inner membrane
(D.165)∆pn = ∆Ψn + Z∆pHn = 168.6 mV
the resting value of the proton motive force
(D.166)∆Ψinit = ∆Ψn = 145 mV
initial value of mitochondrial inner membrane potential
(D.167)E1,n = E1,NADH,n = 538.8 mV
the normal value of E1
(D.168)E1,NADH,n = E0(CuA) − E0(NADH) + CNADH,n = 538.8 mV
normal value of E1,NADH
(D.169)E2 = E0(cyt a3) − E0(CuA) = 103 mV
the energy provided by transfer of four electrons from CuA,r to to cyt a3,o
(D.170)EPP = 2[ATP]n + [ADP]n + [PCr]n + [P]n = 5.964 mM
the total exhangeable phosphate pool
(D.171)fn =
CMRO2,n
Vmit
= 0.2985 mM s−1
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normal resting rate of f1 and f2
(D.172)G0 = G0,nr04 = 0.001196 mlblood mlbrain−1 mmHg−1 s−1
conductance of the supplying artery compartment
(D.173)G0,n = G0,fracGn = 0.001196 mlblood mlbrain−1 mmHg−1 s−1
normal conductance of the supplying artery compartment
(D.174)glyca,n =
[ADP]n2
km,glycA2 + [ADP]n2
= 0.9615 (dimensionless)
term in the expression for normal glycolysis rate
(D.175)glycg,n =
[gluc]n
km,glycG + [gluc]n
= 0.96 (dimensionless)
term in the expression for normal glycolysis rate
(D.176)glycp,n =
[P]n2
km,glycP2 + [P]n2
= 0.9615 (dimensionless)
term in the expression for normal glycolysis rate
Gn =
CBFn
Pa,n − Pvs
(
1 +
1
G0,frac
+
1
GVArat,n
)
= 0.0002392 mlblood mlbrain−1 mmHg−1 s−1
(D.177)
normal resistance of cerebral circulation
(D.178)gp,n =
[ADP]n[P]n
1000[ATP]n
= 9.524e − 06 (dimensionless)
normal phosphorylation potential
(D.179)Gt,n =
GnG0,nGv
GnG0,n + GnGv + GvG0,n
= 0.0001649 mlblood mlbrain−1 mmHg−1 s−1
normal value of the total conductance of all blood vessel compartments
(D.180)Gv = GVArat,nGn = 0.0009567 mlblood mlbrain−1 mmHg−1 s−1
conductance of the veins
(D.181)HbO2,n = 1000
Va,n[HbO2,a]n + Vv,n[HbO2,v]n
4
Vblood,n = 26.89 µM
normal total oxygenated haemoglobin (NIRS)
(D.182)Hbtn = 1000
(
Va,n + Vv,n
)
[Hbtot]n
4
Vblood,n = 43.88 µM
normal total haemoglobin (NIRS)
(D.183)HHbn = 1000
Va,n[HHba]n + Vv,n[HHbv]n
4
Vblood,n = 16.99 µM
normal total deoxygenated haemoglobin (NIRS)
(D.184)H+m,init = H
+
m,n = 3.981e − 05 mM
initial hydrogen ion concentration in mitochondria
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(D.185)H+m,n = 10
3−pHm,n = 3.981e − 05 mM
normal hydrogen ion concentration in mitochondria
(D.186)hn = −rn +
√
rn2 + 2r0h0 + h0h0 = 0.00214 cm
normal wall thickness of cerebral vessels
(D.187)[H+]n = 1000 × 10−pHo,n = 0.0001 mM
normal hydrogen ion concentration in the cytoplasm
(D.188)JO2,n = CMRO2,n = 0.02 mM s−1
the resting rate of supply of oxygen to the mitochondria
(D.189)k1,n =
fn
CuA,o,n − 1Keq1,n CuA,r,n
= 13.7 s−1
the value of k1 at normal ∆p and [NADH]
(D.190)k2,n =
fn
CuA,r,ncyt a3,o,n − 1Keq2,n CuA,o,ncyt a3,r,n
= 2681 mM−1 s−1
normal forward rate constant for reaction aox
(D.191)k3 =
k3,0
(
1 + exp
(
−c3
(
0 − ∆p30
)))
exp
(
−c3
(
0 − ∆p30
)) = 2.5e + 05 mM−1 s−1
rate constant for reaction box
(D.192)KeqADPATP =
kAK
k−AK
= 2.784 (dimensionless)
equilibrium constant for the conversion of ADP to ATP and AMP
(D.193)kCV =
−1
∆pn − ∆pCV0 ln
(
1 − LCV,0
1 + rCV LCV,0
)
= 0.05927 mV−1
a parameter controlling the sensitivity of Complex V flux to driving
force
(D.194)Keq1,n = 10(−1/Z)(p1∆pn/4−E1,n) = 50.31 (dimensionless)
normal equilibrium constant for reaction ared
(D.195)Keq2,n = 10(−1/Z)(p2∆pn/4−E2) = 0.07735 (dimensionless)
normal equilibrium constant for reaction aox
(D.196)KG =
Gn
rn4
= 1956 mlblood mlbrain−1 mmHg−1 s−1 cm−4
constant of proportionality relating pressure drop to flow
(D.197)km = [ATP]nkm,ATP = 0.03 mM
km for ATP use
(D.198)km,glycA = km,glycA,f[ADP]n = 0.0024 mM
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km for ADP in the caricature of glycolysis
(D.199)km,glycP = km,glycP,f[P]n = 0.1905 mM
km for inorganic phosphate in the caricature of glycolysis
(D.200)km,tcaN = km,tcaN,f[NAD]n = 1.62 mM
km for NAD in the TCA cycle
(D.201)km,tcaP = km,tcaP,f[Py]n = 0.0005 mM
km for pyruvate in the TCA cycle
(D.202)k−PCr =
ln (2)(
Keq,PCr[PCr]n[ADP]n + [Cr]n + [ATP]n
)
t1/2,PCr
= 0.6691 mM−1 s−1
the backward rate of reaction for the reaction in which phosphocreatine
combines with ADP to give creatine and ATP
(D.203)k−pl = t1/2,pl = 10 mM
−1 s−1
rate of backwards reaction in the pyruvate lactate equilibrium
(D.204)kPCr =
ln (2)[PCr]n[ADP]n + [Cr]n + [ATP]nKeq,PCr
 t1/2,PCr = 1.111e + 06 mM
−2 s−1
the forward rate of reaction for the reaction in which phosphocreatine
combines with ADP to give creatine and ATP
(D.205)Keq,PCr =
K∗eq,PCr
[H+]n
= 1.66e + 06 mM−1
equilibrium of the reaction in which phosphocreatine combines with
ADP to give creatine and ATP
(D.206)kTCAn =
1
3
CMRO2,n
Vmit
= 0.0995 mM s−1
normal rate of the TCA cycle
(D.207)LCV,frac = 1 − Llk,frac = 0.75 (dimensionless)
normal fraction of proton entry into mitochondria associated with ADP
phosphorylation
(D.208)LCV,max =
LCV,n
LCV,0
= 10.3 mM s−1
the maximum rate of proton flow through Complex V
(D.209)LCV,n = LnLCV,frac = 4.119 mM s−1
the resting flow of protons into the matrix through Complex V
(D.210)Llk0 =
Llk,n
exp
(
∆pnklk2
) − 1 = 0.002269 mM s−1
first constant controlling rate of Llk of ∆p
(D.211)Llk,n = LnLlk,frac = 1.373 mM s−1
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the resting flow of protons into the matrix via leak channels
(D.212)Ln = ptot fn = 5.492 mM s−1
the total flow of protons back into mitochondria
(D.213)NADHn = Nt − [NAD]n = 0.3 mM
normal concentration of NADH in the mitochondria
(D.214)[NAD]n =
Nt
1 +
1
[NAD]n/[NADH]n
= 2.7 mM
normal concentration of NAD in the mitochondria
(D.215)[O2,a] = φ
(
SaO2
1 − SaO2
)1/nh
= 0.1283 mM
arterial dissolved oxygen concentration
(D.216)[O2,c]init = [O2,c]n = 0.05343 mM
initial concentration of dissolved oxygen in the capillary
(D.217)[O2,c]n = φ
(
ScO2,n
1 − ScO2,n
)1/nh
= 0.05343 mM
normal concentration of dissolved oxygen in the capillary
(D.218)[O2]init = [O2]n = 0.024 mM
initial oxygen concentration in mitochondria
(D.219)p1 = ptot − p23 = 10.4 (dimensionless)
the number of protons pumped by reaction ared
(D.220)P1,n =
Pa2,n + Pv,n
2
= 26.59 mmHg
normal average blood pressure in vessels
(D.221)p2 = 4 × 1 = 4 (dimensionless)
total protons pumped by reaction aox
(D.222)p23 = 4 × 2 = 8 (dimensionless)
total protons pumped by reactions aox and box
(D.223)p3 = p23 − p2 = 4 (dimensionless)
total protons pumped by reaction box
(D.224)Pa2,n =
G0,nPa,n + GnPv,n
Gn + G0,n
= 43.31 mmHg
normal arterial blood pressure at the start of the cerebral arteries
(D.225)PaO2 =
[O2,a]
kH,O2
= 91.68 mmHg
partial pressure of oxygen in the arteries
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(D.226)[P]n =
[PCr]n
[PCr]n/[Pi]n
= 0.9524 mM
the normal concentration of inorganic phosphate in the cytoplasm
(D.227)Pv,n =
Gt,n
Gv
(
Pa,n − Pvs
)
+ Pvs = 9.862 mmHg
normal venous blood pressure
(D.228)r0 = 1 − rfracrocc = 1 (dimensionless)
radius of the supplying artery compartment
(D.229)rfrac = 1 − (1 − occfrac)1/4 = 0.3313 (dimensionless)
fraction by which the radius of the supplying artery compartment is
reduced if the carotid arteries are fully occluded
(D.230)ScO2,n =
SaO2,n + SvO2n
2
= 0.7285 (dimensionless)
normal capillary oxygen saturation
(D.231)σe,n = σe0
exp (Kσ (rn − r0)r0
)
− 1
 − σcoll = −44.89 mmHg
normal elastic stress in vessel walls
(D.232)SvO2n =
[HbO2,v]n
[Hbtot]n
= 0.497 (dimensionless)
normal venous oxygen saturation
(D.233)Te,n = σe,nhn = −0.09604 mmHg cm
normal elastic tension in vessel walls
(D.234)Tmax0 =
Tmax,n
1 + kautµn
= 1.206 mmHg cm
Tmax at normal µ
(D.235)Tmax,n =
Tm,n
exp
− ∣∣∣∣∣∣rn − rmrt − rm
∣∣∣∣∣∣
nm = 1.206 mmHg cm
normal maximum muscular tension developed by circulation
(D.236)Tm,n =
(
P1,n − Pic,n
)
rn − Te,n = 0.5091 mmHg cm
normal muscular tension in vessel walls
(D.237)u = un = 1 (dimensionless)
the representation of “demand” in the model
(D.238)νCO2,n = PaCO2,n = 40 mmHg
normal value of νCO2 (PaCO2 passed through a first order filter)
(D.239)Vglucosein =
[glucc]
kglut + [glucc]
= 0.4609 (dimensionless)
rate term for glucose transported into the cell; this is a michaelis menten
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term, but fixed because blood glucose concentration is fixed
(D.240)vglut =
CMRgluc,n
Vglucosein − [gluc]n[gluc]n + kglut
= 0.01473 mM s−1
Vmax for glucose transport both in and out of the cell from the capillary
(D.241)Vlacin =
[lacc][H+]n(
kMCT + [lacc]
) (
[H+]n + kMCT,H+
) = 0.3333 (dimensionless)
rate of lactate transport into the cell
(D.242)vMCT =
vMCT,val if vMCT,val > 0NaN otherwise = 0.008 mM s−1
rate constant for lactate transport
(D.243)vMCT,val =
2CMRgluc,n − CMRO2,n3
[lac]n[H+]n(
[lac]n + kMCT
) (
[H+]n + kMCT,H+
) − Vlacin = 0.008 mM s
−1
Calculated value for vMCT. If this is not greater than zero, parameter set
is invalid.
(D.244)vglyc,n =
CMRgluc,n
glycg,nglycp,nglyca,n
= 0.004957 mM s−1
normal Vmax for glycolysis which is assumed to be modified by the
ratio of AMP to ATP
(D.245)Va,n =
Vt,n
1 + VAratn
= 0.25 (dimensionless)
normal arterial blood volume as a fraction of total blood volume
(D.246)Vv,n = Vt,n
VAratn
1 + VAratn
= 0.75 (dimensionless)
normal venous volume
(D.247)νO2,n = [O2,c]n = 0.05343 mM
normal value of νO2 ([O2,c] passed through a first order filter)
(D.248)νPa,n = Pa2,n = 43.31 mmHg
normal value of νPa (Pa2 passed through a first order filter)
(D.249)vTCA =
kTCAn
[Py]n[NAD]n
(
km,tcaN + [NAD]n
) (
km,tcaP + [Py]n
)
= 0.16 mM s−1
Vmax for the TCA cycle
(D.250)νu,n = un = 1 (dimensionless)
normal value of νu (u passed through a first order filter)
(D.251)[HHba] = [Hbtot] (1 − SaO2) = 0.216 mM
concentration of haemoglobin O2 binding sites not occupied by O2 (four
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times deoxyhaemoglobin concentration) in the arteries
(D.252)[HHba]n = [Hbtot]n
(
1 − SaO2,n
)
= 0.216 mM
normal concentration of haemoglobin O2 binding sites not occupied by
O2 (four times deoxyhaemoglobin concentration) in the arteries
(D.253)[HbO2,a] = [Hbtot]SaO2 = 5.184 mM
concentration of O2 bound to arterial haemoglobin (four times oxy-
haemoglobin concentration)
(D.254)[HbO2,a]n = [Hbtot]nSaO2,n = 5.184 mM
normal concentration of O2 bound to arterial haemoglobin (four times
oxyhaemoglobin concentration)
(D.255)[HbO2,v]init = [HbO2,v]n = 2.684 mM
initial concentration of O2 bound to venous haemoglobin (four times
oxyhaemoglobin concentration)
(D.256)[HbO2,v]n =
CBFn[HbO2,a]n − JO2,n
CBFn
= 2.684 mM
normal concentration of O2 bound to venous haemoglobin (four times
oxyhaemoglobin concentration)
(D.257)[Hbtot] = [Hbtot]n = 5.4 mM
total concentration of haemoglobin O2 binding sites in the arteries and
veins (four times haemoglobin concentration)
(D.258)[HHbv]n = [Hbtot]n − [HbO2,v]n = 2.716 mM
normal concentration of haemoglobin O2 binding sites not occupied by
O2 (four times deoxyhaemoglobin concentration) in the veins
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